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Abstract 
Mitotic homologous recombination (HR) stabilises the genome by repairing harmful 
double stranded DNA (dsDNA) breaks.  Rad52 promotes the annealing of complementary 
DNA strands and binds to Rad51 suggesting that Rad52 acts in both strand invasion (SI) 
and single strand annealing (SSA) HR pathways. Overexpression of Rad52 in mammalian 
cells can greatly stimulate HR, but the degree of stimulation varies widely between 
studies and inhibitory effects have also been described. The in vivo roles for Rad52 in 
mammalian cells are thus poorly understood as is the potential of using Rad52 as a tool to 
promote genome engineering methods [i.e. gene targeting (GT)].  
 
Here I have systematically compared the effects of overexpressing wild-type (wt) and 
mutant Rad52 proteins on cell viability and various HR assays in human cells.  Mutants 
were designed to test the potential involvement of defined domains/residues in any such 
effects.  Human Rad52 (hRad52) and its derivatives negatively affected cell viability and 
proliferation which correlated with the presence of C-terminal residues 331-418, rather 
than, as expected, the Rad51 binding domain which limited inhibitory effects.  Negative 
effects with yeast Rad52 (scRad52) were not observed. Consistent with previous findings, 
hRad52 inhibited GT, however, this was converted to a stimulatory effect when residues 
331-418 were removed.  When single stranded oligonucleotide (ssO) templates were 
used for GT, both hRad52 and its derivatives were stimulatory.  These results are 
consistent with SI and SSA models for dsDNA- and ssO-mediated GT, respectively, and 
suggest that residues 331-418 cause a dominant-negative effect on SI and their removal 
promotes the strand annealing activity of the N-terminal domain.  ScRad52 stimulated 
and inhibited GT with ds and ss templates, respectively. Altogether, these results provide 
the first evidence that truncated forms of hRad52 may serve as useful tools for promoting 
GT using both ds and ss DNA templates in human cells.  
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Chapter 1 Introduction 
The ability to make locus-specific changes to the cellular genome is an invaluable tool for 
performing research and utilising gene correction for gene therapy.  Gene targeting (GT) 
is an attractive method to make these locus-specific changes and is achieved through 
homologous recombination (HR).  Thus, in order to utilise this process efficiently, there is 
a need to understand the underlying mechanisms and components of HR.  This thesis 
focuses on characterising the role of one such HR component, the single strand annealing 
protein Rad52, and its potential as a tool for stimulating GT.  As an initial overview, the 
DNA repair pathways will be discussed with an emphasis on the DNA double strand break 
(DSB) response and the HR pathway.  This will be followed by a review of the role of the 
Rad52 protein (Section 1.6) which will examine its structure and function and highlight 
the differences between the yeast and human proteins and include previous attempts to 
overexpress Rad52 as a means of stimulating HR and GT (Section 1.9).  The approaches 
and limitations of techniques used for previous study of Rad52 will be discussed and I will 
propose the use of Rad52 overexpression as an effective technique for conducting a 
systematic study of the protein.       
1.1 An Overview of Mammalian DNA Repair Pathways 
Cellular DNA can acquire various types of lesions arising from exposure to internal and 
external sources such as reactive oxygen species, UV light or DNA replication stress.  For 
example, up to 10 000 purine lesions can occur per day (Lindahl, 1993).  It is therefore 
imperative that the cell respond to and repair such DNA damage faithfully or risk 
accumulating mutations, passing these mutations onto progeny and ultimately generating 
chromosomal aberrations, genome rearrangements, tumourigenesis and cell death.  
Fortunately, the cell has developed numerous strategies which can recognise and repair 
specific types of damaged DNA structures.  These strategies include mismatch repair 
(MMR), base excision repair (BER) and the related single strand break repair (SSBR), 
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nucleotide excision repair (NER) and the DSB repair pathways non-homologous end 
joining (NHEJ), microhomology-mediated end joining (MMEJ) and HR.   
1.1.1 Mismatch Repair 
During DNA processing reactions, the polymerase may incorrectly pair uncomplimentary 
nucleotides or insert or delete nucleotides resulting in base pair mismatches.  The 
distortion in the double helix is recognised early by the heterodimers Msh2/Msh6 
(MutSα) or Msh2/Msh3 (MutSβ) which can both repair insertions/deletions containing 2-
10 nucleotides (nt) although MutSα is more efficient in the repair of single base and 2-10 
base mismatches (Figure 1.1a) (Modrich, 2006).  A third heterodimer, Mlh1/Pms2 
(MutLα), interacts with the MutSα and MutSβ repair complexes and increases the 
efficiency of mismatch recognition (Lieber, 2008).  Coordinated nicks made close to the 
mismatch stimulate exonucleolytic resection of the DNA past the mismatch.  The single 
stranded DNA (ssDNA) binding protein, Replication protein A (RPA), stabilises the newly 
generated ssDNA until DNA resynthesis is completed by the DNA polymerase δ (pol δ), a 
replication and repair DNA polymerase (Lieber, 2008). 
1.1.2 Base Excision Repair and Single Strand Break Repair 
Unlike MMR where the bases are undamaged, BER is the cell’s response to the oxidative, 
alkylation or deamination damage of bases.  Similarly, these sources of DNA damage can 
also cause SSBs and additionally modify the bases surrounding the break site (e.g. loss of 
a hydrogen atom) (Dianov, 2007).  The first step in BER involves recognition of the 
damaged base and cleavage of the N-glycosidic bond by one of 11 known DNA 
glycosylases (Figure 1.1b).  A few DNA glycosylases possess an accessory ability to cleave 
the DNA backbone and these are termed AP lyases.  Liberating the damaged base leaves 
an apurinic or apyrimidinic (AP) site which is recognised by an AP endonuclease or 
appropriate AP lyase.  The AP endonuclease or lyase makes an incision 5’ to the AP site 
leaving a 3’ hydroxyl group to prime DNA synthesis of a new base by the low processive  
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(a)                     (c)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 (b) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1. DNA damage repair pathways. (a) MMR i) The distortion in the helix resulting from 
the pairing of uncomplementary nucleotides is recognised and bound by MutSα (or MutSβ) and 
MutLα. The MutSα-MutLα complex coordinates the generation of a nick in one DNA strand and ii) 
Exo1 mediates 5’ to 3’ resection at the nick to generate ssDNA. iii) RPA coats and stabilises the 
ssDNA until a DNA polymerase resynthesises new DNA. (Modrich, 2006) (b) BER i) Cytosine is 
deaminated into uracil. ii) The damaged base is recognised and removed by a DNA glycosylase 
leaving an AP site. iii) The DNA backbone is cleaved 5’ of the damage which iv) primes DNA 
synthesis for pol β. v) Ligation of the strands completes repair. (Robertson, 2009). (c) NER i-iii) A 
DNA lesion is bound by XPC, HR23B and TFIIH. iv) Formation of the complex stimulates the 
helicase activity of TFIIH to unwind and open the DNA. v) RPA, XPA and XPG are recruited to the 
site to form the pre-incision complex. vi) The ERCC1-XPF and XPG endonucleases make incisions 5’ 
and 3’ of the lesion, respectively, to remove the damaged area. vii) RPA stabilises the ssDNA, pol δ 
fills in the gap and ligase I completes repair by ligating the strands. (Gillet, 2006) 
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DNA polymerase, pol β.  Following synthesis, pol β can also remove the 5’ 
deoxyribophosphatase remaining from the AP site to permit ligation of the strands by 
DNA ligase III (Robertson, 2009).  SSBs whose ends have not been damaged can be 
directly religated by DNA ligase III.   
1.1.3 Nucleotide Excision Repair 
NER is characterised by its ability to repair numerous different lesions.  Both pyrimidine 
dimers and other phosphoproducts arising from UV damage are substrates for NER.  In 
addition, damage caused by chemical agents, such as intrastrand crosslinks and base 
modifications, are also recognised by the NER machinery (Gillet, 2006).  In contrast to BER 
and MMR which address repair of base pair mismatches and insertions/deletions, NER 
does not recognise a specific lesion structure but rather the level of helical distortion 
where higher helical distortions correspond with higher rates of repair (Gunz, 1996).  XPC 
is first recruited to the damage and quickly forms a complex with HR23A or HR23B 
(homologues of S. Cerevisiae Rad23) which stabilises the damaged region (Figure 1.1c).  
The TFIIH complex, usually associated with RNA polymerase II during transcription, 
unwinds and opens the DNA allowing formation of the ‘pre-incision complex’ which 
consists of RPA, XPA and the endonuclease XPG.  Through interaction with XPA, the 
endonuclease ERCC1-XPF is recruited to the site and in coordination with XPG, makes 5’ 
and 3’ incisions on either side of the damaged area.  Resynthesis by pol δ in the presence 
of stabilising factors RFC and PCNA fills in the gap and repair is completed by ligation of 
the strands by ligase I (Gillet, 2006).      
1.1.4 Nonhomologous End Joining 
The NHEJ repair pathway is activated upon the introduction of a DSB.  It is a non-
templated repair mechanism where genetic information is often lost at the site of the DSB 
(Figure 1.2a).  Despite the potential mutagenic consequences, NHEJ restores the 
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phosphodiester backbone and structural integrity of the helix and chromosome.  In the 
presence of a DSB, recognition is initiated by the MRN complex (Mre11-Rad50-Nbs1)  
 (a)       (b)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.2. DSB repair end joining pathways. (a) NHEJ. i-iii) A DSB is recognised by the MRN 
complex (not shown) which tethers the two DNA ends together. The Ku70/80 heterodimer slides 
over the DNA ends and recruits DNA-PKcs to the site. iv) The ends may be minimally processed to 
remove damaged nucleotides, overhangs or open hairpin structures. v-vi) The ends are ligated 
together to complete repair. (Helleday, 2007) (b) MMEJ. i-ii) Following a DSB, the ends are 
tethered by the MRN complex. CtIP mediates minimal end resection revealing short sequences of 
homology. iii-iv) Repair may occur through the annealing of the microhomologies, removal of the 
nonhomologous flaps and ligation of the strands. v-vi) Alternatively, annealing of the 
microhomologies may prime de novo DNA synthesis. vii-viii) Dissociation and reannealing with the 
newly generated microhomologies may prime a second round of DNA synthesis followed by 
removal of the flaps and ligation of the strands. (McVey, 2008)   
  
Chapter 1    Introduction 
 
24 
 
which responds by activating a signalling cascade (Section 1.2).  The MRN complex also 
functions to tether the DNA ends to keep them in close proximity for repair.  The Ku70/80 
heterodimer slides over the DNA ends and acts as a scaffold to recruit repair proteins and 
stabilise the helix to facilitate end-processing and ligation (Lieber, 2006; Walker, 2001).  
Interaction of Ku70/80 with the DNA ends recruits DNA protein kinase catalytic subunit 
(DNA-PKcs)(Chen, 2007) and upon Ku70/80 translocation along the DNA, away from the 
end, DNA-PKcs gains access to the ends.  This stimulates DNA-PKcs autophosphorylation 
and phosphorylation of the nuclease Artemis (Ma, 2002; Uematsu, 2007).  These 
phosphorylation events stimulate binding of DNA-PKcs to Artemis which decreases the 
affinity of DNA-PKcs for DNA and activates the nuclease activity of Artemis enabling 
cleavage of 5’ and 3’ overhangs or open hairpin structures.  Cleavage can also serve to 
remove damaged bases.  ssDNA generated as a result of the initial DNA damage or 
minimal processing by Artemis-DNA-PKcs can be used as a template for end filling by the 
polymerases pol λ or pol μ.  Both low fidelity polymerases can exhibit template slippage 
generating mutations (Foley, 2010).  Ligation of the ends and completion of repair is 
performed by ligase IV and enhanced by protein-protein interactions with XRCC4.  Ligase 
IV is a multifaceted ligase and can ligate a number of DNA structures including overhangs 
and blunt ends or strands which are incompatible or separated by 1nt gaps (Grawunder, 
1997; Gu, 2007).  This suggests that maintaining chromosomal integrity and avoiding 
chromosomal rearrangements, fusions and loss are more important than sequence 
fidelity. 
1.1.5 Microhomology-Mediated End Joining 
The MMEJ pathway (also referred to in the literature as Alternative-NHEJ) is less well 
defined than NHEJ and was first identified as a Ku-independent pathway involving repair 
of DSBs by end joining (Figure 1.2b) (Liang, 1996; Ma, 2003). There is evidence that 
suggests this pathway is also independent of the NHEJ repair proteins XRCC4 and ligase IV 
(Guirouilh-Barbat, 2007; Yan, 2007).  The major end joining pathway utilised in cells 
remains under debate.  Controversy exists concerning the extent that cells utilise NHEJ 
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over MMEJ, and vice versa, and may result from discrepancies with the types of repair 
products being associated with each pathway (Bennardo, 2008; Yu, 2010; Yun, 2009).  It 
has been proposed that MMEJ involves 5’ to 3’ resection of the DNA ends exposing 
microhomologies 2 to 10nt in length (Haber, 2008).  The complementary sequences are 
annealed and sequences between the microhomologies are deleted (Decottignies, 2007; 
Yu, 2010; Yun, 2009).  A recent report suggested that resected 3’ strands can also prime 
de novo synthesis to generate microhomologies (Yu, 2010).  This process is similar to the 
single strand annealing (SSA) HR pathway (Section 1.5.3) which involves Rad52.  
Interestingly, Rad52 was implicated in MMEJ in one study (Decottignies, 2007).  Although 
the proteins and mechanisms involved in MMEJ continue to be investigated, disruption of 
the protein CtIP, believed to be required for end resection, and polQ (pol θ in humans), a 
low processive polymerase, have identified these proteins as potential candidates 
involved in the 5’ to 3’ resection and de novo synthesis steps, respectively (Bennardo, 
2008; Yu, 2010; Yun, 2009).   
1.1.6 Homologous Recombination 
A description of the types of HR pathways will be provided in section 1.5 but will be 
described here briefly.  Like NHEJ and MMEJ, HR is a repair pathway utilised for the repair 
of DSBs.  However, unlike NHEJ and MMEJ, HR can be a more faithful and error-free 
mechanism of repair as it utilises the homology of a sister chromatid as a repair template.  
HR is thus limited to late S/G2 phase when sister chromatids have been generated.  
Following a DSB, DNA ends are resected in the 5’ to 3’ direction to generate long 3’ ssDNA 
ends.  RPA coats and stabilises the ssDNA and from here, the pathways can diverge into 
Rad51-dependent and Rad51-independent pathways (Figure 1.8).  Rad51-dependent 
pathways involve Brca2- (and to a lesser extent Rad52) mediated displacement of RPA 
and nucleation of Rad51 onto the ssDNA (Figure 1.3).  Rad51 is central to HR, however, 
Rad51 cannot bind to ssDNA coated with RPA.  Thus, the recombination mediator of 
Brca2 (or Rad52) is essential to ensure the nucleation of Rad51 onto ssDNA.  Rad51 is 
required for the formation of the presynaptic complex which is responsible for homology  
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(b) 
 
 
 
 
 
 
 
 
 
 
Figure 1.3. Recombination mediator activity of Brca2 and Rad52. Following end resection and 
the generation of long regions of ssDNA, RPA binds to and protects the newly generated ssDNA 
while also removing inhibitory secondary structure. (a) i) Brca2 binds to six monomers of Rad51 
(only two are shown) within its central region in addition to oligomeric Rad51 within its C-terminal 
region. ii-iii) Brca2 interacts with and removes RPA, allowing nucleation of Rad51 onto the ssDNA. 
iv) The Rad51-ssDNA filament can perform a homology search and SI of a homologous duplex of 
DNA. (b) i-iv) Similar to Brca2, Rad52 interacts with RPA to displace it and allow Rad51 to nucleate 
onto the ssDNA.  Only the left side of the DSB is shown for simplicity. (San Filippo, 2008)  
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search and strand invasion (SI) of the sister chromatid.  The 3’ end of the invading strand 
primes DNA synthesis and is elongated.  The same can occur with the opposite strand 
using the displaced strand of the homologous duplex.  Resolution and ligation of the 
strands completes repair.  The Rad51-independent pathway involves annealing of 
complementary regions between the resected ssDNA.  SI of the sister chromatid does not 
occur.  The Rad52 protein mediates the displacement of RPA and the annealing of the two 
strands.  This is followed by gap filling and ligation of the strands.  This process can occur 
between direct repeats and results in the loss of sequences between the complementary 
regions.     
1.2 The Double Strand Break Response 
DSBs are the most lethal of the aforementioned classes of DNA damage.  Whereas repair 
by MMR, BER and NER utilise the complementary strand as a template, DSBs affect both 
strands leaving no template for repair.  In addition, both replication and transcription can 
be completely blocked if a DSB is left unrepaired and a single DSB can be lethal to a cell 
(Frankenberg-Schwager, 1985).  NHEJ, HR and MMEJ manage the repair of DSBs.  
However, activation of these repair pathways involves the participation and tightly 
regulated coordination of a vast number of proteins and their corresponding networks.  
This section will provide an overview of the initial steps of the DSB response prior to 
repair, beginning with DSB recognition, signal transduction and amplification. 
1.2.1 Double Strand Break Recognition 
Recognition of the DSB is the first and arguably most vital step in initiating DSB repair.  
Upon introduction of a DSB, the trimeric complex MRN (Mre11-Rad50-Nbs1 in humans, 
Mre11-Rad50-Xrs2 in yeast) quickly responds by tethering the DNA strands, initiating 
unwinding of the DNA, activating the protein kinases ATM (ataxia telangiectasia mutated) 
(Lee, 2005) and ATR (ATM-Rad3-related, Mec1 in yeast) (Stiff, 2005) and behaving as a 
scaffold protein to facilitate chromatin remodelling and recruitment of other effector 
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proteins.  The Rad50 protein forms a flexible coiled-coil where its globular head possesses 
ATPase and DNA binding activity (Figure 1.4) (Chen, 2005; de Jager, 2002).  Mre11 binds 
to the base of the globular head of Rad50 and is the mediator between Rad50 and Nbs1 
(Hopfner, 2001).  In addition, the complex Mre11-Rad50 possesses partial unwinding 
abilities which are further stimulated by Nbs1 (Paull, 1999).  Mre11 forms a homodimer 
which is required for its 3’ to 5’ exonuclease and ssDNA endonuclease activity as well as 
its ability to bind and bridge DNA ends (Williams, 2008).  Unlike Mre11 and Rad50, Nbs1 
does not possess enzymatic activity and rather functions as a regulator protein.  
Mutations in NBS1 result in development of Nijmegen breakage syndrome and cancer 
predisposition.  In addition to its potentiation of Mre11-Rad50 functions, Nbs1 is 
responsible for nuclear localisation of Mre11 and Rad50 and for activation of ATM and 
ATR (Cerosaletti, 2000; Lee, 2005; Stiff, 2005).   
 
Activated ATM, DNA-PK and ATR quickly phosphorylate H2AX histones (γ-H2AX) 
surrounding the break to further potentiate recruitment and retention of other signalling 
proteins (Karmakar, 2006; Stiff, 2004; Stiff, 2005).  H2AX are members of the H2A histone 
family which are important for the structure of nucleosomes.  Recent evidence suggests 
γ-H2AX may influence the choice of repair pathway in accordance with the phase of the 
cell cycle (Helmink, 2011).  Furthermore, ATM and ATR play an essential role in signal 
transduction through phosphorylation and recruitment of a vast number of substrates to 
the site of damage, activating a signalling cascade.  Substrates include p53, 53BP1, MDC1, 
RPA, Nbs1 and Chk1 (Cann, 2007).  Although overlaps exist between the phosphorylation 
substrates of ATM and ATR, specific types of DSB response pathways are dependent on 
activation of only one of ATM or ATR while others require activation of both kinases.  
These pathways will be discussed further in the following section.   
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Figure 1.4. Structure of the MRN complex. Rad50 (brown and green) and Mre11 (light and dark 
blue) form a heterotetramer. Two Rad50 monomers align in an antiparallel fashion (N-terminus – 
green, C-terminus – brown) and form a coiled-coil. The Rad50 dimer tethers the DNA ends to keep 
them in close proximity. The Mre11 homodimer (monomer 1 – dark blue, monomer 2 – light blue) 
possesses 3’ to 5’ exonuclease activity and ssDNA endonuclease activity.  The Nbs1 protein (not 
shown) interacts with the complex through Mre11. (Hopfner, 2001) 
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1.2.2 Regulation of the DSB Response Pathways 
Once the presence of a DSB has been recognised, activation of ATM and ATR are essential 
for carrying out the repair process through recruitment of DNA damage proteins and 
checkpoint activation (Figure 1.5).  The cellular response to DSBs arising from sources 
such as ionising radiation (IR) is ATM-dependent and results in downstream activation of 
the kinase Chk2 (Cuadrado, 2006).  In contrast, ATR-dependent signalling is stimulated by 
the presence of ssDNA resulting from the generation of DSBs arising from processing UV 
damage, or stalled replication forks (Helt, 2005; Stiff, 2005).  The Chk1 kinase is 
phosphorylated downstream of ATR activation (Cuadrado, 2006).  However, there is 
evidence for an overlap between the two directed pathways.  ATR and Chk1 are required 
for the activation of the G2/M checkpoint in response to IR (Liu, 2000) and there is 
evidence that upon exposure to IR in late S and G2, ATM recruits ATR to chromatin 
resulting in downstream activation of Chk1 (Cuadrado, 2006; Helt, 2005).  Once activated, 
Chk1 and Chk2 mediate phosphorylation of Cdc25 isoforms which inhibit the cyclin 
dependent kinases (e.g. Cdk1, Cdk2, Cdk4, Cdk6) required for progression through the cell 
cycle (Bartek, 2003; Xiao, 2003).  Following activation of these upstream effector proteins, 
appropriate repair of the DSB can be selected and performed. 
1.3 DSB Repair Pathways 
The DSB repair pathways are distinct and limited to certain phases of the cell cycle (Figure 
1.6).  NHEJ and the Ku-independent MMEJ function in G1, S and G2 phases of the cell 
cycle though predominate in G1 when there is an absence of a sister chromatid to utilise 
as a repair template (Rothkamm, 2003; You, 2010).  However, following replication HR 
can also be used as a repair pathway in late S/G2 (Rothkamm, 2003).  This section will 
explore the factors influencing the choice of repair pathway and detail the mechanisms of 
each pathway. 
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Figure 1.5. Regulation of the DSB damage response. The generation of a DSB activates the MRN complex which in turn, activates the protein kinases ATR 
and ATM to initiate a signalling cascade. Activation of the G1/S phase and intra-S phase checkpoints involves inhibition of the downstream target Cdk2 and 
results in the arrest of cell cycle progression.  Entry into M phase is prevented by activation of the G2/M checkpoint which involves inhibition of Cdk1 (Cann, 
2007).   
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Figure 1.6. Cell cycle regulated choice over the DSB repair pathways. CtIP regulates the choice of 
DSB repair pathway by regulating the degree of end resection. When no CtIP-mediated end 
resection occurs NHEJ predominates. This can occur in G1, S and G2. Upon interaction with the 
MRN complex, CtIP promotes limited end resection and the MMEJ pathway which can also occur 
during G1, S and G2.  The proteins Brca1, CDK, MRN and ATM are required in addition to CtIP to 
promote long end resection and initiate HR in late S and G2. (You, 2010)    
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1.3.1 Choosing the DSB Repair Pathway 
Exposure to the various types of DSB causing sources can result in different kinds of DSB 
damage which can require further processing.  Endonucleolytic cleavage by the site-
specific enzymes HO or I-SceI generates ‘clean’ ends with ligatable 5’-P and 3’-OH groups.  
However, damage from IR, UV or chemical agents can generate adducts in the bases 
surrounding the DSB which must be removed in order for repair to proceed.  There is 
evidence in yeast that the Mre11 subunit of MRN is the candidate which initiates repair 
processing through its ssDNA endonuclease activity (Llorente, 2004; Lobachev, 2002; 
Westmoreland, 2009).  Indeed, nuclease deficient murine Mre11 exhibited increased 
sensitivity to IR and the chemical agent aphidicolin that mirrored the Mre11-/- null 
mutation (Buis, 2008).  Following cleavage, the Ku70/80 heterodimer can associate with 
DNA ends and promote end joining repair by the NHEJ pathway (Section 1.1.4).   
Alternatively, CtIP (Sae2 in yeast) can localise to the break site through its interaction with 
Nbs1 to form a complex with MRN (Chen, 2008).  There is evidence that supports limited 
end resection promoted by CtIP-MRN to reveal short complementary sequences which 
promote repair by the MMEJ pathway (Section 1.1.5).  However, γ-H2AX and the 
mediator of checkpoint 1 (MDC1) may regulate CtIP through inhibiting its resection 
activity in G1 (Helmink, 2011).  
 
In late S/G2 in the presence of cyclin dependent kinase (CDK), HR is initiated with the 
phosphorylation of CtIP on serine 327 and threonine 847 which mediates interaction with 
BRCA1.  BRCA1-CtIP-MRN is required for the initiation of 5’ to 3’ end resection and further 
processing with other repair proteins eventually leads to the generation of long 3’ ssDNA 
tails (Chen, 2008; Huertas, 2009; Yu, 2004).  The exonuclease Exo1 and helicase BLM have 
been proposed as the complex directly responsible for long end resection (Gravel, 2008; 
Nimonkar, 2008).  RPA quickly coats the newly formed ssDNA to remove inhibitory 
secondary structure and protect it from degradation.  RPA-ssDNA can activate ATR 
through interaction with ATR-interacting protein (ATRIP) resulting in Chk1 activation (Zou, 
2003) and arrest in G2 phase.  A number of HR pathways can be utilised to complete 
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repair and will be discussed in section 1.5.  Details of the main proteins involved in HR are 
in the following section.   
1.4 The Proteins of HR   
HR (briefly described in section 1.1.6) is mediated by the RAD52 epistasis group of genes 
(RAD50, RAD51, RAD52, RAD54, RAD51B, RAD51C, RAD51D, XRCC2, XRCC3, MRE11, NBS1; 
in yeast RAD50, RAD51, RAD52, RAD54, RAD55, RAD57, RAD59, MRE11, and XRS2) first 
discovered in yeast and whose gene products were demonstrated to be required for the 
repair of DNA DSBs after exposure to IR.  RPA, Rad52, BRCA2 and Rad51 play central roles 
in eukaryotic HR and are featured below.  
1.4.1 RPA 
Following recognition of a DSB and 5’ to 3’ end resection (Section 1.2) the long 3’ ssDNA 
strands are quickly coated with RPA which functions to protect and remove inhibitory 
secondary DNA structure from the ssDNA (Baumann, 1998; Sugiyama, 1997).  Mutations 
in RPA have been associated with lymphoid tumours and complete loss of function results 
in embryonic lethality.  RPA is a trimeric protein complex consisting of subunits RPA70, 
RPA14 and RPA32 and all subunits are required for the activity of RPA (Sibenaller, 1998).  
A homologue is also present in yeast (Gasior, 1998; Shinohara, 1998; Sugiyama, 1997).   
 
RPA is phosphorylated on RPA70 and predominantly hyperphosphorylated on RPA32 in 
response to DNA damage.  ATM, ATR, Chk1, DNA-PK and CDKs are among the kinases that 
have demonstrated hyperphosphorylation of RPA32 (Binz, 2004; Brush, 2001; Liu, 2006b).  
Biochemical studies have provided evidence that the strength of ATR phosphorylation is 
stimulated by an increasing length of ssDNA and the presence of 3’ ssDNA ends (Liu, 
2006b).  In further structural studies, hyperphosphorylation induced a conformational 
change in the RPA complex leading to a lower affinity for ssDNA than in the native RPA 
species (Liu, 2005).  Furthermore, phosphorylation of a different site in RPA resulted in a 
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higher affinity for the mediator protein Rad52 and lower affinities for ssDNA in 
comparison to native RPA (Deng, 2009).  These results taken together suggest the 
mechanism of RPA function.  Upon the generation of ssDNA, RPA is recruited to ssDNA to 
provide protection and stabilisation.  ATR (and likely other kinases) recognises the 
nucleoprotein complex and phosphorylates RPA to potentiate repair progression through 
the ‘handing-off’ of ssDNA to Rad52.  A similar mechanism may exist between 
phosphorylated RPA and Brca2 though to my knowledge this has not yet been studied. 
1.4.2 BRCA2 
RPA coated ssDNA is inaccessible to Rad51, the protein required for SI reactions, and thus 
recombination mediators are required to remove RPA and allow Rad51 nucleation of the 
ssDNA.  One such recombination mediator is Brca2.  Brca2 is a large 384kDa protein 
(Rad52 is only 46kDa) and as a result of its large size, has been difficult to purify.  Thus, 
most in vitro studies to date have studied truncations of the protein.  The Brca2 protein 
(Figure 1.7a) contains an RPA binding domain within its N-terminal region, eight BRC (a 
conserved motif in Brca2) repeat regions are located within its central region and six of 
which function to interact with Rad51 and finally, the C-terminal region is composed of an 
additional Rad51 binding domain and binding domains for DNA and the acidic HR protein 
DSS1 (Chen, 1998; Esashi, 2007; Jasin, 2002; Li, 2006; Wong, 2003; Yang, 2002).  Brca2 
knockout mice are embryonically lethal (Sharan, 1997) whereas Brca2-deficient cells 
exhibit significantly increased levels of spontaneous and induced chromosome 
aberrations and decreases in recombination (Feng, 2011; Jasin, 2002; Kraakman-van der 
Zwet, 2002; Moynahan, 2001).  In addition, mutations in Brca2 have been linked to the 
development of several different types of cancer (Milne, 2011; O'Donovan, 2010; 
Ormiston, 1996).  Brca2 is essential for recruiting Rad51 to sites of DSB damage and 
Rad51 foci formation is greatly impaired with Brca2 deficiency (Davies, 2001; Kraakman-
van der Zwet, 2002).   
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(a) 
 
 
 
 
(b) 
 
 
Figure 1.7. Map of the functional domains of Brca2 and Rad52. (a) Brca2 contains a binding 
domain for human RPA (hRPA) at its N-terminus and 8 BRC repeats within its central region.  6 
BRC repeats bind human Rad51 (hRad51) monomers.  Binding to DNA occurs through a region 
containing three oligonucleotide binding folds (OB1, OB2, OB3) and an α-helical domain (HD).  The 
nuclear localisation signal (NLS) and a second hRad51 binding domain that preferentially interacts 
with one hRad51 oligomer, is located within the C-terminus.  Phosphorylation sites S3291 and 
T3387 are also indicated. (San Filippo, 2008) (b) Rad52 (418 a.a) is much smaller than Brca2 (3418 
a.a) and possesses binding domains for DNA, hRPA and hRad51.  In addition, hRad52 can 
oligomerise through its hRad52 binding domain. The N-terminal domain (including the DNA and 
hRad52 binding domains) alone can catalyse strand annealing reactions. A phosphorylation site 
has also been identified on residue Y104.  
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The two Rad51 binding domains interact with the different forms of Rad51 in vitro.  In the 
absence of DNA, the BRC repeats interact predominantly with Rad51 monomers whereas 
the C-terminal region shows preferential binding for the oligomeric form of Rad51 (Esashi, 
2007; San Filippo, 2006).  Recent in vitro evidence has revealed that full length Brca2 can 
coordinate Rad51 nucleation of RPA-ssDNA and a study with the Brca2 orthologue of 
Ustilago maydis, Brh2, suggests that Brca2 directs the Rad51 nucleation of ssDNA to start 
at dsDNA-ssDNA junctions (Liu, 2010; Yang, 2005).  The BRC repeats are essential for 
Rad51 nucleation and may also function to retain and stabilise an activated Rad51 
filament, required for homology search and SI, by inhibiting the Rad51 ATPase activity 
responsible for Rad51 dissociation (Carreira, 2009; Jensen, 2010).  These studies also 
demonstrate that, in the presence of ssDNA and dsDNA, the BRC repeats can direct Rad51 
binding to ssDNA by inhibiting the dsDNA binding site in Rad51.  However, there is 
evidence that the BRC repeats may also negatively regulate the formation of the Rad51 
nucleoprotein filament and that the C-terminal region of Brca2 may attenuate this 
inhibition.  Excess BRC peptides in vitro can disrupt the formation of the Rad51 
nucleoprotein filament (Davies, 2001; Davies, 2007; Esashi, 2007; Galkin, 2005).   Esashi et 
al. proposed that the C-terminal Rad51 binding domain interacts with adjacent Rad51 
protomers to protect the stability of the nucleoprotein filament by preventing Rad51 
dissociation.  Thus in a concentration-dependent manner, it seems that a co-ordinated 
effort is required by both the BRC repeats and C-terminal Rad51 binding domain of Brca2 
to efficiently enhance the stability of the Rad51-ssDNA nucleoprotein filament. 
 
Regulation of Brca2 function also occurs through phosphorylation of serine 3291, 
threonine 3387 and residues within the BRC 1 repeat region (Bahassi, 2008; Esashi, 2005; 
Kim, 2008).  Previous results suggest that phosphorylation of S3291 can abrogate the 
protective effect of the C-terminal Rad51 binding domain of Brca2 on Rad51 
nucleoprotein stability.  Esashi et al demonstrated that the increasing levels of CDK 
phosphorylation of S3291 as cells progress from G2 to M can halt Brca2-mediated HR by 
disrupting the interaction between Rad51 and Brca2 and so prevent HR from occurring in 
M phase (Esashi, 2005).  Phosphorylation of T3387, within the C-terminal domain of 
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Brca2, is controlled by the checkpoint kinases Chk1 and Chk2 (Bahassi, 2008).  This 
modification functions as an additional regulatory measure and mediates the interactions 
between Brca2 and Rad51, perhaps to activate the protein upon DNA damage.  Indeed, 
the recruitment of Rad51 to DNA damage is impaired upon elimination of the 
phosphorylation site.   
1.4.3 Rad52 vs Brca2 
For a more comprehensive description of the structure and function of Rad52 see Figure 
1.7b and Section 1.6.   
 
In yeast, the recombination mediator Rad52 can be distinguished from the other 
mediators by the severity of the recombination and repair deficiencies in Δrad52 null 
mutants (Asleson, 1999; Moore, 2000; Storici, 2006; Symington, 2002).  The phenotype 
associated with Δrad52 strains may be explained by the requirement of Rad52 in not only 
Rad51-dependent HR pathways but also the Rad51-independent pathways involving 
recombination between inverted repeats and break-induced replication (Pohl, 2008).  
However, in contrast, the role of mammalian Rad52 appears to be non-essential.  Rad52-/- 
DT40 and mouse ES cells were not sensitive to DNA damaging agents known to cause 
DSBs though there was a slight reduction in GT frequencies (Rijkers, 1998; Yamaguchi-
Iwai, 1998).   
 
The presence of the Brca2 protein in humans, or an orthologue in vertebrate cells, may 
account for the differing effects observed between the yeast (S. cerevisiae) and 
vertebrate cells deficient in Rad52.  There is no known homologue of Brca2 in yeast and 
Rad52 is currently the only known protein in yeast that possesses recombination 
mediator activity to transfer ssDNA from RPA to Rad51.  In light of the severity of the 
Brca2-/- phenotype in embryonic mice and the absence of repair deficiencies in Rad52-/- 
mammalian cells, questions surrounding the role of Rad52 have been raised.  As Brca2 
possesses overlapping functions with Rad52, such as the recombination mediator activity 
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and the ability to interact with ssDNA and dsDNA, is the function of Rad52 redundant in 
the presence of the more efficient Brca2?  Certainly, DNA repair and recombination are 
more impaired in Brca2-deficient cells than in Rad52-deficient cells (Stark, 2004).  
However, recent evidence demonstrated that the formation of Rad52-Rad51 repair foci 
were unaffected by the status of Brca2 which suggests that Brca2- and Rad52-mediated 
repair of DNA DSBs occur in independent pathways (Feng, 2011).  This study also revealed 
that Rad52 is required for cell proliferation in Brca2-deficient cells and a deficiency in 
both Rad52 and Brca2 is synthetically lethal.  Furthermore, double knockout mutants of 
Rad52 and XRCC3, a paralogue of Rad51, are synthetically lethal whereas cells deficient in 
only one protein are viable (Feng, 2011; Fujimori, 2001).  These double 
knockdown/knockout studies suggest that Rad52 functions in a compensatory capacity 
and is essential in the absence of efficient DSB repair.   
 
The Rad52 protein can also catalyse single strand annealing (SSA) reactions which are 
implicated in all HR pathways (Section 1.5).  The model will be discussed in section 1.5.3 
though briefly, the N-terminal region of Rad52 (Figure 1.7b) possesses the catalytic ability 
to bind and anneal complementary sequences of ssDNA which have been revealed 
through 5’ to 3’ end resection.  Rad52-mediated annealing can be achieved in the 
presence or absence of RPA.  Purified full length Brca2 has been unable to anneal RPA-
coated ssDNA (Jensen, 2010) though experiments with naked ssDNA have not yet been 
performed.  Thus, although Rad52 possesses some similar functions to Brca2, it is a well 
conserved protein that possesses unique and distinct characteristics and functions which 
suggest it plays an important role in an as yet to be discovered mechanism. 
1.4.4 Rad51 
Homologues of Rad51 are present in yeast, humans and mice (Morita, 1993; Shinohara, 
1993).  However, differences exist between the severity of phenotypes associated with 
Rad51-deficient yeast and mammalian cells.  Yeast Δrad51 cells are viable, exhibit mild 
decreases in interchromosomal HR (Bai, 1996) and are sensitive to DNA damaging agents 
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(Game, 1974; Morita, 1993).  However, Rad51 null mutations are embryonically lethal in 
mice (Lim, 1996; Tsuzuki, 1996) and fibroblasts derived from early stage embryos failed to 
proliferate (Lim, 1996).  The lethality resulting from disruption of mammalian Rad51 
highlights the importance of this protein and the differences between yeast and 
mammals. 
 
When inactive, Rad51 oligomerises into a heptamer (Shin, 2003) and dissociates upon 
activation which is stimulated through interaction with Brca2 (Carreira, 2009) or DNA 
(Van Dyck, 1998).  Upon DSB damage and subsequent coating of ssDNA by RPA, the 
recombination mediators Brca2 or Rad52 facilitate loading of Rad51 onto the ssDNA 
strands.  Although Rad51 can bind both ssDNA and dsDNA (Baumann, 1996), binding to 
ssDNA must occur beforehand otherwise strand invasion and strand exchange will be 
inhibited (Baumann, 1997).  Strand exchange refers to the displacement of the 
homologous duplex strand following invasion and homologous pairing of the Rad51-
ssDNA nucleoprotein filament.  Rad51 nucleation results in the formation of a helical 
nucleoprotein filament and occurs most efficiently at amounts of 1 monomer of Rad51 
per 3-4 nucleotides in vitro (Baumann, 1997; Benson, 1994; Shin, 2003; Van Dyck, 1998).  
In concert with other recombination proteins the Rad51 nucleoprotein filament or 
presynaptic filament, can then undergo strand invasion and perform a homology search 
to initiate repair.  Rad51 can bind ATP and this binding promotes homologous pairing and 
strand exchange (Baumann, 1996; Sung, 1994).  Once the presynaptic filament is no 
longer required, Rad51 can hydrolyse ATP to destabilise the presynaptic filament and 
promote Rad51 turnover from DNA (Chi, 2006).   
1.4.5 Repair Centres and Chronology of Foci Formation for HR 
In response to DSBs, a signalling cascade is initiated leading to the activation of 
checkpoint pathways and the localisation of repair proteins to discrete sites, or repair 
centres, on chromatin.  By immunofluorescence these sites appear as nuclear foci.  Foci 
also represent HR repair centres and the proteins involved in HR repair can be seen 
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colocalising during S phase (Barlow, 2008; Lisby, 2003a; Lisby, 2004a; Lisby, 2004b; Rapp, 
2004; Tarsounas, 2003).  Mutants lacking components of the repair cascade display 
reduced or delayed foci formation and exhibit increased sensitivity to DNA damaging 
agents (Sections 1.2, 1.4.1, 1.4.2, 1.4.4).  Cell cycle dependent recruitment may 
additionally be regulated through post-translational modifications (PTMs).  Indeed, a 
number of repair proteins including RPA, Rad51, Brca2 and Rad52 are phosphorylated in S 
phase in response to DNA damage and abrogation of this PTM inhibits protein 
recruitment to repair foci (Bahassi, 2008; Esashi, 2005; Kitao, 2002; Liu, 2006a; Yuan, 
2003).   
 
An individual focus may also contain multiple repair sites which have colocalised to 
facilitate co-ordinated repair of multiple DNA lesions (Lisby, 2003b; Lisby, 2001; Van Dyck, 
1998; Van Dyck, 2001).  In studies using Rad52 focus formation as an indicator for HR 
repair in yeast, cells were exposed to radiation doses which were expected to generate 
~10 lesions per cell that would require Rad52-mediated repair for survival (Lisby, 2001).  
However, only two yeast Rad52 foci were visualised on average per cell.  To demonstrate 
that colocalisation of DSBs could occur at a single Rad52 focus, a reporter construct was 
used in which two fluorescently labelled endonuclease specific DSBs could be generated 
(Lisby, 2003b).  When both DSBs were induced, both fluorescently labelled ends 
colocalised with Rad52 to the same repair focus.  Colocalisation of multiple DSBs may 
serve to concentrate the repair proteins within each focus thus achieving the appropriate 
concentration levels and stoichiometry for efficient interactions and repair.   
 
The chronology of repair protein recruitment to DSBs has been distinguished by use of 
ChIP or fluorescently tagged proteins (Barlow, 2008; Gasior, 1998; Lisby, 2004a; Rapp, 
2004; Wray, 2008).  Most sources agree that Mre11, a component of the MRN complex, is 
recruited early to the repair centre and this is followed by the appearance of the 
phosphorylated histone marker γ-H2AX.  γ-H2AX and Mre11 foci disassemble quickly 
(Rapp, 2004) which is consistent with their roles as early DSB signals and responders, 
respectively.  Recruitment of RPA follows that of γ-H2AX and Mre11 and is not dependent 
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on Rad52, Rad51 or Brca2.  However, the sequence in which Rad52, Rad51 and Brca2 
localise to repair centres remains unclear.  It was initially thought that because Rad51 
requires Rad52 or Brca2 to nucleate onto RPA-coated ssDNA, it would not be found in the 
repair centre prior to Rad52 or Brca2.  Indeed, there is evidence from various sources that 
Rad51 foci formation is severely reduced or abolished in Rad52- or Brca2-deficient cells 
(Feng, 2011; Lisby, 2004a; Sugawara, 2003; Yuan, 1999) and Rad51 did not associate with 
DNA in Δrad52 cells as measured by ChIP (Sugawara, 2003).  However, using analysis of 
foci formation or ChIP, contrasting results were also obtained from other groups which 
support Rad52- or Brca2-independent localisation of Rad51 to repair centres (Tarsounas, 
2003; Wolner, 2003; Wray, 2008).  Although slight differences in the spatial temporal 
recruitment of Rad51 and the other HR proteins may exist in yeast and mammalian cells 
(van Veelen, 2005), it is also possible that the chronology of HR protein localisation may 
be altered depending on the type of DNA damage present, the type of response pathway 
activated (Section 1.1) and the stage of the cell cycle (Section 1.2.2).  Nevertheless, many 
questions still surround the order of recruitment and more studies must be conducted for 
further clarification. 
1.5 The Pathways of Homologous Recombination 
Understanding the mechanisms behind HR is important not only for gaining insight into 
the role of HR in DSB repair or identifying disease-causing mutations but also for using HR 
as a tool to promote gene targeting (GT).  GT involves the introduction of an exogenous 
fragment of DNA possessing homology to a ‘target’ locus of interest where its stable 
integration is achieved through HR.  Using an exogenous dsDNA fragment can be termed 
dsGT whereas an exogenous ssDNA fragment or oligonucleotide can be termed ssGT.  
Because HR is a natural recombination mechanism and a cellular response to DSBs, using 
it for GT is advantageous over creating completely novel proteins.  Thus understanding 
the components and mechanisms of the HR pathways is essential.  The exact mechanisms 
of dsGT and ssGT are unknown though it is thought that dsGT follows a SI pathway: 
synthesis dependent strand annealing (Tenzen, 2010; Yanez, 1999).  Controversy 
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surrounds the mechanism of ssGT as both SI and SSA pathways have been implicated 
(McLachlan, 2009; Radecke, 2006a; Storici, 2003; Storici, 2006).  Details of the HR 
pathways will be discussed below but GT will be discussed in further detail in Section 
1.9.1.   
1.5.1 Classical DSB repair (Double Holliday Junctions) 
The classical DSB repair pathway came from studies of meiotic HR and was first 
developed to explain gene conversion (Figure 1.8a) (Szostak, 1983).  Initially it was 
believed to be the predominant DSB repair pathway based although it is likely not utilised 
for the repair of DSBs.  Classical DSB repair would be expected to yield crossover products 
however, crossover products are rarely observed in mitotically dividing cells (Ferguson, 
1996).  As a result, the synthesis dependent strand annealing model (SDSA) was proposed 
(Section 1.5.2).  Nevertheless, the early steps of classical DSB repair and SDSA repair are 
shared and include 5’ to 3’ resection on both sides of the DSB, formation of the 
presynaptic filament, SI into a homologous duplex or chromosome, D-loop formation, 
elongation of the invading strand and branch migration.  However, the pathways diverge 
at this stage and in contrast to SDSA where the elongated strand dissociates, the D-loop is 
annealed to the resected ssDNA from the other side of the break in what is termed 
second-end capture.  In vitro evidence suggests the annealing activity of Rad52 is 
indispensible for this process (McIlwraith, 2008; Nimonkar, 2009).  This second end is 
then used to prime DNA synthesis using the D-loop strand as a template.  The newly 
synthesised ends are ligated to the corresponding strand from the opposite side of the 
break which results in the formation of double Holliday Junctions.  Resolvases introduce 
nicks into the Holliday junctions and resolution of the strands produce crossover or non-
crossover products.  For reviews see: (Andersen, 2010; Helleday, 2007) 
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(a)       (b)    (c)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.8. The Pathways of HR. (a) Classical DSB repair (Rad51-dependent). i-ii) DNA end 
resection generates ssDNA with 3’ tails on either side of a DSB. iii) One 3’ssDNA tail invades the 
homologous duplex, displacing one of the strands in the homologous duplex and creating a D-
loop. iv) The displaced strand anneals to the complementary 3’ ssDNA tail through second-end 
capture. Both 3’ ends prime DNA synthesis using the homologous duplex strands as templates. v-
vi) Once synthesis has extended past the break point the strands are ligated together to generate 
two Holliday junctions. vii) The Holliday junctions are resolved yielding two kinds of 
recombination products: gene conversion (i.e. non-crossover products) or conversion and 
exchange of flanking sequences (i.e. crossover products) (b) SDSA (Rad51-dependent). i-iii) Similar 
to (a), 3’ ssDNA tails are generated by end resection and one 3’ ssDNA end invades a homologous 
duplex. iv-v) The invading strand is elongated through branch migration. vi-vii) Once the strand 
has been extended past the break point it dissociates and reanneals to the original opposite 
strand resulting in non-crossover products. (c) SSA (Rad51-independent). i-ii) Similar to (a) and 
(b), end resection occurs following a DSB. However, in SSA, end resection reveals complementary 
sequences in the newly generated ssDNA. iii-iv) The complementary sequences are annealed, the 
nonhomologous flaps are trimmed and the ends are ligated which results in the deletion of the 
sequences between the annealed regions. (Helleday, 2007) 
 
  
Chapter 1    Introduction 
 
45 
 
1.5.2 Synthesis Dependent Strand Annealing (SDSA) 
Like the other HR pathways, SDSA involves 5’ to 3’ end resection to generate 3’ ssDNA 
(Figure 1.8b).  The ends are stabilised and secondary structure is removed by RPA.  Brca2 
or Rad52 then mediates the displacement of RPA and the subsequent assembly of the 
Rad51 nucleoprotein filament.  Other recombination proteins are recruited to the Rad51 
nucleoprotein filament to contribute to the formation of the presynaptic filament.  Once 
formed, the presynaptic filament initiates strand invasion of a sister chromatid or 
adjacent duplex and performs the search for homology.  Base pairing with the ssDNA 
results in synapsis where displacement of the opposite strand creates a ‘D-loop’ 
structure.  There is evidence that these reaction intermediates are stabilised by 
recombination proteins including RPA, Rad54 and Hop2-Mnd1 (Chi, 2007; Eggler, 2002; 
Sugawara, 2003).  Following synapse, the 3’ end is used to prime de novo synthesis.  
There is evidence that the DNA polymerase η is responsible for elongation of the strand 
(Kawamoto, 2005; McIlwraith, 2008).  Once synthesis occurs past the initial break point, 
unwinding causes the strand to dissociate and reanneal to the ssDNA that was generated 
on the opposite side of the break.  This reannealing activity may be mediated by the 
Rad52 protein (Liu, 2011).  The final product results only in non-crossover products.  If 
strand elongation occurred past the end of the complementary ssDNA on the opposite 
side of the break, the unannealed flaps are processed by an endonuclease, thought to be 
XPF-ERCC1 (Adair, 2000; Motycka, 2004).  It is interesting to note that the endonuclease 
activity of XPF-ERCC1 is stimulated by Rad52 (Adair, 2000; Motycka, 2004).  Ligation of 
the strands completes repair. (For reviews see: (Andersen, 2010; Helleday, 2007)) 
 
SDSA is a pathway proposed to involve both SI and SSA mechanisms.  DSB repair was 
previously believed to occur through the classical DSB repair model, often associated with 
meiotic recombination to stimulate genetic exchange, which is achieved through double 
Holliday junction resolution of the heteroduplex.  SDSA was proposed to explain the lack 
of crossover products observed from the repair of DSBs in mitotically dividing cells 
(Ferguson, 1996).  Indeed, there is increasing evidence that SDSA is the predominant 
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pathway for the repair of DSBs (Andersen, 2010; Johnson, 2000; Wu, 2003).  Non-
crossover repair products are likely favoured to preserve the genomic composition as 
resolving multiple crossovers simultaneously could potentially lead to genome 
rearrangements through the ligation of strands from different loci (Moynahan, 1997; 
Richardson, 2000).  It should be noted, however, that the HR pathways discussed here are 
theoretical models and need to be validated. 
1.5.3 Single Strand Annealing 
Similar to SDSA and classical DSB repair, SSA repair begins with 5’ to 3’ end resection 
which is followed by coating of the ssDNA with RPA (Figure 1.8c).  SSA is a Rad51-
independent pathway and thus Rad52 next mediates removal of RPA and instead of 
interacting with Rad51, Rad52 nucleates itself onto the ssDNA.  When Rad52 encounters 
a complementary region within another ssDNA strand, it promotes strand annealing.  The 
best characterised example of this is when a DSB occurs between direct repeats as 
previously mentioned.  This is a non-conservative mechanism of DSB repair as it involves 
deleting the DNA between the repeat sequences, as well as one of the repeat sequences.  
Nonhomologous flaps are removed and repair is completed upon ligation of the strands.  
There is evidence both in vivo and in vitro that interaction with Rad51 attenuates the 
annealing activity of Rad52 and suppresses the SSA pathway (Mansour, 2008; Wu, 2008).  
This inhibition by Rad51 may function to direct repair to the SDSA pathway and it also 
highlights an additional role of Rad51 in promoting conservative repair.   
 
The non-conservative repair products resulting from SSA suggest that SSA may be an 
aberrant form of HR repair and in the event of multiple DSBs, may incorrectly anneal 
strands of different chromosomes leading to chromosome translocations (Kolomietz, 
2002; Strout, 1998).  Indeed, translocations were observed with high frequency when 
DSBs were introduced adjacent to identical Alu repeats and were repaired with SSA 
(Elliott, 2005).  Although Alu repeat elements can contain variability in their sequences, 
these elements make up over 10% of the mass of the human genome (Batzer, 2002) and 
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are potential translocation sites in the event of unfaithful DSB repair with SSA.  The 
recombination proteins Rad52 and RPA are required for efficient SSA and in yeast, the 
Rad52 paralogue Rad59 is also required (Sugawara, 2000).  A Rad59 homologue has not 
been identified in humans.  The endonuclease XPF-ERCC1 complex, also implicated in 
SDSA, stimulates SSA perhaps by removing any nonhomologous flaps following strand 
annealing (Al-Minawi, 2008).  Unfortunately, studies aimed at identifying the human 
components of HR have mostly been focused on SDSA and classical DSB repair whereas 
the components of SSA have not been extensively studied.  The mechanism which directs 
or suppresses SSA repair also remains to be defined in greater detail. 
1.6 Structure of Rad52: Yeast vs Human 
The known interaction domains of Rad52 can be mapped to its primary structure in 
S.cerevisiae (yeast), 504 a.a, and human, 418 a.a, (Figure 1.9a).  The Rad52 protein was 
first discovered in yeast and because yeast Rad52 (scRad52) and human Rad52 (hRad52) 
are homologues and share sequence conservation, scRad52 has been the focus of 
continuous study.  The N-terminal domains of scRad52 and hRad52 contain the DNA 
binding and self-association domains, which share 42% identity and 73% similarity, 
whereas there is little sequence homology between the central and C-terminal domains 
(Park, 1995).  Probably because of such clear evidence of both structural and functional 
conservation between scRad52 and hRad52, studies focused on Rad52 domain structure 
or annealing activity are often only conducted on one of these two Rad52 proteins.  This 
can be very frustrating as differences exist between the two Rad52 proteins (see sections 
below) and it cannot be assumed that the observations obtained with one Rad52 species 
will be mirrored by the other.  This section will focus on the function of the domains of 
Rad52 and highlight the differences between scRad52 and hRad52. 
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(a) 
 
 
 
 
 
 
 
 
 
 
 
 
(b)         (c)   
 
 
 
 
 
 
Figure 1.9. The structure of yeast and human Rad52. (a) The domains of scRad52 and hRad52 are 
indicated. Both scRad52 and hRad52 can catalyse strand annealing with their respective N-
terminal domains only. The Y104 phosphorylation site in hRad52 and putative sumoylation sites 
(K) in scRad52 and hRad52 are also indicated. (b) The crystal structure of the hRad521-209 ring. 
Rad52 is predicted to interact with ssDNA along a positively charged groove (dark blue) and with 
dsDNA along the outer edge of the ring (magenta). hRad521-209 forms an 11-mer ring however full 
length Rad52 (both yeast and human) forms heptameric rings. (c) The hRad52-DNA complex. 
Model of ssDNA (yellow) and dsDNA (orange) interacting with hRad52. (Kagawa, 2008) 
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1.6.1 DNA binding 
Both scRad52 and hRad52 can bind ssDNA and dsDNA substrates and show a preference 
for ssDNA in vitro (Benson, 1998; Kumar, 2004; Shinohara, 1998).  The DNA binding 
domain in hRad52 was originally assigned to residues 39-80 (Park, 1996) however, alanine 
scanning mutagenesis (Kagawa, 2008; Singleton, 2002) was used to identify the residues 
important for ssDNA and dsDNA binding and it was observed that these residues did not 
end at a.a 80 but rather extended to at least a.a 177 (Figure 1.9a).  Such fine mapping of 
the DNA binding domain in scRad52 has not been conducted though there is evidence 
that individual residues in the N-terminal domain can modulate the activity of scRad52 in 
HR or the response of scRad52 to IR (Mortensen, 2002).  In addition, there is a second 
DNA binding domain within the C-terminal domain of scRad52 which can interact with 
both ssDNA and dsDNA (Seong, 2008).  Interestingly, a N-terminal truncation mutant of 
scRad52 can still act as a recombination mediator between RPA and Rad51 and promote 
strand exchange (Seong, 2008).  However, to my knowledge the recombination activity of 
the central and C-terminal domains of scRad52 has only been demonstrated in this one 
study.  Thus far there is no evidence to support the existence of a similar binding domain 
in hRad52 and biochemical studies have demonstrated that truncation mutants Δ202-418 
and Δ238-414 cannot bind DNA (ssDNA and dsDNA) or perform strand exchange, 
respectively (Bi, 2004; Kito, 1999).  The N-terminal domain of hRad52 is therefore 
essential for its recombination activity. 
1.6.2 Self-Association Domain of Rad52 
In vitro, scRad52 and hRad52 can each form heptameric rings (Shinohara, 1998; Stasiak, 
2000) through their self-association domain (Seong, 2008; Shen, 1996b) and this ring 
structure may be the functional form of Rad52 in vivo.  Electron microscopy was used to 
visualise hRad52 ring structures in complex with 3’ and 5’ ssDNA as well as connecting 
two annealed ssDNA substrates (Van Dyck, 1998; Van Dyck, 1999; Van Dyck, 2001).  In 
addition, multiple Rad52 rings bound to ssDNA can associate to bring complementary 
ssDNA strands in close proximity (Van Dyck, 2001).  The crystal structure of the N-
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terminal domain of hRad52 (1-209) bound to ssDNA shows the proteins associate in an 
undecamer ring structure (Figure 1.9b).  In these structures, ssDNA is predicted to 
interact with a positively charged groove while dsDNA interacts with residues along the 
outside of the groove (Figure 1.9c) which allows the close pairing interaction between 
complementary ssDNA and dsDNA residues, which may be important for performing a 
homology search  (Kagawa, 2008; Singleton, 2002).   
 
These models are elegant in proposing that Rad52 oligomerisation promotes the close 
interactions required for annealing of ssDNA as well as alignment of homologous ssDNA 
and dsDNA.  However, size-exclusion chromatography coupled with multiangle light 
scattering of a RPA-ssDNA-Rad52 complex (Section 1.4.1) suggests that protein-protein 
interactions and ‘handing-off’ of ssDNA from RPA to Rad52 are most efficient with 1:1 
stoichiometric ratios of RPA:Rad52, arguing against a functional mediator role for the 
Rad52 ring which would be expected in a 1:7 ratio (Deng, 2009).  As high concentrations 
of Rad52 are required for visualisation by electron microscopy, it is possible that Rad52 
only oligomerises under non-physiological conditions when present in excess and that the 
ring structure does not truly stimulate Rad52 activity.  Excess scRad52 and hRad52 
aggregate with long ssDNA (>5000 nt) (Song, 2000; Van Dyck, 1998) which inhibits the 
annealing activity of hRad52 (Benson, 1998; Kumar, 2004; Van Dyck, 2001).  However, 
inhibition of Rad52 activity at high protein concentrations in vitro does not necessarily 
argue against a functional role of the Rad52 ring in vivo.  In yeast, Rad52 oligomerisation 
was required for proper nuclear localisation of the protein (Seong, 2008).  In contrast to 
the observations made by one group (Deng, 2009), two studies from the another group 
demonstrated that Rad52-mediated annealing is most efficient when ssDNA is wrapped 
around the Rad52 heptameric ring (Deng, 2009; Grimme, 2010; Rothenberg, 2008).  In 
addition, these studies demonstrated that Rad52 interaction with RPA was also most 
efficient when a Rad52 ring was interacting with RPA.  Finally, it was also observed that 
high concentrations of Rad52 resulted in stretching of ssDNA between Rad52 rings which 
inhibited annealing and may be the mechanism responsible for the aggregation and 
inhibition observed in the aforementioned studies.   
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1.6.3 Strand Annealing and Strand Exchange Activity of Rad52 
ScRad52 and hRad52-mediated annealing of complementary ssDNA regions has been well 
documented and its importance in second-end capture (classical DSB repair, section 1.5.1) 
and the SSA pathway (Section 1.5.3) have been demonstrated in vitro and in vivo, 
respectively (Bennardo, 2008; Fishman-Lobell, 1992; Ivanov, 1996; McIlwraith, 2008; 
Mortensen, 1996; Nimonkar, 2009; Prado, 1995; Stark, 2004; Sugiyama, 1998; Van Dyck, 
2001; Wu, 2008).  Interestingly, in addition to its DNA binding activity, the C-terminal 
domain of scRad52 may also catalyse strand annealing of complementary ssDNA 
fragments (Plate, 2006).  It was surprising that the C-terminal domain alone, which is 
unable to self-associate, exhibited a higher annealing efficiency of complementary naked 
and RPA-coated ssDNA than the N-terminal domain.  The presence of two catalytic 
domains in scRad52 as opposed to only one in hRad52 is possibly the reason scRad52 has 
a greater catalytic efficiency over hRad52 (Kumar, 2004).   
 
The annealing activity of both Rad52 proteins appears to be regulated through their 
interaction with Rad51.  Biochemical experiments with scRad52 demonstrated that the 
annealing efficiency of scRad52 was attenuated in the presence of scRad51 (Wu, 2008).  
This observation has yet to be confirmed for hRad52 although it has been noted that 
Δrad51 yeast cells and Rad51 depleted Chinese hamster ovary (CHO) cells exhibit higher 
frequencies of SSA-mediated HR (Mansour, 2008; Storici, 2006).  The Rad51 depleted CHO 
cells also inhibited Total NHEJ (NHEJ + MMEJ) (abbreviated to: Tot-NHEJ) suggesting that 
Rad51 may inhibit SSA while indirectly promoting Tot-NHEJ. 
  
In addition to strand annealing, both scRad52 and hRad52 possess an additional activity; 
the ability to catalyse Rad51-independent strand exchange, a process involving strand 
annealing which has been observed in vitro.  Assays to measure strand exchange involve 
duplex DNA 83bp in length containing one 32P-labelled strand and one 83mer single 
strand oligonucleotide (ssO) sharing 100% homology with the labelled strand.  Strand 
exchange was detected when the 32P-labelled strand was displaced by the 83mer ssO 
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which annealed to the complementary strand to form dsDNA (Bi, 2004; Kumar, 2004).  
These results were surprising as Rad52 cannot catalyse SI and strand exchange would be 
expected to be mainly associated with proteins which can perform SI, such as Rad51, the 
bacterial recombination protein RecA and the meiosis-specific recombination protein 
Dmc1, a homologue of Rad52.  The in vivo significance of Rad52-mediated strand 
exchange, if any, remains unclear.  It is possible that it may be involved in known Rad51-
independent HR pathways or may be involved in a novel pathway.  However, currently 
there is no in vivo evidence to support either of these.  Thus the strand exchange activity 
of Rad52 has only been observed under non-physiological conditions.   
1.6.4 The RPA and Rad51 Binding Domains 
Because of the indispensible role of the N-terminal domain in hRad52-mediated strand 
annealing and strand exchange, the central and C-terminal domains have not been the 
focus of the same degree of extensive study.  To date only the crystal structure of the N-
terminal domain (residues 1-212) (Figure 1.9a) of hRad52 has been determined (Kagawa, 
2008).  No known catalytic activity has been associated with the central regions of 
scRad52 and hRad52 and until recently, it was not known that the C-terminal region of 
scRad52 also harbours DNA annealing activity (Plate, 2006).  The inability of the C-
terminal region of hRad52 to bind DNA suggests this annealing activity was not 
conserved.  Nevertheless, the central and C-terminal regions of both Rad52 proteins 
possess domains which are vital not only for their recombination mediator function but 
also for nuclear localisation and foci formation (Figure 1.9).   
 
Binding domains for RPA and Rad51 are present in the central or C-terminal domains, 
respectively.  The minimal regions required for interaction with RPA or Rad51 have been 
finely mapped in hRad52 (Park, 1996; Shen, 1996a) but are not as well defined in yeast 
Rad52 (Barlow, 2010).  As previously mentioned (Section 1.6.1), the DNA binding domain 
in the scRad52 C-terminal domain can function in conjunction with the RPA and Rad51 
binding domains to mediate ssDNA transfer between RPA and Rad51 which promotes 
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Rad51 filament assembly on the ssDNA (Seong, 2008).  As the crystal structure of scRad52 
is not available, it is unknown whether the N- and C-terminal DNA binding domains adopt 
a similar conformation.  However, the a.a sequences in the N- and C-terminal domains 
share approximately 50% similarity thus it is possible their structure may also be similar.   
 
The NLS sequences and properties affecting foci formation have been elucidated for both 
proteins.  However, systematic comparisons between the two Rad52 proteins are rarely 
conducted which has left questions surrounding which properties are conserved and 
which are species specific.  Although the NLS of scRad52 is present within the RPA binding 
domain, efficient localisation cannot be achieved by monomeric Rad52 and is instead 
dependent on oligomerisation for nuclear import (Plate, 2008a).  In contrast, the NLS of 
hRad52 is at the C-terminus and contains sumoylation sites which may enhance nuclear 
localisation (Saito, 2010).  The correlation between oligomerisation and nuclear 
localisation has not been tested for hRad52.  Furthermore, scRad52 focus formation in 
response to DNA damage is dependent on its interaction with RPA.  The introduction of 
point mutations which impair the ability of Rad52 to bind RPA also negatively affect its 
ability to form foci and act as a recombination mediator (Plate, 2008b).  A similar 
dependency has not been tested for hRad52 although phosphorylation within its N-
terminal domain can enhance focus formation in response to DNA damage (Section 1.4.5) 
(Kitao, 2002).  Again, neither study has been repeated using the other Rad52 species 
which further highlights the lack of comparative studies involving scRad52 and hRad52.  
Nevertheless, the studies noted in this section emphasise the observed and potential 
differences between the two proteins. 
1.7 Post-translational Modifications of Rad52 
Post-translational modifications (PTMs) are an additional means of regulating proteins.  
Phosphorylations and sumoylations are PTMs that can have a range of effects including 
introducing conformational changes, regulating stability of protein-protein or protein-
DNA interactions and targeting the protein for proteasomal degradation.  Indeed, other 
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HR proteins including Rad51 and RPA are regulated through phosphorylations as 
discussed below and in sections 1.4.1 and 1.4.4.  Briefly, in vitro evidence revealed that 
phosphorylation of human RPA decreases its affinity for ssDNA and conversely increases 
its affinity for hRad52 (Deng, 2009).  This process was described as RPA ‘handing-off’ the 
ssDNA to Rad52.  Furthermore, there is evidence both in vivo and in vitro that human 
Rad51 is phosphorylated by c-Abl which may contribute to mediating the continuation of 
the ‘handing-off’ process by increasing its affinity for Rad52 (Chen, 1999; Shimizu, 2009).  
In addition, evidence suggests that Rad51 phosphorylation primarily occurs in S and G2/M 
phases of the cell cycle and that the formation of Rad51 foci in response to IR is 
dependent on its phosphorylation by c-Abl (Yuan, 2003).  As the phosphorylated Rad51 
species exhibits increased affinity for Rad52, it is possible that this interaction mediates 
localisation of Rad51 to repair centres following localisation of Rad52. 
1.7.1 Phosphorylation of Rad52 
HRad52 and scRad52 also possess PTM sites which are targeted by kinases or small 
ubiquitin like modifier (SUMO) conjugating proteins (Figure 1.9).  It is currently difficult to 
assess whether the effects of these PTMs are conserved between hRad52 and scRad52 as 
comprehensive comparative studies have not been conducted.  HRad52 is believed to be 
phosphorylated on tyrosine 104, which lies within the N-terminal domain.  One study 
demonstrated that, as for hRad51, this phosphorylation of hRad52 is not only dependent 
on the activity of c-Abl following exposure to IR but also contributes to Rad52 focus 
formation in response to IR (Kitao, 2002).  This suggests that recruitment of Rad52 to 
repair centres may be mediated through interaction with a repair protein recruited early 
to the repair centre, possibly RPA, and that this interaction is enhanced upon Rad52 
phosphorylation.   
 
ScRad52 is also phosphorylated though similar contributions to foci formation were not 
tested.  However, in contrast to hRad52, there is evidence that scRad52 can be 
phosphorylated twice (Antunez de Mayolo, 2006).  Interestingly, scRad52 is 
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phosphorylated on serine and/or threonine residues, (contrasting with tyrosine in 
hRad52) in one a cell cycle independent manner and the other during S phase.  These 
phosphorylations were also dependent on the presence of the C-terminal domain and it 
was proposed that the phosphorylation sites were present in this domain or alternatively 
that the C-terminal domain was required to promote phosphorylation.  Unfortunately, 
the effects of the PTMs on recombination and repair were not determined and follow-up 
studies were not conducted leaving many questions surrounding their role in HR.   
1.7.2 Sumoylation of Rad52 
Sumoylations involve the covalent addition of SUMO to lysine residues within the target 
protein.  Like phosphorylations, sumoylations can also upregulate or downregulate 
protein activities and affect protein localisation.  A cluster of three putative sumoylation 
sites have been identified within the NLS of hRad52 (Figure 1.9a).  In contrast, the five 
putative sites that have been identified in scRad52 are scattered within the N-terminal 
and central domains.  Saito et al. proposed that in hRad52, sumoylation of the K411, 412, 
414 residues within the NLS were required for efficient nuclear localisation (Saito, 2010).  
However, it is possible that the K to R a.a substitutions which were designed to eliminate 
sumoylation also disrupted the NLS and thus improper nuclear import of hRad52 would 
be independent of its sumoylation state.  Biochemical studies of the sumoylated species 
also revealed no discernable effect on annealing activity, D-loop formation, hRad51 
interaction or DNA binding.  Nevertheless, the study highlighted sumoylation as a 
potential regulator of cellular localisation.   
 
A number of different conditions can stimulate sumoylation of scRad52.  High levels of 
scRad52 sumoylation have been found to correlate with: promoting scRad52 
oligomerisation, exposure to the DNA damaging agent methylmethane sulfonate (MMS), 
and the presence of resected ssDNA (Altmannova, 2010; Ohuchi, 2008a; Sacher, 2006).  
Like hRad52, scRad52 is similarly sumoylated within its NLS consensus sequence, K233, 
which lies within the central domain (Ohuchi, 2008b).  However in contrast to hRad52 
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where no effects on HR were observed, K233 sumoylation deficient cells exhibit defects in 
DSB-induced intrachromosomal homologous recombination (recombination between 
homologous regions in a locus, section 1.9.1) as well as both spontaneous and MMS-
induced sister chromatid exchange (recombination between sister chromatids).  In 
addition, it was demonstrated that sumoylation of K233 was dependent upon nuclear 
localisation.  Sumoylation of other residues, K43,44,253, can increase the half-life of 
scRad52 although it did not affect the cellular sensitivity to MMS or the annealing activity 
of scRad52 (Sacher, 2006).    Results from another group studying the role of the same 
lysine residues, reported contrasting findings (Altmannova, 2010): K43,44,253R 
sumoylation deficient scRad52 exhibited elevated levels of strand annealing and DNA 
binding.  The authors proposed that sumoylation may function to direct the choice of 
recombination pathway and this was supported by the observation that in an 
intrachromosomal HR assay, gene conversion products were favoured over SSA products 
by the mutants.  There is evidence that K159 is also sumoylated though the effect of this 
modification has not yet been studied in detail (Ohuchi, 2008a). 
 
Although the significance of sumoylation of hRad52 is unknown, it is possible that 
sumoylation affects hRad52 in similar ways to scRad52.  However, further comparative 
research must be conducted to determine if such similarities exist. 
1.8 The Role of Rad52 in Homologous Recombination: Yeast vs 
Human 
The structures and functions of scRad52 and hRad52, discussed in Sections 1.6-1.8, have 
emphasised the differences between the two Rad52 homologues.  Clearly, it cannot be 
assumed that the characteristics identified in one Rad52 homologue will be maintained in 
the other without performing confirmation studies.  The scRad52 protein is essential for 
the HR-mediated repair of damage caused by DNA damaging agents as well as 
coordinating, mediating and catalysing recombination reactions.  It possesses auxiliary 
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functions not present in hRad52, such as its ability to anneal ssDNA and mediate 
recombination with both N- and C-terminal domains (Plate, 2006).  In addition, thus far, 
scRad52 appears to be the only yeast protein able to efficiently nucleate Rad51 onto RPA-
coated ssDNA making it indispensible.  In contrast, hRad52 is less efficient in strand 
annealing than scRad52 and with the presence of Brca2 in humans, which may be the 
more efficient mediator, hRad52 remains an important protein although is no longer 
essential.  However, hRad52 does support and contribute to HR repair.  Its ability to act as 
a recombination mediator, possibly through a pathway independent of Brca2 (Feng, 
2011), and to catalyse strand annealing reactions have been conserved.  In addition, 
double knockouts or knockdowns of hRad52 with Brca2 or the Rad51 paralogue XRCC3 
have resulted in synthetic lethalities which suggest that hRad52 plays an integral role in 
the cell (Feng, 2011; Fujimori, 2001).  Disregulation of hRad52 is also a potential 
mechanism for the upregulation of SSA observed in transformed human cells (Cramer, 
2008).  Thus, although cell survival is less dependent on Rad52 in human cells than in 
yeast cells, hRad52 is clearly a significant component of the HR machinery and therefore 
of interest in the ongoing studies of HR. 
1.9 Increasing the Efficiency of Homologous Recombination to 
Enhance Genome Engineering Methods 
The involvement of Rad52 in both SI and SSA-type pathways, in addition to its known 
interactions with DNA, RPA, Rad51 and, in humans, the ERCC1/XPF complex, makes it an 
attractive candidate to study HR.  Not only could a greater understanding of the 
mechanism of HR be achieved but, in addition, such knowledge might be used to improve 
the efficiency of genome engineering methods such as GT.  In most somatic cells 
spontaneous HR events are infrequent and can be more than 50-fold less frequent than 
Tot-NHEJ events (Di Primio, 2005; Vasquez, 2001; Yanez, 1999).   However, induction of a 
DSB in chromosomal target locus can stimulate HR upwards of 5000 fold (Donoho, 1998; 
Liang, 1996; Taghian, 1997).  Other approaches for promoting HR are based on the 
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observation that the major DSB repair pathways, Tot-NHEJ and HR, may inhibit one 
another or compete for the same repair substrates.  Hence strategies for impairing Tot-
NHEJ in favour of promoting HR efficiencies have been pursued (Bennardo, 2008; Liang, 
1996; Mansour, 2008; Stark, 2004; Storici, 2006).  For example, Ku70-/- mammalian cells 
exhibited approximate 8-fold and 7-fold increases in SI- and SSA-mediated HR 
frequencies, respectively, over wild-type cells in the presence of a DSB (Stark, 2004).  
Other approaches for stimulating HR are based on overexpressing recombination proteins 
that may be rate-limiting.  Rad51 overexpression in mammalian cells stimulated 
intrachromosomal HR (ICHR, Section 1.9.1), which involves both SI- and SSA-mediated HR, 
up to 20-fold (Vispe, 1998).  However, a 2-fold inhibition in ICHR from Rad51 
overexpression has also been observed (Kim, 2001).  The effects of overexpressing Rad52 
have yielded both stimulations and inhibitions of SI- and SSA-mediated HR.  A summary of 
the experimental results are discussed below (Section 1.9.3). 
1.9.1 Assays for Measuring Homologous Recombination 
HR can be measured using a number of different reporter assays and each assay can 
favour a particular HR pathway or a combination of them.  The most commonly used HR 
assays are named as follows: extrachromosomal HR (ECHR)(Johnson, 1996; Yanez, 2002), 
intrachromosomal HR (ICHR)(Johnson, 2000; Kim, 2001; Yun, 2004), single strand 
annealing (SSA) (Stark, 2004), GT using dsDNA templates (dsGT) (Urnov, 2005; Yanez, 
2002) and GT using ssDNA templates (Igoucheva, 2001; Radecke, 2006a).  Examples are 
depicted in Figure 1.10.  These assays may also utilise site specific endonuclease 
restriction sites within the constructs to introduce DSBs and stimulate the overall 
frequencies    of    HR    events.    The    specific   HR    mechanism(s)   responsible   for   the  
 
  
Chapter 1    Introduction 
 
59 
 
(a)          
 
 
 
(b)  
 
 
 
 
(c)  
 
 
 
 
(d)          (e)  
 
 
 
 
 
 
Figure 1.10. Assays for measuring HR. (a) ECHR. One plasmid contains a functional promoter but is 
disrupted for EGFP expression resulting from an insertion. The second plasmid contains a functional EGFP 
but no promoter.  ECHR is measured by the percentage of cells with restored EGFP expression. (Yanez, 
2002) (b) ICHR. An integrated construct containing a hygromycin resistance cassette is flanked by two non-
functional neomycin genes. One gene is disrupted by an I-SceI recognition sequence and the second gene is 
truncated at the 5’ end. ICHR restoring neomycin resistance can occur through conservative or non-
conservative pathways. (Yun, 2004) (c) SSA. The integrated cassette contains a GFP ORF truncated at the 3’ 
end which is upstream of a puro selection marker. Downstream is the 3’ region of the GFP ORF which 
contains an I-SceI recognition sequence. SSA is measured by GFP expression. (Stark, 2004) (d) dsGT. A 
hygromycin disruption cassette is used which contains homology to a locus of interest.  Homologous 
regions are indicated with thick black lines. Selection is performed in hygro and dsGT is measured by 
disruption of the locus of interest. (Yun, 2004) (e) ssGT. A reporter construct is integrated into cells and 
contains a reporter gene disrupted by an I-SceI recognition sequence. A repair ssO removes the I-SceI site 
and restores the wild-type reporter sequence. ssGT is measured by expression of the reporter gene. 
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recombination observed in each assay is unknown and controversy exists surrounding the 
mechanisms proposed.  However, there is stronger evidence supporting the differential 
use of SI- or SSA-mediated recombination in each assay.  In addition, as my work focuses 
on determining the functions of Rad52 and identifying its role in SI and SSA pathways, it 
will be noted which SI or SSA pathway is associated with each assay.   
 
Extrachromosomal Homologous Recombination 
ECHR involves two homologous plasmids, each containing the same reporter gene (e.g. 
GFP or antibiotic resistance selection markers).  However, expression of both reporter 
genes is disrupted by different mutations, such as insertions or deletions within the ORF 
or removal of the promoter (Figure 1.10a).  Reporter gene expression is restored when 
recombination between the two plasmids occurs.  There is evidence that ECHR occurs via 
the SI and SSA pathways in the absence of DSBs (Seidman, 1987) however, the pathway 
choice is shifted in favour of SSA-mediated pathways when both plasmids are linearised 
(Lin, 1984; Pont-Kingdon, 1993).   
 
Intrachromosomal Homologous Recombination 
ICHR requires chromosomal integration of a reporter cassette that contains two 
homologous though non-functional reporter genes separated by a functional selection 
marker (e.g. hygro) (Liang, 1996; Yun, 2004).  In Figure 1.10b, a neomycin gene (S2neo) is 
disrupted by an insertion (i.e. an endonuclease restriction site or premature stop codon) 
which yields non-functional reporter gene products.  In the second neomycin gene 
(3’neo), both the promoter and 5’ ORF sequences are deleted.  Variations of this reporter 
cassette may include a functional ORF of the second reporter gene instead of a truncation 
though the absence of a promoter directly upstream remains the same (Ludwig, 1994; 
Nickoloff, 1992).  Introduction of a site specific DSB, within S2neo, stimulates ICHR.  
Conservative ICHR between S2neo and 3’neo, which restores functional expression of the 
neomycin gene while maintaining the presence of the selection marker, is believed to 
occur by SI-mediated pathways.  In contrast, non-conservative ICHR which restores 
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functional expression of the neomycin gene but deletes the selection marker is thought to 
be achieved through SI- and SSA–mediated pathways (Agmon, 2009; Yun, 2004).  
 
Single Strand Annealing 
The design of this reporter construct is similar to that of ICHR with slight modifications.  
Two non-functional reporter genes are separated by a selection marker though the first 
reporter gene (5’GFP, Figure 1.10c) is truncated at its 3’ end and the second reporter 
gene (SCEGFP3’, Figure 1.10c) contains an inserted endonuclease restriction site.  
Successful SA results in deletion of the selection marker and restoration of reporter gene 
expression.  The recombination products of this assay are largely generated through SSA-
mediated pathways (Stark, 2004). 
 
Gene Targeting with Double Stranded DNA 
dsGT is conducted with a replacement-type strategy (Hasty, 1991) and involves the 
construction of an exogenous linear dsDNA targeting construct.  The targeting construct 
contains non-homologous sequences of interest which are surrounded by regions sharing 
homology to the target locus (Figure 1.10d) (Yanez, 1999).  The non-homologous 
sequences of interest can be selection markers used to disrupt the target locus or 
mutations used to modify expression at the locus.  Recombination between the targeting 
construct and the endogenous locus results in the introduction of the sequences of 
interest into the target locus.  The frequency of dsGT can be stimulated as high as 5000-
fold with the generation of a site specific DSB within the target locus (Donoho, 1998; 
Liang, 1996; Taghian, 1997).  dsGT is largely believed to occur through SI-mediated 
recombination as Rad51 overexpression is stimulatory and the recombination products 
are conservative, implying that SSA-mediated recombination is not responsible 
(Pennington, 1991; Yanez, 1999). 
 
Gene Targeting with Single Stranded DNA 
ssGT is similar to dsGT except the targeting construct is replaced with ssDNA (Figure 
1.10e).  The ssDNA templates used can include single stranded oligonucleotides (ssOs) or 
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chimeric RNA/DNA oligonucleotides, although chimeric RNA/DNA oligonucleotides are 
used with less frequency as a result of variable and conflicting results (Ino, 2004).  A DSB 
can be introduced into the target locus as spontaneous ssGT frequencies are low.  There 
is conflicting evidence regarding the mechanism of ssGT.  One study suggested that the 
mechanism of ssGT is distinct from HR (Wang, 2006) while evidence from other studies 
support HR.  However, these studies supporting HR pathway have observed contrasting 
results ranging from evidence suggesting that ssGT is SSA-mediated, dependent on Rad52 
(Radecke, 2006b) and inhibited by Rad51 (Storici, 2006) or alternatively, that ssGT is SI-
mediated and dependent on Rad51 and the Rad51 paralogue XRCC3 (Liu, 2004; 
McLachlan, 2009).  Considering the discrepancies, it is possible that ssGT may be achieved 
through multiple recombination pathways. 
1.9.2 Gene Targeting: An Ideal Form of Gene Therapy 
GT involves the introduction of an exogenous fragment of DNA possessing homology to a 
target locus of interest where its stable integration is achieved through HR.  This method 
is ideal for studying the function of a specific locus, such as generating knockout cells or 
introducing known mutations to an endogenous locus.  It is ideal for gene therapy 
strategies where the disease locus is corrected (gene correction).  The drawback for use in 
gene therapy is the inefficiency of GT with respect to the total number of targeted events 
as well as the high number of off-targeting events (random integrations) (Chapter 6).  
Although gene augmentation strategies using viral vectors can yield high integration 
frequencies (up to almost 60% of infected cells) (Cavazzana-Calvo, 2007; Gaspar, 2004), 
negative outcomes can include inappropriate regulation and/or unstable expression of 
the therapeutic gene and risks associated with insertional mutagenesis, such as activation 
of proto-oncogenes.  Integrating lentiviruses have more appeal over retroviruses because 
they are thought to be less likely to integrate close to genes like retroviruses.  
Alternatively, the use of non-integrating lentivirals removes the risks associated with 
insertional mutagenesis however, expression of the therapeutic gene is lost in 
proliferating tissue (Wanisch, 2009). Thus GT remains the ideal therapy for correcting a 
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disease locus as transgene expression will be sustained under control of the endogenous 
locus.  However, for this method to be used as a practical approach, a more 
comprehensive understanding of the mechanism of HR is required so that GT efficiencies 
can be improved.   
1.9.3 Rad52 Overexpression Studies: The Potential of Promoting HR and 
GT 
As Rad52 is involved in both SI- and SSA-mediated pathways, its overexpression has the 
potential to increase the efficiency of HR, including GT.  With this in mind, several groups 
conducted Rad52 overexpression experiments though large variations were observed 
between the resulting effects, such as dsGT efficiencies ranging from a 3-fold inhibition 
(Yanez, 2002) to a 37-fold stimulation (Di Primio, 2005).  In some cases, increases in ECHR 
or ICHR were accompanied by increased resistance to IR (Johnson, 1996; Park, 1995) 
providing evidence for the physiological significance of the HR assays used.  It is likely that 
the variability of observed HR effects reflects the differences in the choice of host cell, 
type of HR assay, species of Rad52, and degree of Rad52 overexpression.  As the 
mechanism(s) directing spontaneous vs DSB-induced HR are unknown, the use of a DSB 
within the target locus to stimulate HR may also differently influence the resulting HR 
efficiencies.  In only a few instances was the effect of changing just one variable explored.  
A summary of the experimental variables and results of Rad52 overexpression is displayed 
in Table 1.   
 
In the absence of a DSB, hRad52 stimulated ECHR though inhibited dsGT in HT1080 cells 
(Table 1, Rows 2 and 5).  Again in HT1080 cells, a discrepancy was observed when dsGT 
and ssGT were measured.  For dsGT, overexpressed hRad52 was inhibitory while for ssGT 
it was stimulatory (Table 1, Rows 5 and 8).  A negative effect of hRad52 on ICHR in 
hamster cells was also noted and this effect was the same for both transient and stable 
expression of hRad52 (Row 12) (Kim, 2001).  The results of the hRad52 overexpression 
studies suggest that excess hRad52 may negatively affect SI mechanisms (i.e. dsGT and 
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non-SSA forms of ICHR) and conversely, positively affect SSA mechanisms (i.e. ECHR and 
ssGT).  However, it would seem that the effects of overexpressing hRad52 and scRad52 
are not shared.  In HeLa cells, expression of scRad52 stimulated DSB-induced dsGT by up 
to 37-fold (Row 3) (Di Primio, 2005).  In addition, purified scRad52 protein with the ability 
to permeate the nuclear membrane, was able to elevate DSB-induced ICHR and DSB-  
 
Table 1.1. Effects of Rad52 overexpression on HR. 
 
HR Assay 
Rad52 
Species 
Host Cella 
I-SceI 
DSB 
Effect on HR Reference 
1 ECHR Yeast HT1080 N ↑ 12-fold (Johnson, 1996) 
2 ECHR Human HT1080 N ↑ 2.5-fold (Yanez, 2002) 
3 dsGT Yeast HeLa N ↑ 37-fold (Di Primio, 2005) 
4 dsGT Yeast HeLa N ↑ 50-fold (Kalvala, 2010) 
5 dsGT Human HT1080 N ↓ 2-fold (Yanez, 2002) 
6 dsGT Human HT1080 N ↓ 4-fold a 
7 dsGT Human HT1080 Y No effect a 
8 ssGT Human HT1080 N ↑ 12-fold a 
9 ssGT Human HT1080 Y ↑ 3-fold a 
10 ICHR Yeast HeLa N ↑ 63-fold (Kalvala, 2010) 
11 ICHR Human FSH2 N ↑ 3-5-fold (Park, 1995) 
12 ICHR Human CHO Y ↓ 2-fold (Kim, 2001) 
13 ICHR Human HT1080 N ↑ 2-fold (Kim, 2001) 
14 ICHR Human HT1080 Y ↓ 2-fold (Kim, 2001) 
a. Vangala & Porter, unpublished 
 
induced dsGT up to 63-fold and 50-fold, respectively (Rows 4 and 10) (Kalvala, 2010).  Di 
Primio et al. proposed that scRad52 is characteristically more efficient than hRad52 in HR.  
The observation that scRad52 possesses two domains which can perform SSA and 
mediate recombination (Section 1.6.1) supports Di Primio et al.’s hypothesis.  
Alternatively, scRad52 may have an advantage over hRad52 in promoting HR in human 
cells because scRad52 is unlikely to interact efficiently with human proteins and will thus 
not inhibit or conversely, be inhibited by the human proteins.  Indeed, scRad52 does not 
interact efficiently with hRad51 (Wu, 2008) and the same is likely of hRPA as the Rad51 
and RPA binding domains of scRad52 and hRad52 do not share large regions of homology.   
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1.10 Aims and Objectives 
Although Rad52 is conserved between yeast and humans, it is evident that the two 
proteins possess different functions in their respective species and with one another.  
DNA repair in Δscrad52 mutants is largely impaired whereas hRad52-/- cells do not exhibit 
sensitivity.  In addition, the HR effects between the two overexpressed Rad52 proteins in 
mammalian cells are not comparable.  Both scRad52 and hRad52 have been subjected to 
extensive study though rarely were comparative studies of the two proteins performed.  
This has resulted in disjointed comparisons between scRad52 and hRad52 and has raised 
questions regarding the roles of scRad52 and hRad52 in dsGT, ssGT and other 
recombination pathways.  Research studying scRad52 and hRad52 in parallel could 
enhance our understanding of the functional roles of each protein in HR and DNA repair 
as well as contribute to optimising the efficiency of GT.  
 
My research focuses on using an inducible promoter system to regulate stable 
overexpression of seven Rad52-related proteins in the human fibrosarcoma cell line 
HT1080.  Ideally, variables such as transgene expression level, host cell line and locus 
harbouring the Rad52-related transgene will remain constant while experimental 
variables are changed one at a time.  The focus of this work was directed by the following 
hypotheses:   
 
• scRad52 will not inhibit SI or SSA pathways because it lacks the sequence 
homology to interact with, and therefore sequester, hRad51, hRPA and other 
human proteins.  As a result, scRad52 will stimulate both SI and SSA pathways. 
 
• Excess hRad52 is inhibitory to SI pathways (including dsGT) by sequestering 
hRad51 and hRPA which generates a dominant negative effect.  Truncation and 
deletion mutants designed to remove the hRad51 and hRPA binding domains from 
hRad52 will be relieved of the dominant negative effect and will stimulate SI 
pathways to a level similar to scRad52. 
Chapter 1    Introduction 
 
66 
 
 
• Sequestering of hRPA or hRad51 will not affect the efficiency of SSA pathways.  
Full length hRad52, deletion and truncation mutants will all stimulate SSA 
pathways.  
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Chapter 2 Materials and Methods 
2.1 Bacterial Cell Culture 
Competent Escherichia coli (E. Coli) strains NEB-10-beta (New England Biolabs) and TOP10 
(Invitrogen) were used for standard cloning techniques.  Transformations were carried 
out according to the manufacturer’s instructions.  Bacterial cultures were grown in LB 
medium or on LB agar plates supplemented with ampicillin (amp) (75μg/mL).  Cultures 
were frozen at -80°C in 15% glycerol volume per volume (v/v) for long term storage. 
2.2 DNA Isolation and Manipulation 
2.2.1 Isolation of Plasmid and Genomic DNA 
Plasmid DNA was isolated from bacterial cells using mini preparation kits (QIAGEN, 
Zymogen) or HiLink Pure maxi preparation kits (Invitrogen) as directed by the 
manufacturers.  For genomic DNA, cells were washed in PBS and 2x106 cells were 
pelleted.  Genomic DNA was extracted using the Gentra Puregene kit (Qiagen). 
2.2.2 Quantification of Nucleic Acids 
A BioPhotometer (Eppendorf) or NanoDrop ND-1000 spectrophotometer (NanoDrop 
Technologies) was used to quantify DNA.  Concentrations were determined by measuring 
the optical density (OD) at 260nm and converted to μg/mL using: 1 OD unit = 50μg/mL 
DNA. 
2.2.3 Restriction Enzyme Digests and Ligations 
Restriction enzymes were supplied by New England Biolabs (NEB) and reactions were 
performed as per their instructions.  Generally, 5 units of enzyme were used for an 
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incubation of 1hr at the recommended temperature.  Ligations were performed using a 
1:3 molar ratio of vector to insert in a 20μL reaction containing 400 units T4 DNA ligase 
(NEB) and 1x T4 ligase reaction buffer.  Ligations were performed at 16°C for 18hrs. 
2.2.4 Purification of DNA 
Agarose Gel Electrophoresis and DNA Isolation from Agarose Gels 
Agarose gels contained 0.8 – 1% agarose weight per volume (w/v) (BDH or Bioline), tris-
acetate EDTA (TAE, Section 2.12.2) and Sybr Safe (Invitrogen).  Agarose gels were run 
from 50 – 125V.  100bp or 1kb DNA ladder (NEB or Invitrogen) were run alongside DNA 
samples that were mixed with loading dye.  Visualisation was achieved with a blue light 
transilluminator (Invitrogen) and pictures were acquired with Grabit software (UVP).  
Following DNA separation, DNA bands of interest were excised and purified using a 
QIAquick gel extraction kit (QIAGEN) as per the manufacturer’s instructions. 
 
Phenol Extraction and DNA Precipitation 
Plasmids digested at two restriction sites were run on a 0.8% agarose gel to isolate the 
vector of interest.  Bands were gel extracted and purified with gel extraction kits 
(Cambridge Biosciences).  Plasmids digested at one restriction site were first phenol 
extracted to remove protein before being precipitated.  DNA solutions were brought up 
to at least 100μL with dH2O which was followed by the addition of an equal volume of 
phenol chloroform solution (phenol:chloroform:iso-amyl alcohol, 25:24:1) equilibrated 
with 10mM Tris, pH 8.0 (Sigma).  The mixture was vortexed for 30sec and centrifuged for 
1min at 13 000rpm in a bench top centrifuge.  The upper aqueous phase was isolated and 
the volume was again brought up to at least 100μL with dH2O if necessary.  1/10 volume 
or 10uL 3M sodium acetate, pH 5.4 was added and the solution was vortexed.  2x final 
volume or 220μL ethanol was added followed by vortexing.  The DNA was precipitated at 
-80°C for one hour or -20°C overnight.  Samples were centrifuged at 13 000rpm for 15min 
at 4°C and the supernatant was removed.  The DNA pellet was washed in 500μL 70% 
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ethanol and centrifuged for 5min at 4°C.  The supernatant was removed and any excess 
ethanol allowed to evaporate.  The DNA was resuspended in an appropriate volume of TE.   
2.2.5 Polymerase Chain Reaction (PCR) Conditions 
All PCR reactions were carried out in a Peltier Thermal Gradient Cycler 200 (MJ Research).  
In general, each reaction consisted of 1x High Fidelity Buffer, primers (0.5μM, Invitrogen 
and Sigma), dNTPs (250μM each), 3% dimethyl sulfoxide, less than 250ng of template 
DNA, Phusion High-Fidelity DNA Polymerase (0.02U/μL) and varying amounts of dH2O to 
bring each reaction to a volume of 50μL.  All reagents were supplied by NEB, unless 
otherwise specified.    
 
PCR of Rad52-related transgenes for insertion into pINSneoMCS 
PCR was performed with Pfu Polymerase (Promega) with an initial denaturation step at 
96°C for 45sec followed by 30 cycles of 96°C for 45sec, 66°C for 45sec and 72°C for 2min.  
A final extension was carried out at 72°C for 10min.   
 
Colony PCR 
Cells were gently washed in phosphate buffered saline (PBS) and a minimal amount of 
PBS was used to completely cover the surface of the well.  Cells were scraped from wells 
of a 12-well plate with a pipette tip while simultaneously pipetting up a 15μL volume of 
the cell/PBS solution.  10μL of lysis buffer was added to yield final concentrations 1x 
QIAGEN PCR Buffer, 1.0μg/mL Proteinase K (QIAGEN) and dH2O in a final reaction volume 
of 25μL.  The mixture was incubated at 55°C for 1hr and the Proteinase K was heat 
inactivated at 95°C for 10min.  PCR was performed with primer pairs O1/O2 and O1/O3 
with an initial denaturation step at 95°C for 1min.  This was followed by 29 cycles of 95°C 
denaturation for 1min, 57°C annealing for 1min and 72°C extension for 3 min.  The final 
extension was completed at 72°C for 10min. 
 
Site-directed mutagenesis 
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Site-directed mutagenesis (NEB) was performed on pTRE-hRad52 and pTRE-scRad52 (for 
primers, see Appendix).  PCR was carried out using 25 cycles of a denaturation at 96°C, 
annealing at 65°C for 30sec and extension at 72°C for 2:30min.  A final extension at 72°C 
was performed for 10min.   
2.3 Plasmids and Constructs 
2.3.1 pINSneo Derivatives Containing the Rad52-related Transgenes 
pINSneo-Δ238 was created from pINSneo-hRad52 (also referred to as pIN2-neoR52) 
(Brough, 2007) using site-directed mutagenesis (Stratagene) and contains a C to A point 
mutation at position 717 in the open reading frame (ORF) of wild-type hRad52 (Harrison, 
2007).  To generate hRad52-related insertion fragments modified to contain truncations 
or the hemagglutinin (HA) epitope tag (Bialkowska, 2005), PCR was performed using 
pINSneo-hRad52 and pINSneo-Δ238 as templates.  The 12CA5 influenza HA epitope tag 
sequence referred to as HA* in this report, was included in certain primers (See 
Appendix).  In this report, transgenes or proteins containing N-terminal or C-terminal HA 
tags will be indicated with ‘HA’ appearing at the front/end of the transgene name or with 
‘*’ appearing at the front/end of the protein name.  The scRad52 insertion fragment was 
generated by PCR using pREPY52 as a template (A kind gift from C. Campbell, University 
of Minnesota Medical School).  The newly generated Rad52-related transgene inserts 
were digested with the appropriate enzymes (See Appendix) and ligated into 
pINSneoMCS (Brough, 2007).   
2.3.2 pTRE-derived Rad52 Expression Constructs 
PCR of the wild-type hRad52 and scRad52 ORF was performed using pINSneo-hRad52 and 
pREPY52 as templates, respectively.  All reverse primers contain a HA epitope tag 
sequence (Rouet, 1994) denoted as ‘HA’ in this report.  The nuclear localisation signal of 
SV40 large T-antigen (NLS)(Kalderon, 1984a; Kalderon, 1984b) was included in certain 
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primers (See Appendix).  Transgene insertion fragments of hRad52-HA, (NLS)hRad52-HA, 
scRad52-HA and (NLS)scRad52-HA were digested and cloned into the NotI/SalI sites of 
pTRE-Tight (Clontech).  Primers (see Appendix) were used to amplify insertion fragments 
Δ284-HA, (NLS)Δ284-HA, Δ238-HA and (NLS)Δ238-HA by PCR using pTRE-hRad52 or pTRE-
(NLS)hRad52 as a template.  These insertion fragments were cloned into pTRE-Tight.  Site-
directed mutagenesis (NEB) was used, as per the manufacturer’s instructions, to generate 
pTRE-derived plasmids with deletions (Δ405-414 or Δ290-330) or point mutations (Y104E 
and Y104F).  pTRE-hRad52 was used as a template.   
2.4 Cell Culture and Cell Lines 
All cell lines used in this work were derived from the human fibrosarcoma cell line, 
HT1080.  Cell lines were maintained in Dulbecco’s minimal essential medium 
supplemented with 10% fetal calf serum, 50μM L-Glutamine, 20mL of 100x non-essential 
amino acids, 5 mL of 100x penicillin and streptomycin and 25μM sodium pyruvate (all 
reagents provided by GIBCO).  Cells were grown in a humidifying chamber (Napco 5410, 
Precision Scientific) maintained at 37°C with 5.0% CO2.  Antibiotics used and their 
corresponding concentrations under selection or maintained conditions are listed in Table 
2. 
 
Table 2.1. Antibiotic concentrations used for selection or maintenance of cell lines.  
Antibiotic Selection (μg/mL) Maintained (μg/mL) Supplier 
Tetracycline N/A 1.0 Sigma 
Zeocin N/A 100 Invitrogen 
Puromycin 0.4 0.4 Sigma 
Geneticin (G418) 400 300 GIBCO 
Hygromycin 200 100 Sigma 
6-Thioguanine 15 15 Sigma 
HAT 
1x (5mM sodium 
hypoxanthine, 20uM 
aminopterin, 0.8mM 
thymidine) 
1x GIBCO 
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Cells were passaged at a confluency of less than 80%.  Passaging was performed by first 
washing the cells in PBS, trypsinising in 0.25% trypsin (Gibco) and adding fresh medium to 
halt the trypsinisation.  Cells were frozen in 1mL of freezing medium (10% DMSO, 50% 
fetal calf serum, 40% fresh medium) in cryovials (Nunc) and stored at -80°C for at least 
24hrs.  Following this, the cryovials were transferred to a liquid nitrogen storage tank.  
2.4.1 Derivatives of Rht14-10 
Rht14 and Rht14-10 clones were generated by Brough et al. These clones constitutively 
express the tet-transactivator protein which supports tetracycline-regulated expression of 
transgenes in a Tet-Off system.  Derivatives of Rht14-10 (Table 3) were constructed as 
described (Brough, 2007).  Briefly, 2μg of the pINSneo-Rad52-related insertion constructs 
were co-lipofected with 2μg of the cre-recombinase expression plasmid pMC-Cre15 
(kindly donated by H.Gu, University of Köln) per well of a 6-well plate using Lipofectamine 
2000 (Invitrogen) (for Lipofection methods see Section 2.4.5).  The next day, the cells 
were transferred to 10cm plates in varying dilutions.  Selection in G418 was performed 
the following day and continued for 12-14 days.  For flp-mediated excision, 4μg pCAGGS-
flpe (Cambion) were lipofected per well of a 6-well plate.  Following the 4hr incubation 
with the lipofectamine solution, tetracycline (tet) was added to all cultures.  Cells were 
plated at limiting dilutions the following day in 10cm plates and colonies were picked for 
screening after 12-14 days.   
 
Table 2.2. Rht14-10 derivatives containing Rad52-related transgenes in this report.  
Parent Clone Rad52-related Protein N- or C-Terminal HA-Tag Clones 
Rht14-10-hRad52 hRad52 None N/A 
Rht14-10-*hRad52 *hRad52 N-terminal N/A 
Rht14-10-hRad52* hRad52* C-terminal A5, B2 
Rht14-10-*Δ284 *Δ284 N-terminal A4, B1, B4 
Rht14-10-Δ238 Δ238 None N/A 
Rht14-10-*Δ238 *Δ238 N-terminal B2, B3 
Rht14-10-Δ238* Δ238* C-terminal A1, A5 
Rht14-10-scRad52* scRad52* C-terminal N/A 
* denotes N- or C-terminal HA-tag 
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2.4.2 Derivatives of Rht14 
Derivatives of Rht14 expressing the Rad52-related proteins (Table 4) were generated 
through electroporation (for electroporation methods see Section 2.4.5) with SpeI 
linearised pBL-PuroR (Yun, 2004) and a PvuI linearised pTRE-derived Rad52 construct in a 
1:20 molar ratio, respectively.  20μg of pTRE-hRad52 was used with molar equivalents of 
the other pTRE-derived Rad52 constructs.  48hrs prior to electroporation, tet was added 
to all cultures and maintained unless specified.  48hrs post transfection, puro was added 
to all cultures and individual colonies were selected after 10-12 days in selection.  
 
Table 2.3. Rht14 derivatives containing Rad52-related transgenes in this report. 
Clone Rad52-related Protein NLS or C-terminal HA-Tag 
Rht14-hRad52 hRad52* HA-tag 
Rht14-(NLS)hRad52 (NLS)hRad52* NLS, HA-tag 
Rht14-Δ284 Δ284* HA-tag 
Rht14-(NLS)Δ284 (NLS)Δ284* NLS, HA-tag 
Rht14-Δ238 Δ238* HA-tag 
Rht14-(NLS)Δ238 (NLS)Δ238* NLS, HA-tag 
Rht14-Δ290-330 Δ290-330* HA-tag 
Rht14-scRad52 scRad52* HA-tag 
Rht14-(NLS)scRad52 (NLS)scRad52* NLS, HA-tag 
Rht14-Y104E Y104E* HA-tag 
Rht14-Y104F Y104F* HA-tag 
  * denotes C-terminal HA-tag 
2.4.3 Integration of the Mouse hprt Minigene into Rht14-Rad52-Related 
Clones 
Stable clones containing the mouse hprt (mhprt) minigene were generated by linearising 
the mhprt minigene plasmid, pSV2neo-mHPRT, with NdeI.  4μg linearised pSV2neo-
mHPRT was electroporated into HPRT- Rht14-Rad52-related clones.  Selection in G418 
was performed 2 days post-transfection.  Colonies were selected on days 12-14 post-
transfection and tested for tet-regulated expression of the Rad52-related proteins by 
immunoblot.   
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2.4.4 Integration of the SSA Reporter Construct into Rht14-Rad52-Related 
Clones 
To generate stable clones containing the SSA-GFP reporter construct (also referred to as 
hprtSAGFP) (Stark, 2004), 104 Rht14 cells were electroporated with 10μg linearised 
KpnI/SacI SSA-GFP construct.  Selection was performed in puro 2 days following 
electroporation.  Twelve clones were isolated and tested for SSA-repair, as measured by 
GFP expression, by nucleofecting the clones with an I-SceI expression plasmid.  Four days 
post-nucleofection, the cells were analysed for GFP expression by flow cytometry.  Two 
clones, Rht14-SSA-GFP#6 and Rht14-SSA-GFP#9, demonstrated the highest percentages 
of cells with detectable GFP expression levels.  Rht14-SSA-GFP#6, referred to as Rht14-
SSA-GFP in this report, was used as the main clone for the SSA assay. 
2.4.5 Transfection Methods 
Electroporation 
Cells were replated to ~30% confluence 24hrs prior to electroporation to achieve less 
than 75% confluence on the day of transfection.  On the day of transfection, cells were 
washed in PBS, trypsinised and centrifuged at 350xg for 5min.  The desired number of 
cells were resuspended in PBS and pelleted once more.  The cells were resuspended in 
800μL PBS and mixed with DNA and transferred to a pre-chilled 0.4cm gap cuvette 
(Sigma).  The cells were incubated on ice for 5min and electroporated at 400V and 250μF 
using a gene pulser (Biorad) with a capacitance extender.  Cells were immediately placed 
on ice for a further 5min before being transferred to 9.2mL pre-warmed medium.  Cells 
were then plated at the appropriate dilutions. 
 
Lipofection 
Twenty four hours prior to transfection, 2.5x105 cells or 1.3x105 cells were seeded into 6-
well plates or 12-well plates, respectively, which contained antibiotic-free medium.  For 
stable clones containing Rad52-related transgenes, tet was maintained until transfection.  
On the day of transfection the lipofection solution was prepared, as per the 
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manufacturer’s instructions, and contained the DNA to be transfected, Lipofectamine 
2000 (Invitrogen) and OptiMEM.  The cells were washed with PBS and 2mL of antibiotic-
free medium (without tet) was added.  The cells were incubated with the lipofection 
solution for 4hrs where then the solution was removed and fresh medium was added 
(with tet, if applicable).  Cells were replated the following day for stable transfections or 
harvested after 18hrs post-transfection for transient transfections.       
 
Nucleofection 
Cells were trypsinised and washed in PBS and 1x106 cells were resuspended in 100μL of 
nucleofector T solution (Amaxa).  The cell suspension was mixed with 1μg DNA and 
transferred to a nucleofection cuvette.  Cells were nucleofected with program L-005.  
500μL pre-warmed media was added to the cuvette immediately following nucleofection 
before cells were replated.  Similar to post-lipofection, cells were harvested 18hrs post-
transfection to detect transient expression of proteins or antibiotic selection began 48hrs 
post-transfection. 
2.5 Protein Analysis 
2.5.1 Sample Preparation and Protein Quantification 
Cells were washed in PBS, trypsinised and pelleted at 350xg for 5min.  Cells were 
resuspended in 50 - 200μL RIPA buffer (Section 2.12.1) supplemented with 3% v/v of a 
protease inhibitor cocktail (Sigma).  The lysate was incubated at 4°C on a roller for 30min 
and debris was removed by centrifuging at 4°C for 20min at 13 000rpm.  The pellet was 
resuspended in PBS and protein concentrations were quantified using a bicinchoninic acid 
assay (Sigma), as directed by the manufacturer. 
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2.5.2 Immunoblots 
Protein samples were denatured in loading buffer at 65°C for at least 20min.  In general, 5 
- 20μg total protein were loaded into 12% acrylamide gels.  Separation was achieved 
using a Mini-Protean electrophoresis cell (BioRad) at 50V while the samples moved 
through the stacking gel and then 125V when they reached the 12% gel.  Prestained 
protein markers (GE Healthcare, NEB) were used a molecular weight estimates.  The 
proteins were transferred onto an Immobilon-P polyvinylidene difluoride membrane 
(Sigma) using a Trans-Blot SD semi-dry cell (BioRad).  Transferring was generally achieved 
at 500 mAmp for 30min for one membrane.  Membranes were blocked for 1hr in blocking 
solution (5% w/v skim milk powder, 1% v/v Tween20 in tris-buffered saline (TBS)) at room 
temperature with shaking.  Following blocking, membranes were washed in TBS and 1% 
Tween20 (TBST) for 5min and incubated in primary antibody solution (primary antibody 
diluted in blocking solution, for dilutions see Table 5) at 4°C for 16hrs with shaking.  The 
blots were then washed in TBST thrice for 15min and incubated in blocking solution 
containing diluted secondary antibody (Table 5)coupled to horseradish peroxidise (HRP).  
Membranes were again washed thrice in TBST and proteins were detected with ECL 
blotting reagent (GE Healthcare) and visualised on X-OMAT LS-1 film (Kodak).  For 
visualising loading controls, the blots were washed in TBST (4 x 15min) and reprobed with 
anti-actin or anti-GAPDH.   
 
Table 2.4. List of primary and secondary antibodies Used for immunoblotting.  
Target Dilution Species Supplier 
hRad52 1:1000 Rabbit S. West, South Mimms 
hRad52 
1:1000 – Immunoblot 
1:100 - Immunofluorescence 
Rabbit Cell Signaling 
scRad52 1:500 Rabbit Santa Cruz 
12CA5 1:2000 Mouse Autogenbioclear 
HA Tag 1:1000 Mouse Cell Signaling 
Actin 1:250 Rabbit Sigma 
GAPDH 1:1000 Rabbit Cell Signaling 
HA Tag 1:10 
Mouse (Alexa Fluor 488-
coupled) 
Cell Signaling 
Rabbit 1:2000 Goat (HRP-coupled) DAKO 
Rabbit 1:2000 Goat (HRP-coupled) Cell Signaling 
Mouse 1:1000 Goat (HRP-coupled) DAKO 
Mouse 1:2000 Goat (HRP-coupled) Cell Signaling 
Rabbit 1:250 Goat (Alexa Fluor 488-coupled) Cell Signaling 
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2.6 Flow Cytometry 
2.6.1 Analysis of GFP Expression Levels in Rht14-10 
Cells were grown in a 75cm2 flask with or without tet for 48 hours.  Rht14-10 cells used 
for transfection with the control plasmid pmax GFP (Amaxa) were harvested 18 hours 
after nucleofection.  A fix and perm kit (Caltag Laboratories) was used to prepare 5x105 
cells as per the manufacturer’s instructions.  Cells were resuspended in a final volume of 
1mL PBS and analysed by flow cytometry. 
2.6.2 DNA Content Analysis 
At least 106 cells were harvested, washed in PBS and resuspended in 300μL PBS.  Ice cold 
ethanol (700μL) was added to the cells while vortexing which was followed by incubating 
the cells on ice for 1hr or storing the samples at -20°C overnight.  Cells were centrifuged, 
washed and resuspended in 500μL of a solution containing PBS and 0.2mg/mL RNase A 
(QIAGEN).  The samples were incubated at 37°C for 1hr prior to adding propidium iodide 
(PI) to a final concentration of 40μg/mL.  The cells were then analysed by flow cytometry. 
2.7 Stabilities of the Rad52-related Proteins 
Clones were grown without tet for 48hrs to induce expression of the Rad52-related 
proteins before adding tet.  For transient expression, Rht14 cells were nucleofected with 
1μg of pTRE-Rad52-related expression plasmid in the absence of tet 48hrs prior to the 
addition of tet.  Following the addition of tet, cells were harvested at various time points 
for 24hrs.  Harvested cells were lysed in RIPA containing protease inhibitor cocktail and 
stored until they were prepared for immunoblot analysis. 
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2.8 Immunofluorescence 
Cells were grown on cover slips in a 6-well plate for 48 hrs with or without tet.  Cells were 
first fixed with 4% paraformaldehyde for 10 min followed by permeabilisation in 0.5% 
Triton X-100 for 10min.  Blocking (5% v/v fetal calf serum, 3% w/v bovine serum albumin, 
in PBS) was performed for 1hr at room temperature.  Detection of human Rad52 
derivatives was performed by incubation with primary anti-hRad52 antibody (1:100 
dilution) for 1hr followed by washing three times with blocking solution for 5min each.  
Incubation with secondary antibody conjugated to an Alexa Fluor molecule (1:250 
dilution) was performed for one hour.  HA-tagged proteins were incubated with a primary 
antibody directly conjugated to a fluorescent Alexa Fluor molecule for 1hr (1:10 dilution, 
Cell Signalling Technology), incubation with a secondary antibody was not required.  
Following antibody incubation, cells were washed twice with blocking solution and once 
with PBS.  Cover slips were mounted on slides with VectaShield containing 1.5μg/mL DAPI 
(Vector Labs).  Visualisation was achieved with a Deconvolution microscope (Leica). 
2.9 γ-Irradiation 
Clones were grown in 10cm plates in the presence or absence of tet for 48hrs prior to γ-
irradiation with a cesium-137 irradiator using various doses (0-8Gy).  Cells were 
immediately trypsinised and replated at limiting dilutions in 10cm or 15cm plates.  Tet 
was not readded to –tet cultures following irradiation.  Colonies were stained with crystal 
violet solution and counted 12-16 days post-irradiation.   
2.10 Growth Curves 
Clones were grown with or without tet in 10cm plates for 48hrs prior to counting the cell 
numbers.  The presence or absence of tet was maintained in cultures throughout the 
duration of the experiment.  Every 2-3 days the cells were passaged to maintain 
subconfluent cultures and numbers of cells were counted.  Rht14 and induced and 
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uninduced Rht14-hRad52, Rht14-(NLS)Δ284, Rht14-(NLS)Δ238 and Rh14-(NLS)scRad52 
clones were grown in parallel while induced and uninduced Rht14-Δ290-330, Rht14-
Y104E and Rht14-Y104F clones were grown in parallel. 
2.11 Homologous Recombination Assays 
2.11.1 Gene Targeting with Double Stranded DNA 
Cells were grown for 48 hrs in the presence or absence of tet.  Cells (2x107) were 
electroporated with 10μg SalI-digested pHPRThyg.  For nucleofections, 1.5x107 cells were 
nucleofected (3x106 cells/cuvette in 5 cuvettes) with 1μg of SalI-digested pHPRThyg.  The 
number of targeted integrants was measured by seeding 2.5x106 cells/15cm plate for 
electroporations or 2x106 cells/15cm plate for nucleofections, in seven plates where 
hygromycin (200μg/mL) was added on day 2 post-transfection and 6-thioguanine 
(15μg/mL) on day 7 post-transfection.  To measure the number of random integrations, 
105 – 2x105 cells were plated in 10cm plates in triplicate and hygromycin was added on 
day 2.  100 - 250 cells were plated in triplicate and grown without selection to measure 
plating efficiencies.  On day 2 post-transfection, tet was added to all cultures and 
maintained throughout the experiment.  Colonies were stained with crystal violet and 
counted on day 12 - 14. 
2.11.2 Gene Targeting with Single Stranded Oligonucleotides 
Clones were grown in the presence or absence of tet 48hrs prior to lipofection and 
supplementation with 6-TG was discontinued.  Lipofections were performed in 6-well 
plates using 2μg I-SceI expression plasmid and 2μg repair ssO.  The day following the 
transfection, 1.75x105 cells were seeded in triplicate in 15cm plates and 1 x HAT 
supplement was added on day 5 post-transfection.  75 – 200 cells were also plated in 
triplicate without selection.  All plates were stained with crystal violet solution on day 12-
14.     
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2.11.3 Single Strand Annealing Assay 
Rht14-SSA-GFP or Rht14-SSA-GFP#9 were nucleofected with 0.4μg I-SceI expression 
plasmid and 0.6μg pTRE-(NLS)scRad52 or equimolar amounts of the other pTRE-Rad52-
related expression plasmids or pTRE-Tight control plasmid.  0.5μg pmax GFP (Amaxa) was 
also used as a positive control plasmid.  3 days post-transfection, the cells were harvested 
and analysed for GFP expression by flow cytometry.   
2.12 Commonly Used Solutions 
2.12.1 Solutions for Protein Analysis 
20x TBS 
400mM Tris-HCl, 2.75M NaCl, pH 7.4 
 
TBST 
1% v/v Tween 20 in 1x TBS 
 
Blocking Solution 
5% w/v skim milk powder in TBST 
 
3x protein loading buffer 
34mM Tris-HCl, pH 6.8, 5.7% w/v SDS, 15% v/v β-mercaptoethanol, 28% v/v glycerol, 
0.06% w/v bromophenol blue 
 
5x running buffer 
250mM Tris-base, 2M glycine, 17mM SDS 
 
RIPA 
150mM NaCl, 1% NP-40, 0.5% deoxycholic acid, 0.1% SDS, 50mM Tris-HCl, pH 8.0 
 
Stacking gel 
375mM Tris-HCl, pH 6.8, 4.5% v/v acrylamide, 3.5mM SDS, 0.4% v/v TEMED, 2.6mM 
ammonium persulfate 
 
12% Separating gel 
375mM Tris-HCl, pH 8.8, 12% v/v acrylamide, 3.5mM SDS, 0.33% v/v TEMED, 2.2mM 
ammonium persulfate 
 
Transfer buffer 
200mM glycine, 25mM Tris, 20% v/v methanol 
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2.12.2 Solutions for DNA Analysis 
50x TAE 
2M Tris, 50mM EDTA, 57.1% v/v glacial acetic acid 
 
DNA loading dye (10x) 
0.5% w/v Orange G, 60% glycerol, 180mM Tris, pH 8.0, 100mM EDTA, pH 8.0 
2.12.3 Solutions for Culturing Bacteria 
LB medium 
10% w/v bacto-tryptone, 5% w/v bacto-yeast extract, 170mM NaCl, pH 7.0 
 
LB Agar 
15% w/v agarose in LB medium 
 
SOC medium 
20% w/v bacto-tryptone, 5% bacto-yeast extract, 9mM NaCl, 2.5mM KCl, 10mM MgCl2, 
20mM glucose, pH 7.0 
2.12.4 Other Solutions 
Crystal Violet Staining Solution 
100mL ethanol, 10g crystal violet, 900mL dH2O 
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Chapter 3 Locus Specific Tet-Regulated Expression of 
the Rad52-Related Proteins 
3.1 Introduction 
3.1.1 Tet-Regulated Transgene Expression 
To address the hypothesis that hRad52 truncation mutants lacking the Rad51 and/or RPA 
binding domains will not generate a dominant-negative effect on dsGT, a regulated 
expression system is desirable because it allows a systematic comparison of the effects of 
overexpressing different transgenes.  If combined with site-directed integration of the 
transgene, the regulated expression system can achieve similar transgene expression 
levels between clones in addition to providing control over protein expression.  Similar 
transgene expression levels would enable more meaningful comparisons of different 
clones expressing different transgenes.  Furthermore, the ability to regulate transgene 
expression would be useful should the transgene product be harmful to the cells.  Indeed, 
in one study overexpressed hRad52 was unstable and negatively affected cell viability 
(Yanez, 2002) thus demonstrating that regulation of hRad52 would be ideal.  With 
regulated transgene expression, the ability to induce or inhibit expression within the 
same clone would allow informative comparisons to be made because cells with inhibited 
transgene expression could be used as a negative control.  This would avoid the problem 
of phenotypic differences that relate to clonal variation rather than the transgenes.  
Overall, site-directed integration and regulated transgene expression would circumvent 
the problems associated with variable day-to-day transfection efficiencies and clonal 
variability when directly comparing the overexpression effects between different clones.  
For instance, although Di Primio et al. reported that overexpression of scRad52 generated 
a 37-fold increase in dsGT efficiencies over the control clone, the result may not be 
meaningful because the comparisons were made between different clones (Di Primio, 
2005).   
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For such reasons, a stringently regulated expression system was thus adopted in the 
HT1080-derived Rht14-10 cell line (Figure 3.1) (Brough, 2007).  The system, termed 
screen and insert (ScIn), utilises site-specific recombination to integrate a promoterless 
insertion construct, containing a neomycin selection marker followed by a transgene of 
interest, at a pre-determined genomic site.  The genomic site is known to support tight 
tet-regulated gene expression which is achieved through the tet-responsive promoter 
(TRP).  The TRP, which consists of a minimal CMV promoter and tet-responsive element 
(TRE), is activated upon association with the tet-transactivator (tTA) which is 
constitutively expressed in Rht14-10 cells.  In the absence of tet, the tTA binds to the TRE 
and promotes expression of the integrated transgene.  However, in the presence of tet, 
the tTA binds to tet and dissociates from the TRE which inhibits transgene expression.  
Successful integration events of the promoterless insertion construct can be enriched 
through selection in G418 in the absence of tet, to promote expression of the neomycin 
gene. A second round of site-specific recombination then follows and results in excision of 
the neomycin gene which brings the transgene of interest under control of the TRP.  This 
step is performed in the presence of tet.  The ScIn system is attractive because different 
transgenes can be integrated at the same locus in different clones and can still achieve 
similar transgene expression profiles.   
 
The ScIn system was used to generate clones Rht14-10-hRad52 (also referred to as 10IN-
R52.1flp) (Brough, 2007) and Rht14-10-Δ238 (Harrison, 2007) which, respectively, express 
hRad52 and Δ238, a hRad52 truncation mutant lacking the central and C-terminal 
domains.  Inducible expression of hRad52 in clone Rht14-10-hRad52 was confirmed by 
immunoblot (Brough, 2007), but a similar analysis of Rht14-10-Δ238 was not carried out.  
Thus, comparison of Rad52-related protein expression levels in these two clones was 
therefore a starting point for investigating the effects of the Rad52-related proteins.   
This chapter also focuses on the design of additional Rad52-related proteins and the 
generation of stable clones with site-specific and tet-regulated expression of the Rad52-
related transgenes.  
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Figure 3.1. Screen and Insert (ScIn) Strategy. A. ‘Pop-in’ or insertion step: Cre-mediated 
recombination between two recombinant LoxP sites (Lox71 and Lox66) found within the locus of 
interest (a) and the promoterless expression construct (b) directs site-specific integration of the 
construct (c) behind the tet-responsive promoter (TRP).  In the absence of tet, enrichment of cells 
that performed cre-mediated recombination occurs by selection in G418.  B. ‘Pop-out’ or deletion 
step: Flpe-mediated recombination between two frt sites on either side of the neomycin gene 
results in deletion of the neomycin gene which brings the Rad52-related transgene under control 
of the TRP (d). (Modified from Brough, 2007) 
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3.2 Results 
3.2.1 The Rad52-Related Proteins 
To determine the effect on HR of removing the hRad51 and/or hRPA binding domains 
from hRad52, two C-terminal truncation mutants were designed (Figure 3.2) in the lab by 
Alex Harrison.  Δ284 lacks the Rad51 binding domain whereas Δ238 consists only of the N-
terminal domain.  At the time of protein design, the location of the NLS within the C-
terminal domain of hRad52 had been overlooked.  In addition, a function had not been 
associated with the C-terminal domain of hRad52 and, as there was evidence that the N-
terminal domain was sufficient to catalyse strand annealing reactions in vitro (Bi, 2004; 
Singleton, 2002), it was removed in both truncation mutants.     
 
Although Rht14-10-hRad52 and Rht14-10-Δ238 were already created by Rachel Brough 
and Alex Harrison, respectively, they could not be used for systematic comparisons with 
the Rht14-10-Rad52 clones in development as neither Rad52-related protein product 
contained an epitope which would permit antibody detection alongside scRad52.  
Because this would make comparing the clones difficult, the Rad52-related proteins were 
redesigned to include hemagglutinin (HA) sequences at the N- or C-terminus (Figure 3.2).  
For use in the ScIn system, new promoterless insertion constructs for the redesigned 
Rad52-related transgenes were generated using standard cloning techniques (described 
in Section 2.2.5 and 2.3.1).  The plasmid pINSneo-hRad52 (also referred to as pIN2-
neoR52), which was used to generate clone Rht14-10-hRad52 (Brough, 2007), was used 
as a starting point for the generation of the new insertion constructs.  Site-specific 
integration of the insertion constructs into Rht14-10 will be discussed in Section 3.2.3. 
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Figure 3.2. Map of the Rad52-related proteins. Schematic representation of the known domains 
of hRad52 and scRad52 (see Figure 1.9).  The Rad52-related proteins contain HA-tags at the N-
termini or C-termini as indicated. 
  
Chapter 3    Locus Specific Tet-Regulated Expression of the Rad52-Related Proteins 
 
87 
 
3.2.2 Overexpression of hRad52 and Δ238 and Their Effects on Gene 
Targeting with Double Stranded DNA 
Whilst the HA-tagged Rad52-related transgenes were undergoing insertion into Rht14-10 
using the ScIn system, the previously generated clones Rht14-10-hRad52 and Rht14-10-
Δ238 (Brough, 2007; Harrison, 2007) were used to obtain preliminary evidence regarding 
the effect of removing the hRad51 and hRPA binding domains on dsGT.  However, tet-
regulation of the two Rad52-related proteins first needed to be confirmed.  The clones 
were grown in the presence (+tet) or absence (-tet) of tet to inhibit or induce transgene 
expression, respectively, for 48hrs.  Rad52-related protein levels were visualised by 
immunoblot using a monoclonal α-hRad52 antibody raised against an epitope in the N-
terminal domain.  Tightly regulated expression of the Rad52-related proteins was noted: 
detectable levels of Rad52-related protein products are observed in the absence of tet 
(lanes 2 and 4) but cannot be observed in the presence of tet (lanes 1 and 3) (Figure 3.3).  
Although I neglected to perform loading controls for this immunoblot, protein 
concentrations of cell lysates were measured and similar quantities (10μg) were loaded 
into each well.  hRad52 levels appear higher than Δ238 though both Rad52-related 
protein levels are in excess of endogenous levels of hRad52, which are only faintly visible 
on the blot and may not be easily discerned in the figure (Figure 3.3). In previous work 
using HT1080, endogenous hRad52 levels were similarly low or undetectable (Brough, 
2007; Yanez, 2002).  The upper bands present in lanes 2 and 4 correspond with the MWs 
of hRad52 and Δ238, respectively, whereas the lower bands are likely degradation 
products. 
 
dsGT of Rht14-10-hRad52 and Rht14-10-Δ238 were measured with a GT assay that uses a 
dsDNA targeting construct to disrupt the HPRT locus (Figure 3.4).  The advantage of 
targeting the HPRT locus is that random integration (RI) events can be measured with 
selection in hygromycin (Hygr) while targeted integration (TI) events can be measured by 
selection in hygromycin and 6-thioguanine (6-TG) (6-TGr+Hygr),the latter of which is toxic 
to HPRT+ cells.  Cells were grown for 48hrs with or without tet prior to transfection and 
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tet was added to cultures 2 days post transfection (For detailed descriptions of the 
methods, see Sections 2.11.1).  TI to RI ratios were calculated for each transfection (Table 
6) and used to calculate fold stimulations of dsGT by comparing the experiments 
conducted in the presence or absence of tet for each clone.  Overexpression of hRad52 
slightly stimulated dsGT (1.4-fold) which was contrary to the 2-fold inhibitions previously 
observed (Yanez, 2002).  However, expression of Δ238 enhanced dsGT greater than 3-fold 
which was largely due to a decrease in the absolute frequency of RI events.  It should be 
noted that there were problems with efficient selection in hygromycin and that the 
experiment was only performed once and would need to be repeated.  Nevertheless, the 
preliminary results suggest that removal of the hRad51 and hRPA binding domains of 
hRad52 can increase dsGT by inhibiting RI. 
 
Table 3.1. dsGT Efficiencies in Rht14-10-hRad52 and Rht14-10-Δ238. 
Cell Line Tet 
6-TGr+Hygr Events 
(per 7.5x105 cells 
plated) 
Hygr Events 
(per 1.6x104 
cells plated) 
Absolute Frequency 
(per 105 cells plated) TI:RIc 
TIa RIb 
dRht14-10-
hRad52 
+ 33 51 4.4 318 1:71 
- 39 44 5.2 275 1:52 
dRht14-10-
Δ238 
+ 18 76 2.4 475 1:197 
- 22 27 2.9 169 1:57 
a Calculated by dividing the number of 6-TGr+Hygr events by 7.5. 
b Calculated by dividing the number of Hygr events by 0.16. 
c The absolute targeted frequency was subtracted from the absolute RI frequency.  Both the absolute 
targeted frequency and this difference were divided by the absolute targeted frequency to obtain the 
ratio. 
d Each dsGT experiment was performed once for each clone (n=1). 
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Figure 3.3. Immunoblot of hRad52 and Δ238 protein levels in clones Rht14-10-hRad52 and 
Rht14-10-Δ238. Tet-regulated expression of the full length Rad52 (46kDa) in clone Rht14-10-
hRad52 was previously detected (Brough, 2007) though not compared with levels of Δ238.  Tet-
regulated expression of Δ238 in Rht14-10-Δ238 was tested.  No expression was detected when tet 
was present (lane 3) and protein of the expected size (26kDa) was visible in lane 4 in the absence 
of tet.  The immunoblot was performed with a monoclonal α-hRad52 antibody that was raised 
against an epitope in the N-terminal region.  Protein estimates were performed for each sample 
and 10μg of total protein was loaded per well.  The band above the estimated size of hRad52 
(lane 2) may be a form of hRad52 containing a PTM.  The bands below hRad52 may be 
degradation products. 
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Figure 3.4. Human HPRT Gene Targeting Assay using a dsDNA Targeting Construct. Step 1: 
Rht14-10-hRad52 and Rht14-10-Δ238 clones were grown +/- tet for 48hrs and electroporated 
with linearised pHPRThyg.  pHPRThyg was designed to disrupt exon 2 of the hHPRT locus.  Step 2: 
The disruption construct integrated randomly or within exon 2 of the hHPRT locus.  Step 3: 
Hygromycin was added to one pool of cells from days 2-14.  Hygromycin (days 2-14) and 6-TG 
(days 5-14) were added to a second pool of cells.  Step 4: After 14 days, the frequency of total 
integrations (hygror colonies) or the frequency of TI (hygror + 6-TGr) were calculated.  The 
frequency of RI was calculated by subtracting the frequency of TI from the frequency of total 
integrations. 
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3.2.3 Screen and Insert of HA-Tagged Rad52-Related Proteins into Rht14-
10 
The ScIn system was used to insert promoterless insertion constructs, containing a 
neomycin selection marker followed by the Rad52-related transgene of interest (encoding 
the protein products are depicted in Figure 3.2), downstream of the TRP in Rht14-10 cells.  
This was performed through cre-mediated recombination (‘pop-in’) (Figure 3.5a, for 
detailed descriptions of the methods see 2.3.1 and 2.4.1).  No G418r colonies were 
generated unless the promoterless insertion constructs were co-transfected with the cre-
expression plasmid, indicating that Cre-mediated insertion of the constructs was achieved 
(Table 7).  Co-transfection with the cre-expression plasmid in conjunction with selection 
and in the presence of tet yielded at most one G418r colony.  This confirmed that, for the 
bulk of G418r colonies, neomycin expression was stringently regulated by the TRP.   
 
Finally, flpe-mediated (‘pop-out’) recombination was performed to remove the neomycin 
gene and bring the Rad52-related transgene under control of the TRP.  Following 
transfection of a flp-expression construct, individual clones were obtained by performing 
limiting dilutions of the ‘pop-out’ cells and allowing colonies to form.  To determine if the 
‘pop-out’ event was successful, individual clones that exhibited sensitivity to G418 were 
identified and screened by colony PCR using primers pairs (O1/O2 or O1/O3) that 
annealed within the TRP and the particular Rad52-related transgene (Figure 3.5a) (for a 
description see 2.2.5).  Clones containing both the neomycin and scRad52 genes (i.e. 
‘pop-in’ products) were expected to amplify a 2.8kb fragment, while their ‘pop-out’ 
derivatives were expected to amplify a 689bp fragment (Figure 3.5a).  Colony PCR 
products of potential Rht14-10-scRad52 ‘pop-out’ clones are displayed in Figure 3.5b.  
PCR of clones containing the hRad52-related transgenes (hRad52, Δ284 and Δ238) was 
expected to yield a 2.6kb fragment for ‘pop-in’ events and a 530bp fragment for 
successful ‘pop-out’ events (Figure 3.5a).  Colony PCR products of potential Rht14-10-
Δ284 ‘pop-out’ clones are displayed in Figure 3.5c.  Neither 2.8kb nor 2.6kb ‘pop-in’ 
fragments could be amplified for ‘pop-in’ clones which was unexpected because they 
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were amplified in previous work using similar primer pairs (Brough, 2007).  Although 
amplification of the 689bp or 530bp fragments was successful in identifying ‘pop-out’ 
clones, and the absence of accompanying ‘pop-in’ products suggested the ‘pop-out’ 
clones were pure, it was later determined that at least 103 cells were needed to amplify 
the ‘pop-in’ bands by colony PCR whereas as little as 100 cells were required to amplify 
the ‘pop-out’ products (Figure 3.5d).  This, plus the likely preferential amplification of the 
small ‘pop-out’ products over the larger ‘pop-in’ products, suggests that the PCR screen 
was unlikely to be able to detect any contaminating ‘pop-in’ cells in any population of 
‘pop-out’ clones.  Nevertheless, 2 or 3 clones which produced the 689bp or 530bp 
amplicons were expanded and tested for Rad52-related protein expression. 
 
Table 3.2. An example of cre-mediated insertion frequencies in Rht14-10.  
Rad52-Related 
Transgene 
G418r colonies (per 105 cells plated) 
Cre No Cre Cre + Tet 
scR52* 46 0 1 
hR52* 49 0 1 
*Δ238 110 0 0 
*Δ284 82 0 0 
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Figure 3.5. PCR strategy to confirm flpe-mediated excision. (a) Oligonucleotide annealing sites 
are represented by black arrows (O1 and O2).  O1 anneals within the TRP while O2 anneals within 
the scRad52 gene.  Cells which have undergone successful ‘pop-out’ events will amplify a 689bp 
fragment while those that have not will amplify a 2.8kb fragment.  The same strategy was used for 
the other clones containing hRad52-related transgenes except the reverse oligonucleotide (O3) 
was designed to anneal within the N-terminal region of the hRad52-related genes.  Expected 
fragment sizes were 530bp and 2.6kb for the ‘pop-out’ or ‘pop-in’ events, respectively. (b) 
Agarose gel of colony PCR products from clone Rht14-10-scRad52 displaying the expected 689 
fragment in 4 of the 6 colonies tested.  (c) Example of agarose gel of colony PCR products for 
Rht14-10-Δ238* displaying the expected 530 fragment in 5 of the 6 colonies tested. Similar results 
were obtained for Rht14-10-hRad52 and Rht14-10-Δ284 clones (N- or C-terminal HA-tags) and 
Rht14-10-*Δ238.  (d) Limiting dilutions of Rht14-10-hRad52 cells were made to determine the PCR 
sensitivity required to amplify ‘pop-in’ and ‘pop-out’ events. 
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3.2.4 Tet-Regulated Expression of HA-Tagged Rht14-10-Rad52 Clones 
Tet-regulation of Rht14-10-hRad52, -Δ284, -Δ238 (N- or C-terminal HA-tags) clones was 
tested by immunoblot using an α-hRad52 antibody (Figure 3.6a).  It was unexpected and 
disappointing that only four clones exhibited detectable expression of the Rad52-related 
proteins (Lanes 6, 12, 14, 16) however, it was encouraging that those clones were tet-
regulated.  Both Rht14-10-hRad52* (C-HA tag) clones were induced for expression of 
hRad52* however, relatively strong protein levels were present in clone A5 (Lane 12) 
whereas only relatively moderate levels were present in clone B2 (Lane 14).  These 
differences were unexpected as both clones should have been genotypically identical.  A 
band corresponding to Δ238* is faintly visible (arrow, lane 16) in only one of the four 
Rht14-10-Δ238-related clones tested (lanes 1-4 and 15-18).  Similarly, in only one out of 
the three Rht14-Δ284 clones is *Δ284 faintly visible (arrow, lane 6) on the blot however, it 
had required an additional 30min (i.e. seven-fold longer) of membrane exposure to 
achieve visualisation.  Expression of scRad52* was initially detected by immunoblot with 
an α-scRad52 antibody (Figure 3.6b) because an α-HA antibody had not yet been 
obtained.  A relatively weak band was detected (arrow, lane 2) in comparison to the 
strong non-specific band at 38kDa.  The expressed levels of scRad52* were compared 
with those of hRad52* from clone Rht14-10-hRad52* A5 once an α-HA antibody was 
acquired (Figure 3.6c).  scRad52* was faintly observed on the blot though may be difficult 
to observe in Figure 3.6c.  In contrast, the level of hRad52* was comparatively high 
indicating that scRad52* was indeed not expressed in high amounts.  In addition, the 
Rad52-related protein levels were highly variable even between clones expressing the 
same Rad52-related protein (Figure 3.6a, lanes 12 and 14), which was unexpected.  These 
differences could not be solely attributed to differences in protein stabilities which 
suggested they may instead have stemmed from loss of TRP-regulated control (see 
Discussion).   
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(b)       (c)  
 
 
 
 
 
 
 
 
Figure 3.6. Overexpression of the Rad52-related proteins in ‘pop-out’ clones. (a) Subclones  
confirmed for successful ‘pop-out’ events by PCR were grown in the presence or absence of tet to 
test for tet-regulated transgene expression.  The immunoblot was performed with an α-human 
Rad52 antibody.  The weak band indicated by the arrow in lane 6, corresponds to the expected 
size of Δ284*.  Strong and moderate induced expression of hRad52* (47kDa) are evident in lanes 
12 and 14.  Δ238* (27kDa) appears as a weak band in lane 16.  Non-specific bands appear at 
31kDa and are likely the result of long exposure times.  (b) Rht14-10-scRad52* was confirmed for 
successful ‘pop-out’ by PCR.  Tet-regulated expression levels of scRad52* were visualised by 
immunoblot with an α-scRad52 antibody.  The arrow indicates the weak band corresponding to 
scRad52*  All other bands likely represent non-specific detection.  (c) Clone Rht14-10-hRad52* A5 
(Figure 3.5a, lanes 11 and 12) was compared to Rht14-10-scRad52*.  An α-HA antibody was used 
to detect both induced levels of hRad52* and scRad52*.  A faint band of the expected size of 
scRad52* (57kDa) is faintly visible in lane 4 though may be difficult to discern in the figure.  
Protein estimates were performed for each sample and 10μg total protein was loaded per well. 
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3.2.5 Reinvestigation of Tet-Regulated Expression in Rht14-10 
The inconsistent protein expression observed in the Rht14-10-Rad52 clones prompted 
quantitative analysis of the parent strain Rht14-10.  Rht14-10 was originally selected for 
its stringent regulation of GFP expression in the presence or absence of tet (Brough, 
2007). In addition, its GFP expression profile was largely unaffected even after continuous 
passage for 42 days (Brough, 2006).  To explore whether the Rht14-10 cells used to 
perform ScIn of the Rad52-related transgenes still exhibited a tightly regulated GFP 
expression profile, they were cultured in the presence or absence of tet and analysed by 
flow cytometry for GFP expression (Figure 3.7).  The GFP expression profile was 
surprisingly different to what was observed by Brough et al.  For the Rht14-10 cells 
described in this chapter, only a small population (22.6%) of cells was positive for GFP in 
the absence of tet (Figure 3.7a).  As cell density may also influence transgene expression, 
the experiment was repeated with cells that were grown to ~50% confluence, in contrast 
to the first measurement where they were allowed to reach ~90% confluence (Figure 
3.7b).  Cells plated at the lower density were greater than 90% positive for GFP when 
grown in the absence of tet and the expression profile was comparable to that originally 
reported (Brough, 2007).  Thus, stringent transgene regulation in Rht14-10 appeared to 
be negatively affected by high cell density.  This may serve as an explanation for the 
different hRad52* expression levels from Rht14-10-hRad52* A5 and B2 (Figure 3.6a, lanes 
12 and 14) however, cell density was not monitored and may have varied between 
samples.  To determine if the cell densities affected the cellular levels of hRad52* in 
clones Rht14-10-hRad52* A5 and B2, the cellular densities could be monitored for the 
two clones and the immunoblot could be repeated.  However, this was not conducted as 
an alternative approach was selected for achieving regulated overexpression of the 
Rad52-related proteins (see Discussion). 
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 (a)         
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Figure 3.7. FACS expression profiles of GFP in Rht14-10. (a) Rht14-10 cultures grown in the 
presence of tet (yellow line) or the absence of tet (green line).  22.6% of cells were positive for 
GFP expression when cells were ~90% confluent at the time of harvesting.  (b) Rht14-10 cultures 
grown in the presence of tet (yellow line) or the absence of tet (green line).  92.4% of cells were 
positive for GFP expression when cells were ~50% confluent at the time of harvesting. 
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3.3 Discussion 
The Rad52-related proteins hRad52, scRad52, Δ284 and Δ238 were designed to 
investigate the effects on GT from using truncated hRad52-related proteins and a Rad52 
protein from a different organism which is known to stimulate dsGT and ECHR (Di Primio, 
2005; Johnson, 1996; Kalvala, 2010).  To eliminate differing transgene expression levels as 
a variable and avoid the potential harmful effects of continuously expressing the Rad52-
related proteins, the ScIn system was used to achieve site-specific integration and 
inducible expression of the Rad52-related proteins.   
3.3.1 Overexpression of hRad52 and Δ238 and Their Effects on Gene 
Targeting with Double Stranded DNA 
The ScIn system was successfully deployed however, induced overexpression of untagged 
hRad52 and Δ238 did not generate similar levels of the Rad52-related proteins.  Δ238 
levels were much weaker than those of hRad52 by immunoblot (Figure 3.3).  Initially, it 
was hypothesised that the lower intensity of the Δ238 band was the result of protein 
misfolding leading to an increased rate of degradation.  Previous work in S. cerevisiae 
revealed the importance of sumoylation in increasing the stability of the scRad52 protein 
by almost two-fold in comparison to the scRad52 protein in a sumoylation deficient 
mutant (Sacher, 2006).  This degradation was also demonstrated to be dependent on the 
proteasome pathway.  Although such stabilising sumoylations of hRad52 have not yet 
been identified, this does not exclude them from potentially affecting human Rad52.  
Thus it is possible that putative stabilising sumoylation sites, or other putative stabilising 
sites, were deleted in the Δ238 truncation mutant resulting in an increased propensity for 
hyper degradation.  Alternatively, the mRNA of Δ238 may be less stable than the mRNA of 
hRad52 which may account for the differences in Rad52-related protein levels.  This 
possibility could be tested by real-time PCR however, differences between equivalent 
Rht14-10-hRad52* clones suggested that other explanations were more relevant (see 
below). 
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Regardless of the differences between hRad52 and Δ238 levels, both proteins were 
present in much higher levels in comparison to endogenous hRad52, which was barely 
detectable.  This gave me confidence that these excess levels would be sufficient to test 
for an effect on dsGT, if such an effect existed. Overexpressed hRad52 was expected to 
yield a 2-fold inhibition of dsGT as was previously observed (Yanez, 2002).  However, 
induction of hRad52 in clone Rht14-10-hRad52 slightly stimulated dsGT (TI:RI – 1.4-fold) 
where the absolute frequency of TI events increased slightly (1.2-fold) and the absolute 
frequency of RI events decreased slightly (1.2-fold) (Table 6).  It is possible the slight 
stimulation was the result of experimental error such as selection problems in 
hygromycin, as previously noted, variability in the transfection efficiency or cell plating 
errors.  Thus, the experiment needs to be repeated to confirm these results and to 
determine statistical significance.   
 
Overexpression of Δ238 resulted in a larger increase in dsGT efficiencies (TI:RI – 3.5-fold) 
which was largely attributed to a decrease in the absolute frequency of RI (2.8-fold).  This 
was surprising as it was initially hypothesised that overexpression of Δ238 would increase 
the frequency of TI events rather than inhibit RI events.   The similarity between the 
absolute TI frequencies in the presence or absence of tet suggested that Δ238 did not 
affect the mechanism responsible for targeting.  On the other hand, the decrease in the 
absolute frequency of RI suggested that instead, excess Δ238 inhibited Tot-NHEJ, perhaps 
by competing with Ku for free DNA ends.  Indeed, in a biochemical study comparing the 
preference of Ku and hRad52 for different DNA-end structures, both proteins were able 
to bind linear blunt ends and linear substrates containing 2-200nt of 3’ or 5’ overhangs 
(Ristic, 2003).  Thus, overexpressed Δ238 may coat the free DNA ends and prevent access 
to the Tot-NHEJ machinery whereas interactions mediated through the central and C-
terminal domains of overexpressed hRad52 may inhibit it from disrupting Tot-NHEJ.  
However, such speculation may be premature as these experiments involving Rh14-10-
Δ238 and Rht14-10-hRad52 were only performed once; it is necessary to repeat these 
experiments to confirm the results.   
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3.3.2 Generation of Clones Overexpressing HA-tagged scRad52, hRad52, 
Δ284 and Δ238 
Rad52-related transgenes containing N- or C-terminal HA sequences were integrated into 
Rht14-10 with the ScIn approach (Brough, 2007)(Figure 3.1 and Figure 3.2).  Successful 
site-specific ‘pop-in’ of the Rad52-related constructs was achieved as G418r colonies did 
not arise in transfections performed in the absence of the cre-recombinase, which was 
required for ‘pop-in’ events.  In addition, tet-regulation of the TRP and neomycin gene 
was confirmed as all or nearly all cells died in G418 selection when cultured in tet 
medium in contrast to at least 40 colonies that arose when tet was absent.  Despite the 
initial problems with amplifying the 2.8kb or 2.6kb ‘pop-in’ bands, whose presence or 
absence would have been useful indicators of clonal homogeneity, visualising the 530bp 
or 689bp ‘pop-out’ PCR fragments provided evidence that the ScIn system was successful 
in generating clones with tet-regulated expression of the Rad52-related proteins.   
 
However, contrary to expectations, the induced cellular levels of the Rad52-related 
proteins were not comparable and levels of Δ284 and Δ238 were largely undetectable.  A 
number of possibilities may provide explanations for these differences in protein levels.  
As previously noted, sumoylation of scRad52 can enhance its stability and half-life 
(Sacher, 2006) and although similar sumoylation sites have not yet been elucidated for 
hRad52, the possibility remains that such protein stabilising residues are absent in Δ284 
and Δ238 thus leaving the proteins susceptible to proteasomal degradation.  It is unlikely 
that scRad52, despite not sharing homology with the central and C-terminal domains of 
hRad52, would be misfolded or recognised as a foreign protein because other groups 
which overexpressed scRad52 were able to  achieve high stimulations of HR (Di Primio, 
2005; Johnson, 1996; Kalvala, 2010).  However, these possibilities do not address the 
variable expression levels observed between clones Rht14-10-hRad52*A5 and B2 (Figure 
3.6, lanes 12 and 14) which implicate loss of controlled transgene regulation.   
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Epigenetic mechanisms, such as DNA methylation, can cause transgene silencing (Pikaart, 
1998).  Methylation of the TRP and tTA gene have been noted in the past though the TRP 
and tTA used in this study were modified to remove potential splice sites and CG 
dinucleotides (Krestel, 2004).  One way to minimise silencing would be to include 
insulator sequences (blocking elements) on each side of the transgene though none of 
the constructs used in the ScIn system possess these.  If silencing of the TRP or tTA 
occurred in Rht14-10, this population would be eliminated during the ‘pop-in’ step as 
constitutive activation of the TRP and tTA are required for cell survival during G418 
selection.  Thus only after the ‘pop-out’ event could silencing of these sequences occur 
and would have to occur in unpredictable manner i.e. in some clones more than others.  
Alternatively, the Rad52-related transgenes themselves may also have been silenced.  If 
so, this would pose a problem as selection against such events would be difficult.  
Treatment with the demethylating agent 5-aza-2’-deoxycytidine could provide a means of 
relieving potential methylation inhibition.  If an increase in Rad52-related proteins levels 
is observed following treatment, this could suggest that epigenetic silencing is responsible 
for variability in the Rad52-related protein levels.   
3.3.3 Reinvestigation of Tet-Regulated Expression in Rht14-10 
Rht14-10 was investigated to determine the extent of its tet-regulated expression of GFP, 
after numerous freeze/thaws and passages, in comparison to the original clone (Brough, 
2007).  The proportion of GFP positive cells decreased by almost 80% in the passaged 
clone and the GFP expression profile was very broad, indicating variable cellular levels of 
GFP.  Disruption of induced GFP transgene expression seemed unlikely as the original 
Rht14-10 clone had exhibited a GFP expression profile that was largely unchanged even 
after 42 days of continuous culture (Brough, 2006).  However, upon harvesting the cells at 
a lower cell density (~50%) rather than a high cell density (~90% in the first measurement) 
the proportion of GFP positive cells increased dramatically to greater than 90% and the 
expression profile was restored to that of the original clone.  These results suggest that 
cell density contributes to the amount of Rad52-related protein detected in cells and may 
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provide an explanation for the differences observed in hRad52* levels between clones 
Rht14-10-hRad52 A5 and B2 as cell density was not monitored.  However, as cells were 
generally harvested at 60-80% confluence for immunoblot analysis, cell density cannot be 
solely responsible for the low or undetectable levels of Rad52-related protein in the other 
Rht14-10-Rad52 clones, which suggests other factors are responsible such as stochastic 
gene methylation or alternatively, inaccurate recombination in the final ‘pop-out’ step.  If 
inaccurate site-specific recombination occurred during the ‘pop-in’ step, it would not be 
detected.  Enrichment of clones containing strong and tet-regulated expression of 
neomycin was performed in G418.  In contrast, no selective pressure was present during 
the ‘pop-out’ step and thus clones lacking regulated control over the Rad52-related 
transgene would be able to propagate.  However, problems following the ‘pop-out’ step 
were not reported in previous work (Brough, 2007).  Instead, integration of the luciferase 
gene into Rht14-10 yielded seven clones which exhibited comparable levels of luciferase 
activity.  Clonal impurity could also be responsible for the varying Rad52-related 
expression levels and could be tested by recloning each clone. 
 
In summary, although the parent clone Rht14-10 exhibited stable tet-regulated 
expression of GFP, unfortunately, the ScIn system did not yield clones with comparable 
transgene expression profiles.  Site-specific integration of the transgenes was desirable to 
achieve similar cellular levels of the Rad52-related proteins and allow the effects of each 
protein to be informatively compared.  However, as this was not achieved, random 
integration of the Rad52-related transgenes was favoured as an alternative (see Chapter 
4). 
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Chapter 4 Generation of Clones with Detectable Levels 
of the Rad52-Related Proteins using Random Integration 
4.1 Introduction 
Locus-specific integration of a transgene is ideal not only for comparing the functional 
role of multiple transgenes in parallel but also for controlling expression of the transgenes 
where desired.  This approach (as deployed in the ScIn method) is advantageous in that 
different clones are designed to achieve similar levels of induced transgene expression, 
unaffected by neither promoter nor transgene position within the genome.  Any 
differences in induced protein cellular levels could thus be attributed to differences in 
relative stabilities of mRNA or protein products.   
 
In Chapter 3, this tool was used to clone the Rad52-related transgenes into Rht14-10.  
Unexpectedly, varying cellular levels of the Rad52-related proteins were obtained and this 
was attributed, at least in part, to differences in expression, rather than mRNA or protein 
instability.  Because similar expression levels of the Rad52-related proteins could not be 
achieved through the ScIn method, random integration of the Rad52-related transgenes 
was selected as a more pragmatic approach to investigate the effects of overexpressing 
the Rad52-related proteins.  The use of this approach is described in this chapter along 
with measures taken to ensure the Rad52-related transgene products were expressed in 
the nucleus. 
 
Originally, it was believed that scRad52 lacked a NLS and was carried into nucleus by 
other proteins (Boulikas, 1997).  Later, an scRad52 NLS was identified and shown to 
consist of a basic region of residues which lie within the RPA binding domain (Section 
1.6.4)(Plate, 2008a).  A putative NLS for hRad52 was noted at the C-terminal end of the 
protein (Shen, 1995) but not until 2010 was this validated as a true NLS by a study that 
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identified an essential role for lysine residues K411, 412 and 414 in nuclear localisation 
(Section 1.7.2)(Saito, 2010).  However, when the Rad52-related proteins were being 
designed for the work described in Chapter 3, the proposed NLS in wild-type hRad52 
(Shen, 1995) was overlooked and the study by Saito et al. had not been published.  
Hence, the initial hRad52-related proteins were constructed with no knowledge that the 
NLS was located at the C-terminus. 
 
This chapter will discuss the identification of the NLS region in hRad52, the design of four 
additional Rad52-related proteins, the isolation of the Rht14-Rad52-related clones which 
can stably overexpress the Rad52-related proteins in the nucleus and finally, the relative 
stabilities of each Rad52-related protein. 
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4.2 Results 
4.2.1 Nuclear Localisation of the Rad52-Related Proteins 
Following the expression and regulation problems in Rht14-10 (Chapter 3), the hRad52 
and scRad52 transgenes were cloned behind the TRP in the tet-inducible expression 
plasmid pTRE-Tight (for a description of methods see Section 2.3.2)(Figure 4.1).  The 
Rad52-related proteins were designed with C-terminal HA-tags.  The pTRE-derived 
plasmid containing the hRad52 transgene was used as a template and using site-directed 
mutagenesis, pTRE-derived plasmids containing the transgenes for Δ284 and Δ238 were 
generated.  An advantage of using the pTRE-derived expression vectors was the ability to 
transiently express the Rad52-related transgenes and verify both expression and 
subcellular localisation of the proteins.  This was previously not possible using the ScIn 
method because the insertion constructs were promoterless (See Section 3.1.1).  
Transient expression was achieved in the clone Rht14 which is the parental clone of 
Rht14-10 (Brough, 2007).  Rht14 constitutively expresses the tTA which enabled tet-
regulated control over the Rad52-related transgenes cloned into pTRE-Tight.   
 
Transient expression using lipofection (for description of methods see Section 2.4.5) of 
the Rad52-related proteins was visualised through immunofluorescence using an 
antibody against the HA-tag (Figure 4.2a).  As expected, hRad52* was located in the 
nucleus, although Δ284*, Δ238* and scRad52* were found in the cytoplasm.  Cytoplasmic 
location of scRad52* indicated that the NLS of scRad52 did not function in HT1080 and 
furthermore suggested that it was likely that the scRad52 expressed by previous groups 
did not localise to the nuclei in the human cell lines used (Di Primio, 2005; Johnson, 
1996).  The failure of Δ284* and Δ238* to localise to the nucleus was consistent with a 
putative NLS for hRad52 within residues 285-418.  Upon consultation with Dr Stephen 
Dilworth (Imperial College London), and analysis of residues 285-418 in hRad52, a 
potential NLS was identified within a basic tract of a.a from residues 405-414.  A pTRE-
derived plasmid containing the Δ405-414 mutation was therefore constructed and upon 
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transient expression Δ405-414 did not achieve nuclear localisation (Figure 4.2b).  These 
results confirmed that the NLS of human Rad52 was located within residues 405-414.   
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Figure 4.1. Tet-regulated expression vector: pTRE-Tight. The promoter ‘Ptight’ (i.e. TRP) contains 
the TRE and the minimal sequences of the CMV promoter.  The hRad52* and scRad52* 
transgenes were cloned downstream of Ptight into the multiple cloning site (MCS).  Site-directed 
mutagenesis was used on the pTRE-derived plasmid containing the hRad52* transgene to 
generate pTRE-derived plasmids which contain the Δ284*, Δ238* and other hRad52-related 
transgenes.  The resulting plasmids could be used for transient or stable expression of the Rad52-
related proteins.  Modified from Clontech, 2010. 
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Figure 4.2. Cellular localisation of hRad52*, Δ284*, Δ238*, scRad52* and Δ405-414*.  (a) and (b).  
pTRE-derived Rad52-related plasmids were transiently expressed in Rht14 using lipofection.  
18hrs post-transfection, the localisation of the Rad52-related proteins was visualised by 
immunofluorescence using a fluorescently tagged antibody against the HA-tag.  DAPI stained DNA 
and merged images are indicated.  Pictures shown are artificially coloured monochrome images. 
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4.2.2 Eight Rad52-Related Proteins Are Designed to Investigate HR 
To achieve nuclear localisation of Δ284*, Δ238* and scRad52* expression constructs were 
modified to encode the NLS of the SV40 large T-antigen (Kalderon, 1984a; Kalderon, 
1984b) at the N-terminus of each protein (for a description of methods see Section 2.3.2 
and Appendix) (Figure 4.3).  A second hRad52 expression construct was also designed to 
contain an N-terminal NLS in addition to its natural C-terminal NLS, which would serve as 
a control and demonstrate that the behaviour of hRad52 would be unaffected by the 
additional NLS.  In light of the discovery of the region containing the endogenous hRad52 
NLS, it was reasoned that residues within the C-terminal domain, deleted in both Δ284 
and Δ238, might contain additional unidentified functions or binding domains. To test 
this, a pTRE-derived expression construct for a third truncation mutant, Δ290-330* was 
made.  In addition to investigating scRad52 and the domains of hRad52, two 
phosphorylation mutants were also generated to further investigate the role of 
phosphorylation of hRad52.  Y104 was mutated to a glutamic acid or phenylalanine to 
mimic constitutive phosphorylation or abrogate phosphorylation, respectively.   
 
All eight Rad52-related transgenes were transiently expressed in pTRE-derived Rad52 
expression constructs to confirm nuclear localisation in Rht14 cells using lipofection as a 
delivery method.  Tet was not added for the duration of the experiment and cells were 
harvested 18hrs post-lipofection.  Subcellular localisation of the proteins was visualised 
with immunofluorescence using an antibody against the HA-tag which is directly 
conjugated to a fluorophore.  Nuclear localisation was achieved for hRad52* and all 
Rad52-related proteins possessing the NLSSV40 (results not shown) hence the new pTRE-
derived Rad52 constructs were randomly integrated into Rht14 (see below).  Figure 4.4 
displays the cellular distribution of the Rad52-related protein in the stable Rht14-Rad52-
related clones.  However, in contrast to the more uniform distribution observed with six 
of the Rad52-related proteins, (NLS)Δ284* and (NLS)Δ238* exhibited aggregated 
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configurations regardless of the expression level.  It is possible the removal of the C-
terminal domain or the presence of the NLSSV40 was responsible for the effect.   
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Figure 4.3. Schematic representation of the mapped domains of hRad52 and scRad52.  The N-
terminal domain (hRad52 1-209, scRad52 1-197) contains the DNA binding and multimerisation 
domains; the central domain (hRad52 210-284, scRad52 198-327) contains the RPA binding 
domain; the C-terminal domain (hRad52 285-418, scRad52 328-504) contains the Rad51 binding 
domain and in scRad52 a second DNA binding domain.  
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Figure 4.4. Nuclear localisation of the Rad52-related proteins in the Rht14-Rad52-related clones. 
Induction of the Rad52-related proteins occurred for 48hrs prior to visualisation by 
immunofluorescence using a fluorescently tagged antibody against the HA-tag.  DAPI stained DNA 
and merged images are indicated.  Pictures shown are artificially coloured monochrome images. 
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4.2.3 Tet-Regulated Expression of the Rht14-Rad52-Related Clones 
All eight Rad52-related transgenes were cloned into pTRE-Tight.  pTRE-Tight does not 
contain an appropriate antibiotic selection marker hence the pTRE-derived Rad52 
constructs were co-transfected with a puro plasmid into Rht14 cells (Section 2.4.2).  At 
least ten puroR clones were picked per transfection which was followed by further 
screening for clones expressing Rad52-related protein by immunofluorescence or 
immunoblot.  The number of clones screened from each transfection and the number of 
clones positive for Rad52-related protein expression are shown in Table 8.  The relative 
cellular levels of Rad52-related protein were compared between all positive clones by 
immunoblot (results not shown).  Two clones which expressed relatively high and low 
Rad52-related protein levels (in absence of tet) by immunoblot were selected for each 
type of Rad52-related protein to undergo further study (Figure 4.5a).  Following this, their 
level of tet-regulated control was measured and immunoblot analysis of the higher 
expressing Rht14-Rad52-related clones is displayed in Figure 4.5b.  By immunoblot 
analysis, no detectable levels of the Rad52-related proteins were observed for the eight 
Rht14-Rad52-related clones grown in the presence of tet (odd lanes) however, the 
concentrations of expressed Rad52-related proteins were variable between all clones.  
The clones which exhibited higher cellular levels of Rad52-related proteins were selected 
for use in all following experiments in this work.  The Rht14-Rad52-related clones which 
exhibited lower cellular Rad52-related protein levels were retained to act as comparison 
clones should time allow for this investigation. 
 
Table 4.1. Screening of Clones Positive for Rad52-Related Protein Expression. 
Transfected Rad52-Related 
Transgene 
# Puror Clones 
Selected 
# Positive for Rad52-
Related Protein 
hRad52* 15 10 
(NLS)hRad52* 19 17 
(NLS)Δ284* 24 12 
(NLS)Δ238* 20 13 
Δ290-330 20 1 
(NLS)scRad52* 18 11 
Y104E* 10 4 
Y104F* 10 1 
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(a) 
 
 
 
 
 
 
 
 
 
 
(b) 
 
 
 
 
 
 
 
 
 
Figure 4.5. Tet-regulated expression of the Rad52-related proteins in the Rht14-Rad52-related 
clones.  (a) Comparison of clones exhibiting high (H) or low (L) cellular levels of Rad52-related 
protein.  Where more than one band is evident, the upper band corresponds to the expected MW 
of the Rad52-related protein.  Clones were grown in the absence of tet for 48hrs to induce 
expression of the Rad52-related proteins.  Rht14-Δ290-330 and Rht14-Y104E do not appear 
because only one clone was successfully generated (See Table 4.1). (b) ‘H’ Rht14-Rad52 clones 
were grown in the presence or absence of tet for 48hrs prior to immunoblot analysis with an α-HA 
antibody. 
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4.2.4 Rht14-(NLS)hRad52 Clones are Tetraploid 
Following selection of the eight higher expressing Rht14-Rad52-related clones, the clones 
were used in a dsGT assay (See Chapter 6). Briefly, the assay involves disruption of the 
HPRT locus located on the single X chromosome within the genome.  After numerous 
attempts to perform the assay, Rht14-(NLS)hRad52 was the only clone which failed to 
demonstrate a knockout phenotype.  This suggested that Rht14-(NLS)hRad52 was 
tetraploid and thus the DNA content of the clone was measured by flow cytometry.  In 
comparison to the Rht14 control, Rht14-(NLS)hRad52 exhibited a cell cycle profile 
characteristic of tetraploid cells (Figure 4.6a).   
 
To determine whether the second clone, Rht14-(NLS)hRad52.2,could be used in place of 
Rht14-(NLS)hRad52, despite exhibiting lower levels of induced (NLS)hRad52*, the DNA 
content of Rht14-(NLS)hRad52.2 was also analysed by flow cytometry.  Unfortunately, 
Rht14-(NLS)hRad52.2 was also tetraploid (Figure 4.6b) which resulted in discontinuation 
of further experimentation with any clone expressing (NLS)hRad52*. A second attempt to 
generate a diploid Rht14-(NLS)hRad52 clone was not conducted.        
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Figure 4.6. Ploidy analysis of the Rht14-(NLS)hRad52 clones. Cells were stained with PI and 
analysed for DNA content by flow cytometry. (a) Known diploid cells of the parental clone Rht14 
were compared with (b) Rht14-(NLS)hRad52 cells and with cells of a second clone (c) Rht14-
(NLS)hRad52.2.  Both Rht14-(NLS)hRad52 and Rht14-(NLS)hRad52.2 were generated from the 
same transfection. 
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4.2.5 Characterising the Rad52-Related Protein Levels in the Rht14-
Rad52-Related Clones 
Endogenous hRad52 has a low level of expression.  Immunoblots using an antibody 
against endogenous hRad52 often required exposure times greater than 30min to 
visualise bands in comparison to 1-2min to visualise the stably expressed hRad52-related 
proteins.  The strong minimal CMV promoter within the TRP was expected to promote 
expression of the Rad52-related proteins in excess of endogenous hRad52.  To determine 
the fold increase in concentration of the Rad52-related proteins over endogenous 
hRad52, all Rht14-Rad52-related clones were grown in parallel for 48hrs in the absence of 
tet.  Harvested samples of Rht14-(NLS)Δ284, Rht14-(NLS)Δ238 and Rht14–Δ290-330 were 
diluted by 1/10, 1/25 or 1/75 and compared with undiluted samples of the Rht14 control.  
Immunoblots were conducted with an α-human Rad52 antibody (Figure 4.7a).  Induced 
levels of (NLS)Δ284*, (NLS)Δ238* and Δ290-330* were approximately 20-fold higher than 
endogenous hRad52 levels.   
 
Direct comparisons of the cellular levels of hRad52*, Y104E* and Y104F* could not be 
made with endogenous hRad52 because these Rad52-related proteins possess similar 
MWs to endogenous hRad52 and differentiating between the proteins would have been 
difficult by immunoblot.  In addition, the antibody against hRad52 could not be used to 
detect (NLS)scRad52*.  To overcome these problems, Δ290-330* was used as a 
comparison control (Figure 4.7b) to determine the fold excess of hRad52*, 
(NLS)scRad52*, Y104E* and Y104F* over endogenous hRad52.  An anti-HA antibody was 
used to probe the immunoblots.  Approximate fold excess levels were as follows: 5-fold 
for hRad52*, 4-fold for (NLS)scRad52*, 2-3-fold for Y104E* and 10-fold for Y104F*.  Thus 
the overexpression levels of the Rad52-related proteins range from 2-3-fold to 20-fold in 
excess of endogenous hRad52 (Table 9).   
 
To investigate the Rad52-related protein expression levels within each clonal population 
of Rht14-Rad52-related cells, Rad52-related protein expression was induced for 48hrs 
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prior to immunofluorescent analysis.  The Rad52-related proteins were detected using an 
α-HA antibody directly conjugated to a fluorescent fluorophore.  The percentages of cells 
exhibiting detectable levels of Rad52-related protein are displayed in Table 10.  Greater 
than 75% of Rht14-(NLS)Δ284, Rht14-(NLS)Δ238, Rht14-Δ290-330 and Rht14-
(NLS)scRad52 cells expressed detectable levels of their respective Rad52-related protein.  
However, the percentage of cells exhibiting detectable levels of Rad52-related protein 
was lower for Rht14-hRad52 (51%), Rht14-Y104E (18%) and Rht14-Y104F (41%).  
However, it should be noted that the experiment should be repeated to obtain standard 
deviations and significance. 
 
It is likely the variations in the percentages of Rad52-related protein expressing cells were 
the result of chromosomal position effects of the integrated Rad52-related transgenes, 
however, Rht14-hRad52 was recloned to confirm the purity of the population.  The levels 
of hRad52* in nine subclones were compared by immunoblot (Figure 4.7c).  The amounts 
of hRad52* relative to the actin loading controls were the same for each subclone, which 
confirmed the homogeneity of the Rht14-hRad52 clone.  Rht14-(NLS)scRad52 was also 
recloned and the similarity between the (NLS)scRad52* protein levels in each subclone 
suggested the clone was also pure (results not shown). 
 
Table 4.2. Induced Rad52-related protein expression levels relative to endogenous hRad52.  
Clone 
Fold Excess over 
Endogenous hRad52 
Rht14-hRad52 5 
Rht14-(NLS)Δ284 20 
Rht14-(NLS)Δ238 20 
Rht14-Δ290-330 20 
Rht14-(NLS)scRad52 4 
Rht14-Y104E 2-3 
Rht14-Y104F 10 
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(a) 
 
 
 
 
 
 
 
 
(b) 
 
 
 
 
 
 
 
 
(c) 
 
 
 
 
 
Figure 4.7. Relative cellular levels of the Rad52-related proteins. Clones were induced for 48hrs 
prior to preparing cell lysates. (a) Equal concentrations of (NLS)Δ284*, (NLS)Δ238* and Δ290-330* 
were diluted by 1/10, 1/25 or 1/75 and compared to endogenous hRad52 levels from parental 
Rht14.  Detection was performed with an α-hRad52 antibody. (b) Levels of hRad52*, 
(NLS)scRad52*, Y104E* and Y104F* were compared to Δ290-330* levels from Rht14-Δ290-330 
(Contr.) to determine their fold excess over endogenous hRad52.  Detection was performed with 
an α-HA antibody. (c) Rht14-hRad52 was recloned and nine subclones were selected.  Their levels 
of hRad52* were visualised with an α-HA antibody. 
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Table 4.3. Proportion of cells exhibiting detectable levels of Rad52-related protein. 
Clone 
Total # of Cells 
(DAPI) 
# of Cells with Rad52-
Related Protein 
(α-HA) 
% with Rad52-
Related Protein 
Average % 
Rht14-hRad52 
97 
142 
88 
66 
63 
35 
68 
44 
40 
51 ± 8 
Rht14-(NLS)Δ284 
95 
85 
71 
64 
75 
75 
75 
Rht14-(NLS)Δ238 
167 
164 
147 
130 
88 
79 
84 
Rht14-Δ290-330 
54 
38 
40 
32 
74 
84 
79 
Rht14-(NLS)scRad52 
102 
83 
85 
63 
83 
76 
80 
Rht14-Y104E 
65 
44 
8 
10 
12 
23 
18 
Rht14-Y104F 
36 
30 
16 
11 
44 
37 
41 
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4.2.6 Exploring the Protein Stabilities of the Rad52-Related Proteins 
The relatively low percentage of cells expressing detectable levels of full length hRad52-
related proteins (hRad51, Y104E and Y104F) suggested that these proteins may be 
unstable in excess levels or that they may be cell cycle regulated.  The deletion mutants, 
on the other hand, may not be as susceptible to modifications that promote degradation, 
which would result in the observed higher cellular levels of the proteins.  Differences in 
the tertiary structures of the Rad52-related proteins may also affect the stabilities of the 
proteins.  To investigate the relative stabilities of the Rad52-related proteins, Rht14-
Rad52-related clones were grown without tet for 48hrs prior to suppressing Rad52-
related transgene expression with the addition of tet.  Rad52-related protein levels were 
measured by immunoblot over a 24hr period from the point of tet addition (Figure 4.8a).  
Δ290-330* levels were not measured.  The amount of hRad52*, (NLS)Δ284*, Y104E*, 
Y104F* and (NLS)scRad52* lessened over the 24hr period as expected though, 
surprisingly, the amount of (NLS)scRad52* increased at the 3hr mark.  In contrast, 
(NLS)Δ238* levels did not noticeably reduce over time, though there was an increase in 
the amount of smaller protein products, likely degradation products.  Although all of the 
Rad52-related proteins, except (NLS)Δ238*, exhibited degradation over time, the 
variations between the protein levels in each clone made it difficult to accurately 
ascertain whether the degradation profiles were comparable or not. 
 
To circumvent the issue of variable Rad52-related protein levels, the pTRE-derived 
plasmids encoding hRad52*, (NLS)Δ284*, (NLS)Δ238* and (NLS)scRad52* were transiently 
expressed in parental Rht14 cells to achieve similar expression levels.  48hrs post-
transfection, tet was added to the media to suppress transgene expression and the 
relative rates of degradation were analysed for the four Rad52-related proteins as above 
(Figure 4.8b).  Similar Rad52-related protein levels were observed between hRad52*, 
(NLS)Δ284* and (NLS)Δ238* in the absence of tet though (NLS)scRad52* was expressed in 
considerably less amounts.  The rates of degradation between the four Rad52-related 
proteins appeared similar, which suggested that the different structures of the Rad52-
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related proteins did not largely affect their stabilities nor were they the primary cause of 
the differences in Rad52-related protein levels observed in the Rht14-Rad52-related 
clones.   
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(a) 
 
 
 
 
 
 
 
 
 
(b) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.8. Stability of the Rad52-related proteins. (a) Rht14-Rad52-related clones were induced 
for 48hrs before the addition of tet.  Samples were taken at 0, 3, 16 or 24hrs following tet 
addition. (b) hRad52*, (NLS)Δ284*, (NLS)Δ238* and (NLS)scRad52* were transiently transfected 
and grown without tet for 48hrs prior to tet addition.  Samples were harvested 0, 6, 12 or 24hrs 
post tet addition.  An α-HA antibody was used for detection in both a) and b).  Where more than 
one band is present, the more intense band represents the expected MW of the Rad52-related 
protein.  Bands above the Rad52-related proteins may have PTMs while bands below the Rad52-
related proteins may be degradation products. 
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4.3 Discussion 
4.3.1 Nuclear Localisation and Design of the Rad52-Related Proteins 
Although a putative NLS of hRad52 was previously noted (Shen, 1995), at the time of my 
investigations it had not been tested.  In fact, my mapping of the NLS to the C-terminal 
domain of hRad52 was the first evidence, to my knowledge, of an in vivo role for residues 
within the region from 330-418.  To investigate the role of residues 330-418, the deletion 
mutant Δ290-330* was designed to be comparable to (NLS)Δ284*.  Both proteins 
contained deletions of the hRad51 binding domain (residues 290-330) but the mutant 
Δ290-330* contained the remainder of the C-terminal domain (residues 331-418).  Should 
the (NLS)Δ284* and Δ290-330* proteins yield different experimental effects and thus 
suggest a role for residues 331-418, future experiments could extend to include the 
generation of additional C-terminal domain deletion mutants to further explore the 
domain.   
 
It was unexpected that scRad52* would be located mainly in the cytoplasm.  Two 
different groups previously overexpressed scRad52 in human cell lines and successfully 
stimulated ECHR and dsGT 12-fold and 37-fold, respectively (Di Primio, 2005; Johnson, 
1996).  However, nuclear localisation was never confirmed, likely because the fold-
stimulations appeared significant.  The scRad52 cDNA used by both groups and myself 
were received from the same source (Colin Campbell, University of Minnesota Medical 
School) arguing that nuclear import of scRad52 was deficient in both studies as well.  It is 
possible scRad52 is present in the nucleus following reformation of the nuclear envelope 
during mitosis, however, there is also evidence that diffusion of proteins even greater 
than 60kDa can occur across the nuclear pore (Wang, 2007).  ScRad52 is approximately 
56kDa thus low diffused levels may have been adequate to elicit the HR stimulations 
observed by Di Primio et al. and Johnson et al. which suggests that higher levels of 
nuclear scRad52 may yield even greater stimulations of HR.  In a recent study, a scRad52 
fusion protein, containing the intranuclear permeabilisation sequences from the TAT 
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protein of HIV, was capable of traversing all cell membranes to achieve high nuclear 
concentrations which yielded stimulations of ICHR and dsGT up to 63- and 50-fold, 
respectively (Kalvala, 2010).  It will be interesting if any of the hRad52-related proteins 
will demonstrate similar effects. 
 
Aside from the design of the Δ290-330* mutant and the addition of the NLSSV40 to 
scRad52*, Δ284* and Δ238*, two phosphorylation mutants were designed to address the 
potential role of phosphorylation in influencing the efficiency of endogenous hRad52 in 
HR (Figure 4.3).  Phosphorylation deficient hRad52 on Y104 were impaired in forming 
hRad52 repair foci in response to DNA damage (Section 1.7.1) (Kitao, 2002).  The effects 
of mutating Y104 were not previously tested in HR assays hence Y104 mutations were 
chosen for investigation and their potential role in HR which will be discussed in Chapters 
5-7.  The two mutants constructed mimic constitutive phosphorylation (Y104E*) or 
phosphorylation deficiency (Y104F*). 
 
The nuclear clustering of (NLS)Δ284* and (NLS)Δ238* (Figure 4.4) was unexpected and 
was initially suspected to be the result of protein misfolding leading to aggregation or 
alternatively, their accumulation at sites of proteasomal-mediated degradation.  
However, transiently expressed (NLS)Δ284* and (NLS)Δ238* exhibited similar stabilities to 
hRad52* (Figure 4.8) which argued against relatively increased rates of proteasomal 
degradation or conversely, resistance to proteasomal degradation as a result of 
aggregation.  Upon further comparison of the nuclear distribution of the Rad52-related 
proteins, it was noticed that the full length hRad52-related proteins were excluded from 
certain areas within the nucleus, which were observed as dark spots in the 
immunofluorescent staining (Figure 4.4).  Moreover, it was observed that these dark 
spots often overlapped with the dark spots present in the DAPI stained nuclei.  The low 
resolution and size of the images in Figure 4.4 may make this difficult to observe easily.  
Dark spots in the nucleus usually represent nucleoli, sites of ribosomal RNA synthesis 
within the nucleus (Pontes, 2003).  The three full length hRad52-related proteins 
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(hRad52*, Y104E* and Y104F*) were observed predominantly in the nucleoplasm, the 
area within the nucleus that does not include the nucleoli.  Interestingly, others have 
noted a similar pattern of nuclear distribution of exogenous murine Rad52 in mouse cells 
in G1 phase of the cell cycle, where murine Rad52 also relocalised to the nucleoli during 
S-phase (Liu, 1999).  In contrast to the full length hRad52-related proteins, (NLS)Δ284* 
and (NLS)Δ238* appeared to localise to the nucleoli whereas Δ290-330* and 
(NLS)scRad52 were found throughout the nucleus.  The distribution of (NLS)hRad52* was 
also different to the other Rad52-related proteins and (NLS)hRad52* exhibited what 
appeared to be aggregation although it is unclear whether the aggregation is localised to 
the nucleoli.  The different localisations of the Rad52-related proteins within the nucleus 
suggest that PTMs or interactions mediated by the C-terminal domain of hRad52 leads to 
nucleoplasmic localisation of hRad52 during G1 and that removal of the C-terminal 
domain results in relocalisation to the nucleolus.  In addition, the mechanism which 
directs Rad52 localisation within the nucleus appears to be specific to the human proteins 
as scRad52 was localised throughout the nucleus.  To further ascertain the location of the 
Rad52-related proteins throughout the cell cycle, future experiments could include 
arresting the cells in specific phases of the cell cycle and using immunofluorescence to 
visualise a nucleolar protein (e.g. nucleolin) to determine if it colocalises with any of the 
Rad52-related proteins. 
4.3.2 Tetraploidy in HT1080 
Rht14 are derived from HT1080 which is a human fibrosarcoma cell line.  Although 
tetraploidy is an undesirable event, it is likely that HT1080 cells possess genomic 
instability or disregulated cellular processes which contribute to the generation of 
irregular ploidies.  Indeed, in a HT1080-derived clone generated in our lab, approximately 
11% of the total population of cells were tetraploid (Yanez, 1999).  Thus, although it was 
disappointing that both Rht14-(NLS)hRad52-derived clones were tetraploid, the possibility 
of this occurring was not unexpected (Figure 4.6).   
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4.3.3 Characterising the Rad52-Related Protein Levels in the Rht14-
Rad52-Related Clones 
Site-specific integration of the Rad52-related transgenes (Chapter 3) was designed to 
avoid variable expression levels.  Unfortunately, the system was unsuccessful in my hands 
thus expression constructs containing the Rad52-related transgenes were randomly 
integrated into Rht14 cells.  The Rht14-Rad52-related clones with higher expression levels 
exhibited tet-regulated expression of the Rad52-related proteins however, the 
overexpression levels ranged from 2-3-fold to 20-fold over endogenous hRad52.  The lack 
of similarity between the Rad52-related protein levels must clearly be taken into account 
when these clones are used to compare the effects of overexpressing the Rad52-related 
proteins.  However, the effects of overexpressing a single Rad52-related protein can 
clearly be assessed in these clones by comparing cells grown with and without tet.  
 
Immunofluorescence of the Rht14-Rad52-related clones and recloning of Rht14-hRad52 
suggested that the variability in the cellular levels of Rad52-related protein was not the 
result of clonal impurity and more likely the result of chromosomal position effects.  
However, it was interesting that the clones expressing full length hRad52-related proteins 
(i.e. Rht14-hRad52, Rht14-Y104E, Rht14-Y104F) had the lowest proportions of cells with 
detectable levels of Rad52-related protein.  Although the low cellular levels of the full 
length hRad52-related proteins may be dependent on the loci where their transgenes 
integrated, alternatively, the stability of the full length hRad52-related proteins may be 
cell cycle regulated.  There is evidence in the literature supporting both cell cycle-
independent and -dependent regulation of endogenous hRad52 levels.  In one study, 
endogenous hRad52 levels in G2/M phase were elevated by almost 1.5-fold over G1 
phase (Chen, 1997) while another study briefly mentions that no change in endogenous 
hRad52 levels was observed throughout the cell cycle though the results were not shown 
(van den Ouweland, 1997).  Nevertheless, it is possible the stability of full length hRad52-
related proteins is influenced by the stage of the cell cycle whereas the truncation 
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mutants and (NLS)scRad52* do not possess the regions necessary to be cell cycle 
regulated.   
4.3.4 Exploring the Protein Stabilities of the Rad52-Related Proteins 
Factors affecting the stability of endogenous hRad52 in human cells have not been 
investigated in detail by other groups.  Protein levels observed by immunoblot and 
immunofluorescence were the highest for the C-terminal truncation mutants (NLS)Δ284* 
and (NLS)Δ238* and lowest for the full length proteins hRad52* and (NLS)scRad52*. 
Because part of the central and C-terminal domains were deleted in both (NLS)Δ284* and 
(NLS)Δ238*, I hypothesised that residues present within these deleted regions normally 
contributed to destabilising the protein.  In one study in yeast, the half-lives of two 
scRad52 mutants containing central domain deletions were also higher relative to full 
length scRad52 (Asleson, 2003).  However, it should be noted that at the time the study 
was conducted, the NLS of scRad52 had not yet been identified and the NLS in both 
deletion mutants was deleted.  Thus the scRad52 deletion mutants may not have been 
subjected to nuclear degradation which would explain the observed increases in half-
lives.  Alternatively, sumoylation of scRad52 was demonstrated to affect the half-life of 
the protein in another study (Sacher, 2006) which suggested that for the hRad52-related 
proteins, their relative stabilities may differ as a consequence of removing potential 
stabilising or destabilising PTM sequences.  However, in my analyses transient expression 
of the Rad52-related proteins did not reveal any easily observable differences in the 
stability profiles of the proteins (Figure 4.8).  It is possible the high Rad52-related 
transgene expression levels may have overwhelmed the cellular machinery responsible 
for mediating degradation of the Rad52-related proteins, which would lead to inaccurate 
representation of their stability profiles.  Nevertheless, the evidence suggested that the 
protein structures of hRad52*, (NLS)scRad52*, (NLS)Δ284* and (NLS)Δ238* did not affect 
their stabilities or cellular levels however, mRNA levels should be measured by reverse 
transcriptase PCR to confirm this. 
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Chapter 5 Characterising the Cell Lines Overexpressing 
the Rad52-Related Proteins 
5.1 Introduction 
It is important that the balance of endogenous levels of the DNA repair proteins is 
maintained to ensure proper regulation of the DNA repair pathways, such as HR, within a 
cell where loss or excess of one component can impair HR or divert repair to an 
alternative pathway (Helleday, 2007; Liang, 1996; Mansour, 2008; Stark, 2004; Storici, 
2006; Yanez, 1999; Yanez, 2002; Yun, 2009).  However, changing this balance through 
overexpression of HR proteins may hold the potential for enhancing GT by directly 
increasing HR events or indirectly decreasing Tot-NHEJ events.  On the other hand, such 
manipulations of HR may affect genome stability and in turn cell viability.  Indeed, 
overexpression of HR proteins is associated with non-small cell lung cancer (Saviozzi, 
2009) and elevated levels of SSA activity were attributed to the activity of BCR/ABL and 
other kinases expressed in myeloproliferative leukemias (Cramer, 2008).  Increases in SSA 
activity may implicate Rad52 disregulation as a contributor to the disease.  
Overexpression of another human HR protein, Rad51, resulted in cell aneuploidy and 
chromosomal rearrangements in mouse ES cells (Richardson, 2004).  If overexpression of 
the Rad52-related proteins is ever to be used as a tool to enhance the frequency of GT it 
is essential to understand the overexpression effects, both positive and negative, on 
cellular processes.  This chapter focuses on characterising the Rht14-Rad52-related cell 
lines by determining how overexpression of the Rad52-related proteins affect cellular 
growth, viability, progression through the cell cycle and radiation sensitivity.  
Investigation regarding dsGT and ssGT will be discussed in Chapter 6 and Chapter 7, 
respectively. 
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5.1.1 Growth Curves and Cell Viability 
Negative effects from hRad52 overexpression were previously characterised in this lab 
(Yanez, 2002).  Cells overexpressing hRad52 exhibited a 50% reduction in viability in 
comparison to control cells, as measured by plating efficiencies.  In addition, continuous 
hRad52 expression over increasing passage numbers resulted in loss of (or greatly 
diminished) cellular protein levels, indicating that overexpression of this protein was 
unstable or, alternatively, that cells exhibiting strong overexpression levels were at a 
selective disadvantage.  It is possible that such negative effects resulted from increased 
SSA activity leading to increased genomic instability.  Alternatively, excess hRad52 may 
have disrupted protein interactions (e.g. through its hRPA and hRad51 binding domains) 
by sequestering these proteins or interfering with their activities.  For example, 
interaction mediated through the N-terminal domain of hRad52 enhances the catalytic 
activity of XPF/ERCC1 (Motycka, 2004), an endonuclease which plays a role in processing 
ssDNA flaps during HR, MMEJ or NER (Sections 1.1.3, 1.1.5 and 1.1.6). However, excess 
hRad52 may inhibit XPF/ERCC1 which in turn may impair DNA repair processes and 
recombination. 
 
To assess the effect of the Rad52-related proteins on cell growth and viability, growth 
curves and plating efficiencies were measured for the Rht14-Rad52-related clones 
described in Chapter 4.  Expression of the Rad52-related transgenes was found to affect 
growth rate and cell viability.  To determine if these results could be explained by changes 
in the cell cycle distributions, such as an accumulation of cells in a certain phase, analysis 
of their DNA content was used to generate and compare cell cycle profiles for all clones.   
5.1.2 Cell Cycle Regulation of Rad52 
Because HR is limited to late S and G2 phases of the cell cycle, the HR machinery is often 
tightly regulated at the level of gene expression as well as through PTMs of the protein 
products.  Indeed, hRad52 protein levels are low in G0 and increase to a maximum in G2 
(Chen, 1997).  In contrast, scRad52 protein levels are low but relatively unchanging 
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throughout the cell cycle (Spellman, 1998).  During S phase, scRad52 can be 
phosphorylated (Antunez de Mayolo, 2006) and in response to DNA damage it can be 
sumoylated (Ohuchi, 2008a).  Phosphorylation of hRad52 by the tyrosine kinase c-Abl may 
also occur in a cell cycle-dependent manner.  In response to IR, c-Abl is activated in S 
phase and phosphorylates a number of substrates to activate repair (Liu, 1996).  It is 
unknown at which stage of the cell cycle hRad52 is phosphorylated though, in one study, 
phosphorylation of  hRad52 enhanced its ability to form foci (Kitao, 2002), a relocalisation 
event which occurs predominantly in S-phase (Feng, 2011)(Section 1.4.5).  The co-
ordination of these events suggests that hRad52 is phosphorylated in S phase. However, 
the resulting effects on cell viability and HR efficiency are unknown.   
 
Taking the results of previous studies into consideration, one might expect each of the 
Rad52-related proteins described in Chapter 4 to be regulated differently during the cell 
cycle as a result of possessing different domains, and potentially PTM sites, which in turn 
would affect their stability, annealing activity and localisation.  This would have the 
potential to negatively affect genome stability or HR.  Evidence of such negative effects 
was indeed observed with overexpression of hRad52 and hRad51.  Excess hRad52 
effected an accumulation of cells in G1 (Yanez, 2002) and overexpressed hRad51 affected 
cell cycle progression with an accumulation of cells in G2 (Flygare, 2001).  I therefore 
decided to analyse the DNA content of cells overexpressing the Rad52-related proteins to 
determine if cells in any of the seven Rht14-Rad52-related clones exhibited similar 
disruptions in cell cycle distributions.   
5.1.3 Radiation Sensitivity 
Phosphorylation of tyrosine 104 in hRad52 contributes to its recruitment to sites of DNA 
damage: introducing the Y104F mutation into GFP-tagged hRad52, stably expressed in 
CHO cells, reduced the number of IR-induced Y104F foci as compared to hRad52 repair 
foci (Kitao, 2002).  Resistance to DNA damaging agents was not tested by Kitao et al. 
although increased sensitivity to DNA damage might be expected with the Y104F mutant.  
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A Y104 mutation to a glutamic acid mimics constitutive phosphorylation suggesting that 
the Y104E* and Y104F* proteins used in my studies may confer increased or decreased 
resistance to DNA damage, respectively.  In other studies, there was evidence that 
expression of hRad52 in monkey FSH2 cells elevated resistance to IR (Park, 1995) and 
expression of scRad52 in HeLa cells elevated resistance to MMS and X-irradiation (Di 
Primio, 2005), perhaps by increasing the efficiency of repair involving SSA.  As IR produces 
various types of lesions which can be repaired by HR as well as other repair pathways, it is 
possible that any increased resistance to IR in cells overexpressing a particular Rad52-
related protein may result from a stimulation of SI, SSA or both.  For example, in the 
aforementioned experiments demonstrating that cells overexpressing scRad52 and 
hRad52 were more resistant to DNA damaging agents, these cells also exhibited increases 
in ICHR, which can occur by SI or SSA (Di Primio, 2005; Park, 1995).  Hence, it would be 
interesting to investigate whether overexpression of the Rad52-related proteins will 
affect both sensitivity to DNA damaging agents and HR efficiency in a concerted fashion. 
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5.2 Results 
5.2.1 Effects on Growth Rate from Rad52-Related Protein Expression  
To assess the effect of each Rad52-related protein on cell growth, clones were cultured 
with or without tet for 2 days to fully induce Rad52-related protein expression.  
Subsequently, cell numbers were counted at various points over a 12 day period and the 
number of cell doublings was calculated for each time point (Figure 5.1).  The parental cell 
line Rht14 did not exhibit differences in the number of cell doublings when cultured in the 
presence or absence of tet demonstrating that tet did not affect cellular growth rate.  In 
contrast, all clones expressing hRad52-related proteins exhibited reduced growth rates in 
comparison to their respective controls (same clones grown +tet).  Surprisingly, growth 
rate was enhanced when scRad52 was expressed in comparison to the control.  These 
results suggest that the hRad52-related proteins may directly inhibit growth and/or 
decrease cell viability while scRad52, a non-hRad52-related protein, stimulates cell 
growth and/or viability.  
 
A comparison of the growth rates was made between induced clones and their respective 
uninduced controls.  Table 11 reveals that from days 6-12, the growth rates of the clones 
with the most pronounced growth defects (Rht14-Δ290-330, Rht14-Y104E and Rht14-
Y104F; -tet) increased by 13-16% in comparison to days 0-6.  It is possible the Rad52-
related proteins expressed by these clones negatively affect cellular processes and/or cell 
viability and cells which suppress transgene expression are more viable.  The more viable 
cells would thus represent an increasing proportion of the clonal population as time goes 
on and correlate with an increase in growth rate.  However, the growth rate of Rht14-
hRad52 (-tet) was relatively consistent from days 0-6 and days 6-12 despite also exhibiting 
a noticeably reduced growth rate.  Surprisingly, the growth rate of induced Rht14-
(NLS)scRad52 had diminished to that of its control from days 6-12.  This suggests that 
although (NLS)scRad52 may initially provide cells with a growth advantage, the increased 
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growth rate cannot be maintained perhaps as a result of negatively affecting genome 
stability. 
 
In addition to monitoring the growth rates of the Rht14-Rad52-related clones, the cells 
grown in the absence of tet were visualised by immunofluorescence microscopy, on days 
0 and 12 to determine if there were changes in the proportion of cells expressing 
detectable levels of the Rad52-related proteins (Figure 5.2).  The proportion of cells 
expressing hRad52*, and Y104E* was noticeably reduced at day 12 while the proportion 
of cells expressing (NLS)Δ284* and (NLS)Δ238* remained similar, however, there were 
relatively fewer (NLS)Δ284* cells displaying intense fluorescent signals suggesting that 
expression levels of this protein were also reduced.  In contrast, the proportion of 
overexpressing cells and level of (NLS)scRad52* expression appeared similar on days 0 
and 12.  These results suggest that inhibited growth rate in the presence of the Rad52-
related protein may correlate with loss of expression.  It is also possible that differences 
in immunostaining efficiency were the cause of the observed changes.  The experiment 
therefore needs to be repeated before conclusions can be made regarding changes in 
Rad52-related protein expression levels over time.  That aside, to further explore the 
reason behind the differences in growth rates between each clone cultured with or 
without tet, plating efficiencies were utilised to measure the effects of the Rad52-related 
proteins on cell viability. 
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Figure 5.1. Growth rates of Rht14-Rad52-related clones are affected by overexpressing Rad52-
related proteins. Clones were uninduced (solid black squares, solid line) or induced (open squares, 
dashed line) for Rad52-related protein expression.  Data points indicate the days when cell numbers 
were counted and cultures were split.  Clones Rht14, Rht14-hRad52, Rht14-(NLS)Δ284, Rht14-
(NLS)Δ238 and Rht14-(NLS)scRad52 were grown in parallel and clones Rht14-Δ290-330, Rht14-Y104E 
and Rht14-Y104F were grown in parallel. 
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Table 5.1. Analysis of average growth rates and percent change in growth rates of induced 
Rht14-Rad52-related clones. 
Clone Tet 
Days 0-12 Days 0-6 Days 6-12 
% Change: 
Days 0-6 to 
Days 6-12 
Avg. 
Growth 
Rate 
% 
Change 
(compared 
to +tet) 
Avg. 
Growth 
Rate 
% 
Change 
(compared 
to +tet) 
Avg. 
Growth 
Rate 
% 
Change 
(compared 
to +tet) 
Rht14 
+ 1.42 -- 1.45 -- 1.70 -- -- 
– 1.41 -0.7 1.44 -0.6 1.69 -0.4 0.1 
Rht14-hRad52 
+ 1.25 -- 1.32 -- 1.19 -- -- 
– 1.05 -16.2 1.09 -17.1 1.01 -15.3 2.1 
Rht14-
(NLS)Δ284 
+ 1.31 -- 1.28 -- 1.33 -- -- 
– 1.23 -6.2 1.20 -6.7 1.26 -5.6 1.2 
Rht14-
(NLS)Δ238 
+ 1.27 -- 1.30 -- 1.25 -- -- 
– 1.18 -7.4 1.16 -10.7 1.20 -4.0 7.5 
Rht14-Δ290-
330 
+ 1.18 -- 1.16 -- 1.20 -- -- 
– 0.92 -22.2 0.82 -29.2 0.99 -17.6 16.4 
Rht14-
(NLS)scRad52 
+ 1.05 -- 1.01 -- 1.09 -- -- 
– 1.16 +10.2 1.24 22.6 1.08 -1.5 -19.7 
Rht14-Y104E 
+ 1.25 -- 1.22 -- 1.28 -- -- 
– 0.98 -21.6 0.90 -25.9 1.09 -14.9 14.9 
Rht14-Y104F 
+ 1.24 -- 1.20 -- 1.28 -- -- 
– 0.89 -28.7 0.81 -32.2 0.99 -22.8 13.9 
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Figure 5.2. Rad52-related protein levels are reduced after continuous expression. Rad52-related protein samples were harvested from induced Rht14-
Rad52-related clones, used to measure growth rates (Figure 5.1), on days 0 and 14.  Protein levels were visualised using an antibody against the HA-tags.           
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5.2.2 Effects on Cell Viability from Rad52-Related Protein Expression 
Cell viability was measured by growing cells with or without tet for 48hrs followed by 
plating the cells at known limiting dilutions.  Resulting colonies were counted 12-14 days 
following plating.  The cells were continuously grown in the presence or absence of tet for 
the duration of the experiment.  The number of colonies which arose for each induced 
Rht14-Rad52-related clone was calculated as a percentage of the corresponding colonies 
arising in the uninduced clone (Figure 5.3).  A trend can be observed in the plating 
efficiencies.  Induction of hRad52* resulted in a low plating efficiency (~30%) however, 
overexpressing proteins with increasing C-terminal truncations (i.e. (NLS)Δ284* and 
(NLS)Δ238*) resulted in increased plating efficiencies.  Clones overexpressing the 
phosphorylation mutants Y104E* and Y104F*, which are also full length hRad52-related 
proteins, also demonstrated poor plating efficiencies.  Unexpectedly, the plating 
efficiency of cells overexpressing Δ290-330* was severely impaired. These results suggest 
that in excess, the N- terminal domain and residues 331-418 of the C-terminal domains of 
hRad52 are detrimental to cell viability.  
  
To determine if a correlation existed between growth rate and cell viability, the percent 
decreases in cell viability were plotted vs the percent decreases in growth rate for the 
Rht14-Rad52-related clones cultured without tet (Figure 5.4).  A 2nd degree polynomial 
relationship was observed suggesting that growth rate and cell viability are related.  
However, the experiments need to be repeated to determine statistical significance 
before any firm conclusions can be made.  
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Figure 5.3. Human Rad52-related proteins negatively affect cell viability.  Clones were uninduced or induced for 48hrs prior to plating at known limiting 
dilutions.  Cells were cultured for a further 12-14 days in the presence or absence of tet.  Resulting colony numbers of induced clones are expressed as a 
percentage of the number of colonies which arose from the corresponding uninduced control clone.  Experiments were performed in duplicate with the 
exception of Rht14 which was only performed once. 
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Figure 5.4. Relationship between growth rates and cell viabilities. The percent decreases in 
plating efficiencies (Figure 5.3) were plotted against the percent decreases in number of cell 
doublings (Table 11) for Rht14 and the Rht14-Rad52-related clones cultured without tet.  The 
trendline is a second degree polynomial. 
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5.2.3 DNA content 
The severe reduction in cell viability resulting from overexpression of hRad52 mutants 
containing all or part of the C-terminal domain (hRad52*, Y104E*, Y104F* and Δ290-
330*) appeared to correlate with the negative effect on growth rate.  To determine if the 
changes in cellular growth rates and viability also correlated with changes in cell cycle 
progression, the cell cycle profiles of the Rht14-Rad52-related clones were analysed.  
Clones were cultured with or without tet for 4 days at which time their DNA content was 
analysed by flow cytometry (Figure 5.5).  Some effects of Rad52-related protein induction 
on cell cycle distributions were detected but these were generally small.  However, a 
partial relationship was observed between the effect of the Rad52-related proteins on 
growth rates and cell cycle distributions.  Induction of the Rad52-related proteins which 
did not greatly reduce growth rates ((NLS)Δ284*, (NLS)Δ238*, (NLS)scRad52*) also did not 
change the cell cycle distributions in comparison to controls (differences of 2% or less 
between each cell cycle stage).  In contrast, the Rad52-related proteins causing the 
greatest growth rate deficiencies (hRad52*, Δ290-330*, Y104E* and Y104F*)(Figure 5.1), 
exhibited a decrease in the proportion of G0/G1 cells (differences of 4% or higher).  In the 
case of hRad52* and Δ290-330*, the G0/G1 decrease was coupled with a similar increase 
in the proportion of G2/M cells, whereas for Rht14-Y140F (and to a lesser extent Rht14-
Y104E) a corresponding increase in S phase cells was noted.  These result suggest that 
hRad52* and Δ290-330* may be impairing entry into S-phase while Rht14-Y104F and 
Rht14-Y104E may impair completion of S-phase. However, given the small size of these 
effects this experiment needs to be repeated before any firm conclusions regarding the 
potential effects of the Rad52-related proteins on cell cycle progression can be made.   
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Figure 5.5. Cell cycle analysis of the Rad52 Clones. Cells were cultured in the presence or absence of tet for 4 days prior to fixing, PI staining and analysis by 
flow cytometry.  Red bars indicate a decrease of ≥4% while green bars indicate an increase of ≥4%, in comparison to +tet controls.  n=1 for each clone. 
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5.2.4 Overexpression of Rad52 does not confer resistance to ionising 
radiation 
Overexpression of scRad52 and hRad52 have been reported to confer resistance to DNA 
damaging agents (Di Primio, 2005; Park, 1995) presumably by enhancing the efficiency of 
DSB repair by pathways involving SSA or SI reactions.  Although not tested for sensitivity 
to DNA damage, overexpression of Y104F decreased the number of repair foci in response 
to IR (Kitao, 2002).  Impairment of the formation of Rad52 foci would presumably inhibit 
the cell’s ability to repair DSBs and negatively impact its survival.  In contrast, a Y104E 
mutation constitutively mimicking phosphorylation might be expected to stimulate the 
repair of DSBs and increase cell survival although conversely; it might also result in hyper-
recombination leading to genomic instability.  Clones were cultured in the presence or 
absence of tet for 48hrs followed by exposure to γ-irradiation at a range of doses from 0 
to 8Gy (Figure 5.6).  Interestingly, none of the Rad52-related proteins caused any clear 
resistance to DNA damage.  In fact, cells overexpressing hRad52* and (NLS)Δ284* were 
sensitised to IR.  When induced, neither phosphorylation mutant yielded a consistent 
change in survival compared to controls, except at 2Gy where an increase in sensitivity 
was noted.  However, as radiation sensitivity was only measured once for the majority of 
Rht14-Rad52-related clones, these results do not conclusively demonstrate that 
expression of these particular Rad52-related proteins has no effect on resistance to IR.  
Nevertheless, together these results suggest that Rad52 is not a limiting factor within the 
DNA repair pathway and that any increase in SSA or SI activity is more than offset by the 
greater efficiency of the other components of the DNA repair pathway.  
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                 Rht14             Rht14-hRad52                            Rht14-(NLS)Δ284                          Rht14-(NLS)Δ284 
                                
                                  Rht14-Δ290-330                Rht14-(NLS)scRad52                            Rht14-Y104E                            Rht14-Y104F 
                                 
Figure 5.6. The Rad52-related proteins do not increase resistance to γ-irradiation. Clones were grown with or without tet for 48hrs and then exposed to γ-
irradiation at various doses.  +/- tet status was maintained for 12-14 days after which time colonies were counted.    
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5.3 Discussion 
Regulation of the DNA repair pathways is essential for cell survival and viability.  
Disrupting the functions of a single protein can have far reaching effects including 
genomic instability, genome rearrangements and cell death (Buis, 2008; Kraakman-van 
der Zwet, 2002; Lim, 1996; Stark, 2004).  For example, human somatic cells homozygous 
for deletion of the NHEJ protein Ku80 apoptosed after a number of cell divisions (Li, 
2002).  Similarly, overexpression of hRad52 in HT1080 was previously observed to 
negatively affect cell viability and correlated with a 15% increase in the proportion of cells 
in G1 phase of the cell cycle (Yanez, 2002).  In this chapter, cell viabilities and cell cycle 
distributions were measured to determine whether removing the central and C-terminal 
domains of hRad52 could abrogate the negative effects observed in the presence of 
excess hRad52 (Yanez, 2002). Cellular growth rates and sensitivity to the DNA damaging 
agent γ-irradiation were also measured because neither had been investigated using 
human host cells overexpressing hRad52-related proteins.  In addition, investigating the 
effect of the Rad52-related proteins on resistance to DNA damage was of interest 
because in previous overexpression studies enhancements in DNA damage resistance was 
observed in monkey cells expressing hRad52 (Park, 1995) and human cells expressing 
scRad52 (Di Primio, 2005). 
5.3.1 The Domains of hRad52 Negatively Affect Growth Rate  
Although growth rates were only measured once, the preliminary results suggest that 
hRad52-related proteins impair cell doubling time perhaps as a result of decreased cell 
viability and/or a change in cell cycle distribution.  Induction of the C-terminal truncation 
mutants (NLS)Δ284* and (NLS)Δ238* did not generate as great a decrease in growth rates 
as induction of hRad52*, Δ290-330* or the phosphorylation mutants (Figure 5.1).  
Because a larger decrease was also observed with Δ290-330* induction, this raises the 
possibility that region 331-418 of the C-terminal domain of hRad52 may inhibit growth 
rates to a greater degree than the N-terminal or central domains.  It was also interesting 
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that  (NLS)scRad52* induction appeared to increase growth rate implying that while the 
C-terminal domain of hRad52 has a dominant negative effect on growth the C-terminal 
domain of (NLS)scRad52* does not.  However, the growth rates must be measured again 
to obtain more meaningful results.  If expression of (NLS)scRad52* is in fact stimulatory, 
this might be explained in terms of the DNA binding and annealing ability of the N- and C-
terminal domains that could help to stabilise ssDNA intermediates such as those 
generated during repair or replication.  However, whatever positive effect (NLS)scRad52* 
had on growth rate was negated after continuous expression of the protein where growth 
rate was restored to that of its control after 6-12 days of continuous culture (Table 11).  
Thus, (NLS)scRad52* overexpression may ultimately be genome destabilising.  It would be 
interesting to observe the growth rates of induced Rht14-(NLS)scRad52 cells from days 12 
onward to determine whether these cells may eventually exhibit a decreased growth rate 
in comparison to the control. 
 
In general, the induced clones with noticeably impaired average growth rates (Rht14-
Δ290-330, Rht14-Y104E, Rht14-Y104F) exhibited increased growth rates over the last 6 
days in comparison to the first 6 days, with the exception of Rht14-hRad52.  It is possible 
that clones with reduced or silenced expression of the particular Rad52-related protein 
had a growth rate advantage over clones with continued Rad52-related transgene 
expression.  Thus over the last 6 days, a larger proportion of cells would be expected to 
exhibit lower or undetectable expression levels of the particular Rad52-related proteins.  
Indeed, the detectable levels of Rad52-related protein, by immunofluorescence, 
decreased markedly between day 0 and day 12 in Rht14-Y104E (Figure 5.2).  Induced 
Rht14-hRad52 also showed a severe reduction in detectable levels of hRad52* despite 
not exhibiting a change in growth rate between days 0-6 and days 6-12.  Although the 
growth rate of induced Rht14-(NLS)Δ284 was not as impaired as the other Rht14-hRad52-
related clones, the detectable (NLS)Δ284* levels on day 12 also appeared slightly 
reduced.  These results support the previous observation that hRad52 overexpression in 
HT1080 is unstable and expression is lost over time (Yanez, 2002).  Future experiments 
could also include visualising overall Rad52-related protein levels by immunoblot. 
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5.3.2 The Domains of hRad52 Negatively Affect Cell Viability and Growth 
Rate in a Concerted Fashion 
Following the investigation of growth rates, the plating efficiencies of the Rht14-Rad52-
related clones were investigated to determine whether a correlation existed between cell 
viability and growth rate. Similar to the observed decreases in doubling times, induction 
of the hRad52-related proteins also decreased plating efficiencies while overexpression of 
(NLS)scRad52* had no effect (Figure 5.3).  Cells with induced hRad52* were only 30% 
viable however, the cell viabilities of induced cells progressively increased with increasing 
C-terminal truncations of hRad52 (i.e. (NLS)Δ284* - 45% viable, (NLS)Δ238* - 60% viable).  
At first glance, this supported my hypothesis that the hRad51 and/or hRPA binding 
domains were responsible for the negative effects previously reported with hRad52* 
overexpression (Yanez, 2002).  Removing these binding domains appeared to relieve 
these inhibitions of cell viability and in addition, (NLS)scRad52*, which does not share 
homology with the hRad51 and hRPA binding domains, did not impair cell viability.  
However, upon closer inspection, the cell viability with induced Δ290-330* was severely 
impaired to 4% which was much lower than the 59% observed with (NLS)Δ284* induction.  
This argued against the hypothesis that the hRad51 binding domain (and hRPA binding 
domain) generated a dominant negative effect because both (NLS)Δ284* and Δ290-330* 
contain hRad51 binding domain deletions and would thus be expected to yield similar cell 
viabilities when overexpressed.  However, they did not.  In contrast, the results suggest 
that when present in excess, residues 331-418 of the C-terminal domain of hRad52 has a 
greater negative effect than either the RPA or Rad51 binding domains. 
 
A positive second degree polynomial correlation between growth rate and cell viability 
was observed (Figure 5.4) though this did not correlate well with changes in the cell cycle 
distributions.  Because the correlation is not linear, the trend suggests that with greater 
decreases in cell viability there is a greater negative effect on growth rate than would be 
observed with a linear relationship.  The graph also demonstrates that induction of 
hRad52*, Δ290-330*, Y104E* and Y104F* (the four hRad52-related proteins containing 
Chapter 5    Characterising the Cell Lines Overexpressing the Rad52-Related Proteins 
 
148 
 
residues 331-418) resulted in the highest deficiencies in both cell viability and growth 
rate.  Although the doubling times and plating efficiencies were only measured once, the 
results suggest that the hRad52-related proteins inhibit cellular growth rate and viability 
and that this inhibition appears to be influenced most by the presence of residues 331-
418 of the C-terminal domain and not the hRPA or hRad51 binding domains.  Repeat 
measurements of plating efficiencies could also be performed with transient Rad52-
related protein expression while measurements of both cell viability and growth rate 
could be made with clones exhibiting different overexpression levels to determine if the 
concentration of the Rad52-related proteins also has a dose-dependent effect. 
 
Interestingly, in one previous study a direct correlation between growth rate and cell 
viability was also observed in HT1080 cells with induced expression of the HR protein 
hRad51 (Flygare, 2001).  With increasing hRad51 induction levels, both cell viability and 
growth rate progressively decreased.  In addition, there was evidence that hRad51 
overexpression induced apoptosis.  64hrs after hRad51 expression was induced, apoptotic 
levels increased 10-fold over the control (Flygare, 2001).  It is possible that 
overexpression of the hRad52-related proteins might also induce apoptosis as a result of 
disrupting HR or other repair pathways.  Excess hRad52-related proteins containing 
residues 331-418 of the C-terminal domain may produce the greatest apoptotic effect by 
generating a dominant negative effect mediated by the C-terminal domain.  The 
apoptotic effects of the Rad52-related proteins could be tested by staining cells with 
Annexin V and PI to measure the proportion of live and dead cells with flow cytometry.   
5.3.3 The hRad52-Related Proteins do not Result in Large Changes in Cell 
Cycle Distributions 
The correlation between growth rate and cell viability was not mirrored in the cell cycle 
distributions of induced Rht14-Rad52 clones.  However, small differences between the 
proportions of cells found in G0/G1, S and G2/M phases of the cell cycle (Figure 5.5) were 
noted.  Overexpression of hRad52* and Δ290-330* resulted in a small reduction in the 
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number of G1 cells and an increase in G2/M cells while overexpression of Y104F* and 
Y104E* resulted in a small reduction of cells in G1 and an increase in S-phase cells.  The 
decrease in proportion of G1 cells resulting from induction of hRad52* was contrary to 
previous evidence demonstrating that excess hRad52 led to an accumulation of cells in G1 
(Yanez, 2002).  It is possible the discrepancies between my results and that of Yanez et al. 
arose as a result of differences in cell exposure time to the overexpressed hRad52 
proteins.  In the experiments conducted by Yanez et al., hRad52 was constitutively 
expressed in their clone.  The length of time in which the cells had been exposed to 
excess hRad52 levels was not indicated but it certainly exceeded the 10 day period 
required to isolate stable clones overexpressing hRad52 (Yanez, 2002).  In contrast, 
induction of the Rht14-hRad52 clone used in my experiment occurred for 4 days (See 
Materials and Methods, 2.6.2).  Perhaps a large effect on cell cycle progression can only 
occur after prolonged exposure to elevated levels of hRad52 as well as the other Rad52-
related proteins.  To further investigate whether the Rad52-related proteins caused 
changes in the speed of progression through each cell cycle phase, hydroxyurea could be 
used to synchronise the cells in G1 or alternatively, a double thymidine block could be 
used to synchronise the cells in S-phase.  It should be noted, however, that cell cycle 
profiles differ greatly between different clones and that these differences are often 
greater than those observed between + and –tet clones.  This would seem to indicate that 
there is clonal variation in the cell cycle profiles which suggests that it may be important 
to look at the effects of the Rad52-related proteins in more than one clone expressing 
each Rad52-related protein. 
 
Upon comparison of the cell cycle distributions to the growth rates (Figure 5.5, Table 11), 
a tentative relationship can be proposed.  In general, induced clones exhibiting larger 
decreases in growth rate also exhibited larger decreases in the proportion of G1 cells 
(Rht14-hRad52, Rht14-Δ290-330, Rht14-Y104E, Rht14-Y104F).  As there is evidence that 
HR is predominantly active in late S and G2 (Rothkamm, 2003) (Section 1.3.1), hRad52*, 
Δ290-330*, Y104E* and Y104F* may interfere with other components of HR resulting in 
delayed exit from S and G2.  Disruption of HR may in turn lead to genomic instability or 
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cell death which may also lead to an accumulation of cells in a particular phase of the cell 
cycle.  Indeed, Rad51 induction was observed to stimulate apoptosis by almost 10-fold 
and increase the percentage of G2 cells by more than 2-fold (Flygare, 2001).  Thus, in 
excess, the different domains of the Rad52-related proteins may also have the potential 
to affect cell cycle progression and genomic stability.   
5.3.4 The Rad52-Related Proteins are not Resistant to γ-Irradiation 
To further characterise the effects of overexpressing the Rad52-related proteins, Rht14-
Rad52-related clones were induced or uninduced prior to being exposed to various doses 
of γ-irradiation.  Although IR sensitivity was only measured once or twice for the Rht14-
Rad52-related clones, enhanced resistance to IR was not observed upon induction of any 
of the Rad52-related proteins (Figure 5.6).  Moreover, clones with induced expression of 
hRad52* and Δ284* exhibited increased sensitivities to IR.  These results contrasted with 
two previous studies which demonstrated that expression of hRad52 in monkey cells 
(Park, 1995) and scRad52 in HeLa cells (Di Primio, 2005) increased resistance to DSB 
causing agents in comparison to controls.  It is possible these increases were observed 
because the exogenous Rad52 proteins were from a different species to the host cell.  
However, this does not explain why (NLS)scRad52* did not enhance radiation resistance 
in Rht14-(NLS)scRad52.  The reason for this is still unknown but it is possible that induced 
levels of scRad52 in my experiments (but not in those of Di Primio et al. and a Park et al.) 
were insufficiently high to promote resistance. 
 
In previous knockout studies, hypersensitivity to DSB causing agents was not observed in 
Rad52-/- mutants generated in embryonic mouse cells (Rijkers, 1998) and chicken DT40 
cells (Yamaguchi-Iwai, 1998).  This suggested that Rad52 is neither rate-limiting nor 
essential for DSB repair.  For a similar reason, it is possible that induction of the hRad52-
related proteins did not increase the efficiency of DSB repair and consequently did not 
increase resistance to IR.  Nevertheless, the experiments must be repeated to obtain 
significant values.   
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This chapter highlighted the negative effects of Rad52-related protein expression on 
growth rate and cell viability and how these correlated with changes in cell cycle 
distribution.  In addition, residues 331-418 of the C-terminal domain were identified as 
the major region responsible for the negative effects observed upon hRad52-related 
protein induction.  The next two chapters will focus on the effects of the Rad52-related 
proteins on GT. 
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Chapter 6 The Effects of Overexpressing the Rad52-
Related Proteins on Double Stranded Gene Targeting 
Assays 
6.1 Introduction 
Understanding the different roles of the Rad52 domains in HR and their specific effects on 
GT have been central to the aims of this work.  Prior to investigating GT however, the 
effects of Rad52-related protein overexpression on growth rate, cell viability, cell cycle 
distribution and DNA damage were first characterised in the previous chapter to gain a 
wider perspective of the involvement and influence of the Rad52 domains on other 
cellular processes.  A correlation between growth rate and cell viability was established 
where overexpression of hRad52-related proteins possessing residues 331-418 of the C-
terminal domain produced the greatest deficiencies while in contrast, (NLS)scRad52* 
slightly enhanced growth rates and did not negatively affect cell viability.  These results 
suggested that residues 331-418, not the hRPA and hRad51 binding domains as initially 
hypothesised, are harmful to human cells when present in excess.  In contrast, 
(NLS)scRad52* did not yield negative effects, likely as a result of its low sequence 
similarity with the central and C-terminal domains of hRad52 and inability to interact with 
human proteins.  The role of the phosphorylation state of Y104 was difficult to discern.  
Neither Y104E* nor Y104F* was observed to affect radiation sensitivity, as was predicted, 
however both were detrimental to cell viability and negatively affected growth rates.  
Building on the these results, this chapter will investigate the effects of the Rad52-related 
proteins on dsGT and discuss whether a relationship exists between the effects observed 
in the previous chapter and the effects observed on dsGT. 
 
In comparison to random integration (RI) events, targeting with dsDNA is relatively 
inefficient.  Hence, other groups previously attempted to increase dsGT efficiencies by 
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manipulating individual components of the HR machinery, which has been met with 
relatively modest success (See Section 1.9.3).  With overexpression of hRad51, dsGT was 
stimulated by only 2-3-fold using the same human HPRT (hHPRT) targeting construct used 
in Section 3.2.2 (Figure 6.1) in HT1080 cells (Yanez, 1999).  As Rad51 requires a mediator 
protein such as Rad52 to perform SI, it was reasoned that overexpression of hRad52 
might also promote dsGT, especially in conjunction with hRad51 overexpression.  It was 
also encouraging that hRad52 overexpression in monkey cells had been shown to 
promote a 3- to 5-fold increase in ICHR (Park, 1995) and overexpression of scRad52 in 
HT1080 cells to promote a 12-fold increase in ECHR (Johnson, 1996) (Table 1).  
Unexpectedly, however, overexpression of hRad52 in HT1080 cells caused a 2-fold 
decrease in the ratio of targeted to total (random + targeted) integrations, using the 
hHPRT dsGT assay that had been used for observing enhanced dsGT from hRad51 
overexpression (Yanez, 2002).  Furthermore, when hRad51 and hRad52 were co-
overexpressed, there was no net effect on this assay (Yanez, 2002).  In contrast, a 
subsequent study using an alternative dsGT assay (a defective hygromycin cassette was 
randomly integrated into cells and repair was achieved following introduction of a 
hygromycin repair construct) in HeLa cells reported that overexpression of scRad52 
generated stimulations of dsGT by up to 37-fold (Di Primio, 2005).  However, the reported 
stimulation may not be accurate as there was no control for the potential chromosomal 
position effects of the reporter construct, which was randomly integrated into different 
clones.  Nevertheless, most recently, a scRad52 fusion protein able to permeate the 
nuclear membrane was shown to elevate ICHR and dsGT up to 63- and 50-fold, 
respectively (Kalvala, 2010).  In CHO cells, expression of hRad52 yielded a 2-fold increase 
in spontaneous ICHR and a conflicting 1.5-fold decrease in DSB-induced ICHR which 
suggested that the mechanisms required for spontaneous and DSB recognition for ICHR 
repair are different (Kim, 2001). 
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Figure 6.1. Human HPRT Gene Targeting Assay using a dsDNA Targeting Construct.  Step 1: 
Rht14-Rad52-related clones were grown +/- tet for 48hrs and electroporated with linearised 
pHPRThyg.  pHPRThyg was designed to disrupt exon 2 of the hHPRT locus.  Step 2: The disruption 
construct integrated randomly or within exon 2 of the hHPRT locus.  Step 3: Hygromycin was 
added to one pool of cells from days 2-14.  Hygromycin (days 2-14) and 6-TG (days 5-14) were 
added to a second pool of cells.  Step 4: After 14 days, the frequency of total integrations (hygror 
colonies) or the frequency of TI (hygror + 6-TGr) were calculated.  The frequency of RI was 
calculated by subtracting the frequency of TI from the frequency of total integrations.   
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Interestingly, previous work in this lab demonstrated that with expression of the 
bacteriophage SSA protein, Redβ, in mammalian cells, HR was enhanced in all assays 
tested (ICHR, ECHR, dsGT, ssGT) (Xu, Vangala and Porter, unpublished).  Because only the 
SSA domain of Redβ and the N-terminal domain of scRad52 are believed to retain their 
functions in mammalian cells, it was reasoned that hRad52 mutants possessing the N-
terminal domain with C-terminal truncations might also stimulate HR.  This prompted the 
construction of the truncation mutants (NLS)Δ284*, (NLS)Δ238* and later the deletion 
mutant Δ290-330*. 
 
To determine if dsGT would be stimulated by induction of these deletion mutants, as well 
as the other Rad52-related proteins, the hHPRT dsGT assay was used.  In this assay, the 
hHPRT locus is disrupted by pHPRThyg, a dsDNA targeting construct containing a 
hygromycin resistance cassette within 8.8kb of homology to the human HPRT locus 
(Figure 6.1).  This targeting strategy was selected because it has several advantages over 
other methods.  Successful disruption of the hHPRT gene by targeted integration (TI) 
renders cells resistant to both 6-thioguanine (6-TG) and hygromycin, while RI events 
result in resistance to hygromycin only. Thus all integration events (RI+TI) are selected in 
hygromycin while TI events can be selected in hygromycin plus 6-TG.  This system works 
only because the hHPRT locus is located on the X chromosome, of which there is only one 
copy in male cells such as HT1080.  The effects of Rad52-related protein induction using 
this assay will be presented here. 
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6.2 Results 
6.2.1 Double Stranded Gene Targeting Efficiencies in Rht14-Rad52-
Related Clones 
To determine the roles of the hRPA and hRad51 binding domains as well as the Y104 
phosphorylation site, all seven Rht14-Rad52-related clones were tested using the hHPRT 
dsGT assay.  hRad52* and (NLS)scRad52* were expected to inhibit or promote dsGT, 
respectively, based on the results of previous studies (Di Primio, 2005; Yanez, 2002).  It 
should be noted however, that my results represent the first instance where the 
overexpression effects of hRad52 and scRad52 have been tested using the same dsGT 
assay, expression system and cell line.  Prior to transfection with the HPRT targeting 
construct, pHPRThyg, clones were grown for 48hrs with or without tet.  48hrs post 
transfection, tet was added to all cultures.  Total integration or TI events were scored as 
the number of colonies arising after 12-14 days post-transfection in hygromycin only or 
hygromycin and 6-TG, respectively.   
 
The efficiency of dsGT can be measured in two ways.  First, the ratio of TI to RI events can 
be determined.  Thus the TI frequency (frequency of [Hygro+6TG]-resistant colonies) is 
divided by the RI frequency (frequency of Hygro-resistant colonies minus the frequency of 
[Hygro+6TG]-resistant colonies).  This is a useful measurement as it indicates the number 
of stably transfected colonies that would have to be screened (in a situation where 
targeting events cannot be selected) in order to have a reasonable chance of identifying a 
targeted integrant.  The TI/RI ratio is not fully informative, however, because changes in 
the TI/RI ratio may reflect changes to the absolute frequency of TI, RI or both.  For 
example, if Rad52 induction causes a 4-fold increase in the TI/RI ratio, this could reflect a 
4-fold increase in TI, a 4-fold decrease in RI, or a change to both such as an 8-fold increase 
in TI plus a 4-fold increase in RI. 
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A second, more informative, measurement of dsGT is the absolute TI frequency.  Absolute 
TI (or RI) frequencies can be expressed simply as the number of [Hygro+6TG]r (or Hygror 
minus [Hygro+6TG]r) colonies divided by the number of cells plated.  When measuring the 
effect of a treatment on these frequencies, however, one has to compensate for the fact 
that the treatment itself may affect the ability of cells to form colonies, even without 
selection.  Thus absolute frequencies are best normalised appropriately. For example, the 
absolute TI frequency is measured as the frequency of [Hygro+6TG]-resistant colonies 
divided by the plating efficiency (proportion of cells able to form colonies in the absence 
of selection) of the same cell population.  Comparison of these normalised frequencies 
can indicate whether any changes in the TI/RI ratio resulted from changes to the number 
of RI events, TI events or both.  Unfortunately, the variability in cell viabilities (Figure 5.3) 
resulting from Rad52-related protein induction were unknown at the time the dsGT 
experiments were first conducted.  In fact, the differences in plating efficiencies were first 
observed by performing the dsGT experiments and were what prompted the cell viability 
measurements.  As a result, the plating efficiency measurements obtained for the 
majority of dsGT experiments were unoptimised and inaccurate and thus could not be 
used to normalise absolute TI and RI frequencies.   
 
The absolute TI and RI frequencies (un-normalised) and TI/RI ratios obtained from each 
experiment were calculated (Table 12).  The fold changes in TI/RI ratios affected by 
induction of the various Rad52-related proteins were calculated and appear in a graphical 
representation in Figure 6.2 (see also Table 12).  In four of the dsGT experiments, the 
plating efficiencies were measured in triplicate plates and thus normalised frequencies 
could be calculated.  Figure 6.3 displays the changes in normalised absolute RI or TI 
frequencies for single experiments of Rht14-hRad52, Rht14-(NLS)Δ284, Rht14-(NLS)Δ238 
and Rht14-Y104E.   
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Table 6.1. Effect of Inducing Rad52-related Proteins on of dsGT TI and RI Events frequencies 
using the Human HPRT GT Assay of the hHPRT targeting construct pHPRThyg.  
a Exp. # 
b Rad52-Related 
Protein 
c Frequency of TI 
 (6-TG+Hygro)r 
colonies /106 cells 
d Frequency of RI 
(Hygror – [6-TG + 
Hygro]r) /104 cells) 
eFrequency 
Ratio  
(TI:RI) 
Fold 
Stimulation 
1 -hRad52 2.29 1.81 1:79 -- 
 +hRad52 0.69 1.33 1:194 0.4 
2 -hRad52 1.14 1.16 1:101 -- 
 +hRad52 1.03 2.29 1:223 0.5 
1 -(NLS)Δ284 1.83 2.60 1:142 -- 
 +(NLS)Δ284 1.20 1.06 1:88 1.6 
2 -(NLS)Δ284 1.05 0.56 1:53 -- 
 +(NLS)Δ284 1.62 0.40 1:24 2.2 
1 -(NLS)Δ238 6.69 7.09 1:106 -- 
 +(NLS)238 5.26 2.51 1:48 2.2 
2 -(NLS)Δ238 7.10 3.32 1:47 -- 
 +(NLS)238 9.27 0.65 1:7 6.6 
1 -Δ290-330 2.57 2.65 1:103 -- 
 +Δ290-330 0.74 3.87 1:521 0.2 
2 -Δ290-330 7.43 0.80 1:11 -- 
 +Δ290-330 1.26 0.87 1:69 0.2 
1 -Y104E 1.50 1.83 1:122 -- 
 +Y104E 0.65 1.63 1:249 0.5 
2 -Y104E 2.86 0.87 1:30 -- 
 +Y104E 1.26 0.65 1:52 0.6 
1f -Y104F 0.33 0.23 1:70 -- 
 +Y104F 0.07 0.03 -- -- 
1 -scRad52 0.35 1.23 1:35 -- 
 +scRad52 2.00 1.28 1:6 5.4 
2 -scRad52 2.11 1.58 1:75 -- 
 +scRad52 4.11 1.42 1:35 2.2 
a  Experiments 1 and 2 were performed identically but on separate days 
b  Uninduced cells (-) were grown in the presence of tet throughout the experiment.  Induced cells (+) were grown in the absence of tet 
48hrs prior to electroporation and tet was added 48hrs following electroporation. 
c  1.75 x 107 cells were plated out of a total of 2.0 x 107 cells electroporated 
d  3.0 or 4.5 x 105 cells were plated out of a total of 2.0 x 107 cells electroporated 
e  Frequency ratio was determined by first arranging the frequency of TI and frequency of RI values in a ratio of TI:RI. The RI values were 
multiplied by 102. The TI values were normalised to 1 and the corresponding RI x 102 values were recalculated.  
f   Total TI and RI events from +Y104F were too low for accurate measurements 
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Similar to previous results (Yanez, 2002), overexpression of hRad52 resulted in a 2-fold 
inhibition of the TI/RI ratio (Figure 6.2).  Interestingly, the inhibition with Rht14-hRad52 
appeared to be the result of an increase in RI rather than a decrease in TI (Figure 6.3).  
This was surprising because the inhibition was initially hypothesised to result from a 
dominant-negative effect which would be expected to inhibit TI.  (NLS)scRad52* yielded a 
stimulatory effect on the TI/RI ratio, agreeing with Di Primio et al. though the effect was 
only up to 5.4-fold in contrast to their reported 37-fold.  The deletion mutant Δ290-330* 
inhibited the TI/RI ratio by up to 5-fold (Figure 6.2) as was predicted from the presence of 
residues 331-418 of hRad52.  Furthermore, the C-terminal truncation mutants 
(NLS)Δ284* and (NLS)Δ238* both yielded stimulatory effects on TI/RI ratio (Figure 6.2) 
and also on absolute TI frequencies (Figure 6.3), supporting the hypothesis that residues 
331-418 of the C-terminal domain of hRad52 are responsible for the inhibitory effects 
dsGT.  In addition, induction of (NLS)Δ284* and (NLS)Δ238* slightly reduced RI, in 
contrast to hRad52* induction (Figure 6.3).  That (NLS)Δ238*, the shortest truncation 
mutant, stimulated TI to a greater degree than (NLS)Δ284* may indicate that the hRPA 
binding domain may also contribute to inhibiting dsGT though to a lesser extent than 
residues 331-418.  Induction of the phosphorylation mutant Y104E* had up to a 2-fold 
inhibitory effect on TI/RI (Figure 6.2) apparently as a result of promoting RI events (Figure 
6.3) which was similar to the results obtained from hRad52* induction.  This suggests that 
phosphorylation of Y104 does not affect the HR pathways used by dsGT.  dsGT was not 
measured with Rht14-Y104F as cell viability with induced Y104F* was severely affected 
and substantial colony numbers could not be gathered.  
 
The parallels between the effects of the hRad52-related proteins on cell growth and 
viability (Figure 5.1, 5.2, 5.3) and their effects on the TI/RI ratio (Figure 6.2) suggest that 
interference with HR (as indicated by the dsGT assay) leads to poor growth and viability.  
An alternative explanation for the inhibition of dsGT by hRad52 can be proposed, one 
where inhibition is less dependent on the hRPA and hRad51 binding domains and is 
instead more dependent on the presence of C-terminal residues 331-418 of hRad52.   
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Figure 6.2. Rad52-Related Proteins can Stimulate TI:RI ratios. Each fold stimulation value is relative to the clone grown +tet whose value is set to 1.  
hRad52*, Δ290-330* and Y104E* (Rad52 proteins containing residues 331-418 of the hRad52 C-terminal region) inhibit dsGT (red bars) (as determined by 
TI:RI ratios) whereas (NLS)Δ284*, (NLS)Δ238* and (NLS)scRad52* (hRad52 C-terminal region absent) stimulate dsGT (green bars).  Appreciable TI and RI 
colonies were not observed from Y104F induction.  Each set of dsGT experiments (+tet and –tet) were conducted on the same day. 
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(a)         (b) 
    
 
(c)         (d) 
       
Figure 6.3. Effects of Rad52-Related Protein Induction on absolute TI and RI Frequencies. Clones were grown with or without tet for 48hrs prior to 
experimentation. TI and RI frequencies were normalised by dividing by the plating efficiencies (number of cells able to form colonies in the absence of 
selection) to obtain absolute TI and RI frequencies which appear above for (a) Rht14-hRad52, (b) Rht14-(NLS)Δ284, (c) Rht14-(NLS)Δ238, (d) Rht14-Y104E.  
dsGT experiments were conducted on the same day for each control (+tet) culture (blue bars) and its respective induced (-tet) culture (orange bars).    
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6.2.2 Transient hRad52 Overexpression Increases NHEJ 
To assess the practicality of using Rad52-related protein overexpression as a tool to 
increase the efficiency of dsGT, Rht14 cells were transfected with pHPRThyg in addition to 
either a control vector or the hRad52* expression construct, pTRE-hRad52.  Normalised 
absolute frequencies of TI and RI as well as TI/RI ratios were calculated as above (Section 
6.2.1) and are displayed in Table 13.  In contrast to the dsGT experiments described in the 
previous section, the plating efficiencies between hRad52* and control experiments were 
similar and measured in triplicate thus giving me confidence in determining the 
normalised frequencies of TI and RI events.  Overexpression of hRad52 inhibited the TI/RI 
ratio by almost 3-fold (Table 13), similar to the effect seen in the stable clone Rht14-
hRad52 (Figure 6.2).  Analysis of the normalised frequencies, represented graphically in 
Figure 6.4, suggests that transient hRad52* expression promotes RI rather than impairs 
TI, similar to the results obtained with clone Rht14-hRad52 (Figure 6.3).  Although 
transient expression of hRad52* inhibited the TI/RI ratio, this result suggests that 
transient (NLS)Δ284, (NLS)Δ238 and (NLS)scRad52 expression may be a useful tool to 
promote dsGT.  The experiments in section 6.2.2 were performed only once and must be 
repeated to confirm the results, however, they support the hypothesis that excess 
hRad52 promotes RI rather than impairs TI and that this must be eliminated if hRad52 
derivates are to be used practically to promote GT.   
 
Table 6.2. The effect of co-transfecting pTRE-hRad52-HA on TI and RI Events using the HPRT 
gene targeting construct pHPRThyg. 
Expression 
Vector 
a Freq. of TI 
(6-TG+Hyro)r 
colonies /106 
cells 
b Freq. of RI 
(Hygror – [6-TG 
+ Hygro]r)/104 
cells 
Freq. 
Ratio 
(TI:RI) 
Fold 
Stimn 
c Avg. Plating 
Efficiency 
Colonies/ 
102 cells 
dAbsolute 
Freq. TI/ 
106 viable 
cells 
eAbsolute 
Freq. RI/ 
106 viable 
cells 
pBSKS+ 2.75 2.50 1:91 -- 48 5.73 521 
pTRE-
hRad52-HA 2.58 6.80 1:263 0.35 53 4.87 1283 
a 1.2 x 107 cells were plated out of a total of 2.0 x 107 cells electroporated 
b 3.5 x 105 cells were plated out of a total of 2.0 x 107 cells electroporated 
c 102 cells were plated in triplicate without selection 
d Freq. of TI was multiplied by (102 ÷ avg. plating efficiency colonies) 
e Freq. of RI was multiplied by (102 ÷ avg. plating efficiency colonies) and multiplied by 102 
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Figure 6.4. hRad52 Overexpression Increases RI Events. Rht14 cells were transfected with 
pHPRThyg in addition to a control plasmid (pBSKS+) or a hRad52 expression construct.  TI and RI 
events represent the absolute (normalised) frequencies. 
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6.3 Discussion 
6.3.1 dsGT Efficiencies in Rht14-Rad52 
The precise mechanism of dsGT is unknown although there is evidence that it occurs via 
the SI pathway (Langston, 2004).  Manipulation of the proteins of this pathway may 
provide clues to understanding the mechanism and to optimising its efficiency.  hRad52 
overexpression inhibited dsGT 2-fold in a previous study and this was mirrored using both 
stable and transient expression of hRad52* in this chapter (Figure 6.2 and Figure 6.4).  It 
was originally proposed that overexpression of hRad52 generated a dominant-negative 
effect, perhaps by sequestering hRad51 or RPA, and that enhanced levels of dsGT could 
be achieved upon deletion of these domains.  However, the negative effects observed in 
the previous chapter with induction of Δ290-330* provided the first evidence that 
residues 331-418 of hRad52 play a greater inhibitory role than the hRad51 and hRPA 
binding domains. 
 
Overexpression of hRad52* inhibited dsGT up to 2.5-fold, reproducing previous results 
with the same assay and host cell line (Yanez, 2002).  Normalisation of absolute TI and RI 
frequencies were not performed by Yanez et al. and thus, my results demonstrate the 
first evidence that expression of hRad52* increases RI and has little effect on TI (Figure 
6.3 and Figure 6.4).  It is possible the increase in RI is the result of a stimulation of MMEJ.  
There is evidence suggesting that hRad52 increases the activity of the MMEJ pathway, 
which would appear as RI events in the assay and this will be discussed in greater detail in 
the following section. 
 
Expression of (NLS)Δ284* and (NLS)Δ238* did not cause the negative inhibition on the 
TI/RI ratio observed with induction of hRad52-related proteins containing residues 331-
418 (hRad52*, Δ290-330*, Y104E*).  In fact (NLS)Δ284* and (NLS)Δ238* also stimulated 
TI/RI ratios up to 2.2- and 6.6-fold, respectively, reflecting a combination of increased TI 
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and reduced RI frequencies (Figure 6.3).  The stimulatory effect on TI may be attributed to 
enhanced second-end capture activity, which is mediated by the N-terminal domain of 
Rad52 (McIlwraith, 2008; Shi, 2009).  In addition, that (NLS)Δ238* stimulated dsGT to a 
greater degree than (NLS)Δ284* may suggest that removal of the hRad51 binding domain 
can further stimulate dsGT in conjunction with removal of resides 331-418.  Indeed, there 
is evidence that Rad52-mediated SSA activity is inhibited by the presence of Rad51 in vitro 
(Wu, 2008).  Alternatively, it is possible that the differences in dsGT stimulations between 
the truncation mutants were the result of clonal differences or differences in expression 
levels.  In addition, the dsGT experiments must be repeated to obtain statistically 
significant results.   
 
If the presence of the hRad51 binding domain were responsible for inhibiting the TI/RI 
ratio in hRad52* overexpression experiments, Δ290-330* and (NLS)Δ284* (which both 
lack this domain) would be predicted to promote the TI/RI ratio similarly.  In fact, Δ290-
330* caused a 5-fold decrease in the TI/RI ratio while (NLS)Δ284* caused ~2-fold increase 
(Figure 6.2). This provides the first direct evidence that residues 331-418 in hRad52 are 
largely responsible for inhibiting TI/RI ratios, rather than the hRPA and hRad51 binding 
domains, as initially hypothesised.  Besides the NLS, a function has not yet been 
associated with residues 331-418.  There are no known phosphorylation sites in this 
region, although three sumoylation sites at residues 411, 412, 414 within the NLS, may 
contribute to nuclear localisation but do not appear to affect SSA or hRad51 affinity 
(Saito, 2010).  It was also interesting that Δ290-330* induction decreased the TI/RI ratio 
5-fold whereas hRad52* decreased it by at most 2.5-fold.  This difference may also have 
arisen as a result of clonal differences or differences in the expression levels of the two 
proteins, but it is possible that removal of the hRad51 binding domain may generate a 
dominant-negative effect in the presence of residues 331-418.  It would be interesting to 
repeat the dsGT experiments using transient expression of Δ290-330* to determine its 
specific effects on the normalised absolute frequencies of TI and RI events.  Nevertheless, 
the inhibitory effects on dsGT, growth rate and cell viability (Figure 5.1 and Figure 5.3) 
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that require residues 331-418 of hRad52 demonstrate an as yet undefined function for 
this domain that was not previously recognised.   
 
A link between phosphorylation of Y104 of hRad52 and localisation to repair centres 
following DNA damage was previously described (Kitao, 2002), but an effect on HR was 
not investigated and the phosphorylation mutants Y104E* and Y104F* were created to 
explore this.  Expression of Y104E* yielded results similar to expression of hRad52*, 
suggesting that phosphorylation does not contribute to enhancing dsGT under these 
experimental conditions.  As phosphorylation of Y104 is induced upon DNA damage, dsGT 
in the presence of a DSB may be required to generate an observable effect. 
6.3.2 hRad52 Overexpression Increases NHEJ 
Stable expression of the Rad52-related proteins is a useful tool for characterising the 
proteins and achieving sustained expression for study.  In order for (NLS)Δ284, (NLS)Δ238 
or (NLS)scRad52 to be used as tools to enhance dsGT, however, a more practical 
approach must be employed.  Hence dsGT of the hHPRT locus was again conducted using 
transient expression in place of stable expression.  hRad52* was selected for the initial 
experiment to confirm whether its transient expression would be sufficient to yield a 
comparable 2-fold inhibitory effect to the stable clone.  Achieving similar or even greater 
inhibitions would imply that transient expression of (NLS)Δ284, (NLS)Δ238 and 
(NLS)scRad52 would yield similar or greater increases in dsGT in comparison to the stable 
clones.  In the preliminary experiment with hRad52*, dsGT was inhibited almost 3-fold, 
comparable to the 2.5-fold inhibition observed with stable expression of hRad52*.  This 
result supports transient expression of Rad52 derivatives as a tool for enhancing dsGT.    
 
Furthermore, because RI events can be associated with NHEJ and MMEJ while TI events 
can be associated with HR, it can be hypothesised that expression of hRad52* stimulated 
either one or both of NHEJ and MMEJ.  Briefly, classical NHEJ (see Section 1.1.4) is a Ku-
dependent pathway that involves direct ligation of two free DNA ends with limited 
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processing following a DSB.  MMEJ (see Section 1.1.5) involves less well defined Ku-
independent pathways and in the presence of a DSB, it involves limited end-resection 
mediated by CtIP to generate 3’ ssDNA, which may be followed by short template-
directed synthesis or direct annealing of small homologous sequences on either side of 
the break prior to ligation.  To my knowledge there is no evidence suggesting that hRad52 
stimulates NHEJ although there are two reports in yeast which demonstrated that 
scRad52 was important for MMEJ (Daley, 2005; Decottignies, 2007).  However, a study in 
mouse ES cells presented a contrasting result where Rad52 was inhibitory to MMEJ 
(Bennardo, 2008).  Differences between the MMEJ assays, Rad52 species and host cells 
may account for these different results.  The studies in yeast utilised plasmid based assays 
where microhomologies were present close to the induced DSB site and the major repair 
products contained a loss of 1-5nt. On the other hand, the assay in mouse ES cells utilised 
a construct where microhomologies were more distant from the break site and the major 
repair product contained a loss of 35nt.  Recent evidence supports a synthesis dependent 
(SD)-MMEJ model where microhomologies are used as templates for de novo DNA 
synthesis and yield major repair products similar to those observed in the assays used in 
the yeast studies (Yu, 2010).  Thus the possibility exists that hRad52 may play a role in SD-
MMEJ, perhaps by facilitating the annealing of microhomologies.  The increase in RI 
frequencies observed from hRad52* and Y104E* overexpression, and not (NLS)Δ284* or 
(NLS)Δ238*, suggests that should hRad52 be involved in SD-MMEJ, this interaction would 
involve residues 331-418.  Whatever the mechanism behind the stimulation of RI events 
from hRad52* and Y104E* expression, it is clear that the seven Rad52-related clones 
must be more comprehensively studied with respect to the type of repair assay, Rad52 
species and presence or absence of a DSB. 
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Chapter 7 Effects of Overexpressing the Rad52-
Related Proteins on ssGT and SSA Assays 
7.1 Introduction 
In the previous chapter, the effects of stably or transiently overexpressing the Rad52-
related proteins were measured using a dsGT assay.  The inhibitory effect of hRad52* was 
converted to a stimulatory effect by deletion of residues 238-418, but remained at least 
as strong when only residues 290-330 (containing the hRad51 binding domain) were 
deleted.  Because dsGT is thought to occur via a Rad51-dependent SI-type mechanism, 
the simplest explanation for the inhibitory effect was that excess hRad52* had a 
dominant-negative effect on the assembly of an SI protein complex.  The inhibitory 
activity of the Δ290-330* mutant suggested, surprisingly, that interactions mediated 
through the hRad51 (and hRPA) binding domain did not generate a dominant-negative 
effect.  Instead, the results pointed to an interaction involving residues 331-418 of the C-
terminal domain.  In addition, these dsGT inhibitions were found to be the result of 
increased RI as opposed to decreased TI.  It was therefore hypothesised that excess 
Rad52 does not exert a dominant-negative effect on TI but rather promotes RI by 
enhancing end-joining activity, possibly by enhancing activity of the MMEJ protein 
complex through residues 331-418.   
 
In contrast to dsGT, there are reports that ssGT is independent of SI and Rad51-
dependent pathways and instead relies upon SSA mechanisms (Radecke, 2006a; Storici, 
2006; Tsuchiya, 2005), although the exact mechanism remains unknown.  Indeed, recent 
evidence from this lab suggests that, in contrast to the inhibition of dsGT caused by 
excess hRad52 (Chapter 6)(Yanez, 2002), ssGT is stimulated by excess hRad52 (Vangala, 
2011 unpublished).  As only the N-terminal domain of Rad52 is required to perform 
strand annealing in vitro (Bi, 2004; Singleton, 2002), the central and C-terminal domains 
of Rad52 may be superfluous for both ssGT and SSA, implying that all of the Rad52-
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related proteins described in earlier chapters will stimulate these pathways. To test this I 
measured both ssGT and SSA separately to determine how they are affected by Rad52-
related protein induction.  
 
Reported ssGT frequencies are notoriously variable (Igoucheva, 2006; Storici, 2003; 
Tsuchiya, 2005) but a consensus is emerging that frequencies are very low and lower than 
dsGT frequencies (Storici, 2003)(Vangala, 2011 unpublished).  Like dsGT however, ssGT 
can be greatly stimulated by a DSB at its target locus (Radecke, 2006a; Storici, 2006).  To 
measure ssGT in the presence (or absence) of a DSB, a mouse hprt minigene has been 
developed in this lab (Vangala, 2011 unpublished). Within its coding region the mHPRT 
minigene has an I-SceI recognition sequence followed by a premature stop codon (Figure 
7.1). The HPRT minigene was stably integrated into hHPRT- Rht14-hRad52, Rht14-Δ284, 
Rht14-Δ284 and Rht14-scRad52 clones, selecting for the neomycin resistance marker 
located in the minigene construct.  Single stranded oligonucleotides (ssOs) were used as 
repair templates, and following their co-transfection with an I-SceI expression plasmid, 
ssGT was measured as the frequency of resulting HPRT+ (HATr) colonies. No HATr colonies 
are generated when control templates (with sequences identical to the target) are used 
(Vangala, 2011 unpublished).   
 
The second assay measures SSA in the presence of a DSB, and uses a construct consisting 
of the GFP ORF truncated at the 3’ end upstream of a puro selection marker which is then 
followed by the 3’ region of a GFP ORF containing the I-SceI recognition sequence (Figure 
1.10)(Stark, 2004).  Successful SSA events result in functional GFP expression and are 
quantified by flow cytometry. 
 
This chapter describes the effects of inducing the Rad52-related proteins on ssGT and SSA 
and compares the results of these two assays. 
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7.2 Results 
7.2.1 Induction of the hRad52-Related Proteins Stimulates ssGT 
The mhprt minigene construct was randomly integrated into HPRT- clones of Rht14-
hRad52, Rht-(NLS)Δ284, Rht14-(NLS)Δ238 and Rht14-(NLS)scRad52, previously generated 
from targeting the HPRT locus (Section 6.2.1, for methods see Section 2.4.3).  Selection of 
clones was performed in G418 and at least 5 colonies were picked for each Rad52-related 
protein and tet-regulated expression of the Rad52-related proteins was confirmed by 
immunoblot.  These mhprt clones were used to determine whether the presence of the 
N-terminal domain of hRad52 could positively affect ssGT, and if so, whether the other 
mutations in the Rad52-related proteins would influence the effect.  An 80mer sense 
repair oligonucleotide was designed to correct the I-SceI and premature stop codon 
sequences which would result in restored mHPRT expression and HAT resistance (Figure 
7.1).  Four mhprt clones, one for each Rad52-related protein, were grown in the presence 
or absence of tet for 48hrs prior to transfection with the repair oligonucleotide and I-SceI 
expression construct (See Section 2.11.2).  Two days post transfection tet was added to 
the –tet culture medium and maintained in all cultures for the remainder of the 
experiment.  Successful targeting events were scored as the number of HATr colonies.  As 
plating efficiencies differ between clones grown with or without tet (Section 5.2.2), the 
frequencies of HATr colonies were normalised and represent the total number of cells 
plated.  These adjusted numbers of HATr events are displayed in Figure 7.2 and the fold 
stimulations in the presence of induced Rad52-related protein appear in Table 1.   
 
Similar to previous results in the lab (Vangala, 2011 unpublished), hRad52* stimulated 
ssGT 3-fold in the presence of a DSB (Vangala unpublished, 2011).  Induction of both 
(NLS)Δ284* and (NLS)Δ238* were also stimulatory though in decreasing amounts, 
suggesting that the central and C-terminal domains may also contribute to ssGT.  
However, the differences between ssGT stimulations are small and the experiments must 
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(a) 
 
 
 
 
 
 
 
 
 
(b)  mhprt minigene    ATT ACC CTG TTA TCC CTA TAG 
      HPRT (repair ssO)  CAA ACT TTG CTT TCC CTG GTT 
 
Figure 7.1. Assay for measuring ssGT. (a) The mhprt minigene contains an I-SceI restriction site 
followed by a premature stop codon (*).  Step 1: The mhprt minigene is randomly inserted into 
HPRT-cells, which were generated using the hHPRT dsGT assay (See Chapter 6). Step 2: An 80mer 
ssO repair template and I-SceI expression plasmid are co-transfected into cells. Successful 
targeted repair with the ssO results in removal of the I-SceI restriction site and premature stop 
codon and restoration of mHPRT expression.  Selection can be achieved in HAT medium. (b) 
Sequence of the mutated mhprt minigene containing the I-SceI restriction site (underlined) and 
premature stop codon (bolded), and the sequence of the repair ssO. 
  
PGK 
promoter 
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Figure 7.2. ssGT is stimulated with the hRad52-related proteins but not with scRad52. Induced 
clones were grown in the absence of tet for 48hrs prior to lipofection.  An I-SceI expression 
plasmid was co-lipofected with a ssO repair template (80mer, sense) that would restore HATr.  
48hrs post-transfection tet was added or maintained in all cultures for an additional 12 days.  HAT 
selection was started 5 days post-transfection.  All HATr events were normalised for plating 
efficiencies, which were measured in triplicate, and calculated for the total number of plated cells.  
Stimulations are represented as green bars and no stimulations are represented as red bars.  
Black bars indicate uninduced clones.  For Rht14-(NLS)Δ238 and Rht14-(NLS)scRad52, n=2, and for 
Rht14-hRad52 and Rht14-(NLS)Δ284, n=1. 
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be repeated several times to confirm the preliminary results.  Expression of 
(NLS)scRad52* had no effect on ssGT in two separate experiments.  This was surprising 
because, like hRad52*, the catalytic N-terminal domain of (NLS)scRad52* can also 
perform strand annealing in vitro (Bi, 2004; Wu, 2008) and so was expected to stimulate 
ssGT similarly to hRad52*. 
 
Table 7.1. HATr Events and Fold Increases of ssGT. 
Clone Tet 
aHATr Frequency 
(per 5x105 cells) 
bAvg Plating 
Efficiency 
(per 102 cells) 
cNormalised HATr 
Frequency (per 
104 Viable Cells) 
Fold 
Increase 
Rht14-hRad52 
+ 60 29 4.1 -- 
– 32 5 12.2 3.0 
Rht14-(NLS)Δ284 
+ 80 5 34.2 -- 
– 125 3 83.6 2.4 
Rht14-(NLS)Δ238 
(Exp. 1) 
+ 74 30 6.1 -- 
– 58 16 10.0 1.5 
Rht14-(NLS)Δ238 
(Exp. 2) 
+ 61 40 4.9 -- 
– 100 26 7.3 1.6 
Rht14-(NLS)scRad52 
(Exp. 1) 
+ 50 3.5 28.7 -- 
– 25 1.8 27.0 0.9 
Rht14-(NLS)scRad52 
(Exp 2) 
+ 92 13 9.2 -- 
– 84 11 8.4 0.9 
a 3.75 x 105 cells were plated out of a total of approximately 5 x 105 cells lipofected 
b 102 or 2 x 102 cells were plated in triplicate without selection out of a total of approximately 5 x 105 cells lipofected 
c HATr frequencies were expressed relative to plating efficiencies and normalised to the total number of viable cells 
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7.2.2 Effects of Transient Rad52-Related Protein Overexpression on the 
SSA Assay 
Clone Rht14 was transfected with the SSA construct (Section 1.9.1, for detailed methods 
see Section 2.4.4)(Stark, 2004) and selection was performed in puromycin.  Twelve 
isolated clones were transfected with an I-SceI expression plasmid and were screened by 
flow cytometry to measure the relative levels of SSA repair, as determined by GFP 
positive cells, for each clone.  Clone 6, which will henceforth be referred to as Rht14-SSA-
GFP, achieved the highest DSB-induced SSA repair of the construct (~1%) and was used as 
the primary clone for all experiments (Figure 7.3).  In conjunction with an I-SceI 
expression plasmid, all Rad52-related proteins were transiently expressed from their 
pTRE-derived Rad52 expression constructs in Rht14-SSA-GFP (for description of methods 
see 2.11.3).  Each pTRE-derived Rad52 expression plasmid contains a TRP and requires the 
tTA (present in host Rht14 cells) for expression, similar to the stable clones.  Three days 
post-transfection, cells were harvested and analysed for GFP expression by flow 
cytometry.  Unexpectedly, most of the Rad52-related proteins elicited small decreases in 
SSA frequencies in comparison to the control (Figure 7.4).  The phosphorylation mutants 
Y104E* and Y104F* were the only two proteins that did not decrease the frequency of 
SSA whereas the other Rad52-related proteins were inhibitory by as much as 3-fold.  This 
contrasts with the stimulations observed in ssGT in the presence of excess hRad52*, 
(NLS)Δ284* and (NLS)Δ238* (Figure 7.2).  
 
To determine if the decreases in SSA frequency were clone-dependent, the assay was 
repeated using clone Rht14-SSA-GFP.9 and transient expression of hRad52*or 
(NLS)Δ284*.  In this clone, SSA was not altered by hRad52* or (NLS)Δ284* overexpression 
in comparison to the clone Rht14-SSA-GFP (results not shown).  These results suggest that 
the SSA frequencies obtained with Rht14-SSA-GFP are not due to clonal variability. 
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Figure 7.3. SSA activity in Rht14-SSA-GFP. Rht14-SSA-GFP was generated through stable 
integration of the SSA reporter construct (also referred to as hprtSAGFP)(Stark, 2004).  Rht14-SSA-
GFP was selected for its relatively high GFP expression levels in the presence of the restriction 
endonuclease I-SceI (right plot), which stimulated SSA repair.  In the absence of I-SceI, there are 
no GFP positive cells (left plot).  Cells were analysed for GFP expression by flow cytometry 3 days 
post-transfection.  
  
Control: 0.00% GFP positive 
 
I-SceI: 0.927% GFP positive 
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Figure 7.4. SSA assay of the transiently expressed Rad52-related proteins. An I-SceI expression 
plasmid was co-lipofected with a pTRE-derived Rad52 expression plasmid into Rht14-SSA-GFP.  
Values are plotted relative to the control experiment where I-SceI was co-transfected with an 
empty vector.  Red bars are indicative of relative decreases in GFP cells and green bars are 
indicative of no change.  Error bars indicate standard deviations between three separate 
experiments (n=3).  For all other data points, n=1. 
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7.3 Discussion 
For SI pathways, there is evidence that each of the N-terminal, central and C-terminal 
domains of hRad52 are involved in certain steps (Benson, 1998; Kagawa, 2008; Lloyd, 
2005; Park, 1996; Ranatunga, 2001; Sugiyama, 1998).  In Chapter 6, it was shown that 
residues 331-418 of hRad52 were largely responsible for the inhibition of dsGT when 
hRad52-related proteins containing this region were overexpressed.  However, only the 
N-terminal domain of hRad52 and N-terminal or C-terminal domains of scRad52 are 
required for strand annealing, the proposed key mechanism in SSA (Bi, 2004; Plate, 2006; 
Singleton, 2002; Van Dyck, 2001).  Indeed, in rad52 yeast cells, expression of yeast or 
human Rad52 mutants lacking their central and C-terminal domains was able to stimulate 
ssGT (Storici, 2006), a pathway proposed to rely on SSA (Radecke, 2006a; Storici, 2006; 
Tsuchiya, 2005).  This suggests that, in contrast to SI pathways, the central and C-terminal 
domains of Rad52 may not be required for either SSA or ssGT in human cells.  Indeed, in 
the absence of these domains, the N-terminal domain is able to stimulate dsGT, 
presumably by promoting strand annealing during second-end capture (Section 1.6.3 and 
6.3).  The results of Figure 7.1 are consistent with the stimulation of ssGT by the N-
terminal domain.  However, it was surprising that (NLS)scRad52* induction did not affect 
the number of ssGT events while induction of hRad52*, (NLS)Δ284* and (NLS)Δ238* 
proteins were stimulatory. 
 
Focusing on results observed with (NLS)scRad52*, overexpression of scRad52 stimulated 
dsGT, as measured by the TI:RI ratio)(Section 6.2.1)(Di Primio, 2005), and it was 
hypothesised in Chapter 6 that this resulted could result from an increase in the efficiency 
of second end capture, a SSA-mediated mechanism.  This would suggest that the strand 
annealing activity was enhanced by (NLS)scRad52* and that (NLS)scRad52* would 
therefore stimulate ssGT as well.  In fact, the three hRad52-related proteins stimulated 
ssGT efficiencies while (NLS)scRad52* did not (Figure 7.2).  The exact mechanism of DSB-
mediated ssGT is unknown, but it is conceivable that Rad52 can only stimulate ssGT by 
interacting via its N-terminal domain, with other factors, such as the structure-specific 
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endonuclease ERCC1-XPF, known to be involved in SSA reactions (Motycka, 2004).  This 
may be the reason for the ineffectiveness of (NLS)scRad52* in HT1080, supposing that the 
N-terminal domain of (NLS)scRad52* is unable to interact with human factor(s) such as 
ERCC1-XPF, despite conservation with hRad52.   
 
Taken together, the GT assay results clearly suggest that the mechanisms, and role of 
Rad52, are different between the dsGT and ssGT assays used.  However, it should be 
noted that the dsGT assay was not stimulated by an I-SceI DSB whereas the ssGT assay 
was.  It is possible that the presence or absence of a DSB is the relevant difference 
between the two GT assays and there is evidence of this in the literature (Kim, 2001).  
This could be tested by comparing dsGT and ssGT at the mHPRT locus with or without I-
SceI.  
 
The results of the SSA assay (Figure 7.4) greatly contrasted with the stimulations of ssGT 
where the majority of Rad52-related proteins inhibited SSA.  At first glance this suggests 
that the SSA and ssGT pathways are not affected by the Rad52-related proteins in the 
same way and thus do not share the same mechanisms.  However, previous in vitro 
experiments provide a possible explanation for the differing stimulation effects on ssGT 
and SSA observed in this chapter. Purified scRad52 was utilised in a strand annealing 
assay using either long ssDNA (over 5000 nt in length) or short (83mer) ssOs (Song, 2000).  
Using optimal concentrations, scRad52 stimulated strand exchange with both long ssDNA 
and ssOs.  However, when the concentration of Rad52 was increased by 10-fold, scRad52 
and the long ssDNA formed aggregates and consequently inhibited strand exchange.  In 
contrast, no inhibitory effect or aggregation was observed when high concentrations of 
scRad52 were used with ssOs.  This study proposed that the aggregation was mediated by 
the oligomerisation domain (within N-terminal domain) of Rad52.  These in vitro results 
mirror the in vivo results I observed with the SSA and ssGT assays and suggest that 
aggregation may also be taking place in vivo. It is possible that long ssDNA strands formed 
during end resection of SSA form aggregates with excess Rad52.  Under optimal 
physiological conditions, RPA would be expected to remove inhibitory secondary 
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structure from the long ssDNA, however, excess Rad52 might outcompete RPA for binding 
to the ssDNA, thus resulting in aggregation.  It would be interesting to repeat the ssGT 
experiment using long ssDNA or short ssOs to determine if ssDNA length affects ssGT in 
the presence of excess Rad52.   
 
Interestingly, the expression of the phosphorylation mutants had no observable effect on 
the SSA frequencies (Figure 7.4) in contrast to the inhibition observed with the other 
Rad52-related proteins.  There is evidence that phosphorylation of distinct sites in RPA 
and Rad51 (Chen, 1999; Deng, 2009; Wu, 2005; Yuan, 2003) also mediates foci formation 
of these proteins in response to a DSB.  These phosphorylation modifications may induce 
a conformational change, promoting interactions with ssDNA or other HR proteins (See 
Section 1.4.1 and 1.4.4).  Thus, if the phosphorylation of hRad52 plays similar roles to 
those observed in RPA and Rad51 it would follow that the mutations which mimic 
unphosphorylatable (or constitutively phosphorylated) hRad52 species may lock the 
protein in a specific conformation and increase (or decrease) its activity and affinity for a 
particular substrate.  Based on the inhibitions observed with hRad52* and (NLS)hRad52* 
in the SSA assay and the lack of effect with Y104E* or Y104F*, it appears that mutation of 
the phosphorylation site does affect the behaviour of hRad52 in the assay.  However, the 
mechanism for the change is unknown. 
 
These results taken together support the use of short oligonucleotides (e.g. 80mer) as a 
means of increasing ssGT (in combination with hRad52 overexpression) and suggest that 
phosphorylation of Y104 may affect the behaviour of hRad52 in the SSA assay. 
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Chapter 8 Final Discussion and Future Work 
8.1 Introduction 
The Rad52 protein is involved in mitotic HR and has been implicated in MMEJ.  Rad52 is 
involved in both Rad51-dependent (SI) and Rad51-independent (SSA) pathways of HR 
(Section 1.5).  The unique ability of Rad52 to act as a mediator between RPA and Rad51 in 
addition to catalysing strand annealing makes it an attractive candidate for studying HR.  
Indeed, knockouts, knockdowns and overexpression experiments have been used to 
investigate Rad52 in addition to the other proteins of HR (Sections 1.4.1, 1.4.3 and 1.4.4).  
Although knockouts and knockdowns have the potential to identify which processes are 
more dependent on a particular HR protein, or which processes are upregulated in its 
absence, overexpression has the potential to be used as a tool to increase the efficiency 
of HR as well as a method to study the mechanisms responsible for this increase.  
Overexpression of scRad52 was able to stimulate ECHR, ICHR and dsGT in mammalian 
host cells (Johnson, 1996; Kalvala, 2010) while hRad52 stimulated ssGT (Vangala, 2011 
unpublished) but in contrast inhibited dsGT (Kim, 2001; Yanez, 2002) and its effects on 
ECHR and ICHR were not tested in human cells.  The dsGT results obtained from hRad52 
overexpression demonstrated that excess hRad52 decreased the TI/RI ratio; this 
appeared to reflect a decrease in TI (although TI absolute values were not normalised in 
that study) suggesting a dominant-negative effect of excess hRad52 on TI (Yanez, 2002).  
Furthermore, that both scRad52 and the SSA bacteriophage protein Redβ stimulated 
dsGT in human cells led to the hypothesis that excess hRad52 is inhibitory to dsGT 
because it sequesters hRad51 and hRPA, whereas scRad52 and Redβ do not. Such 
sequestration would be expected to generate a dominant-negative effect on SI-mediated 
pathways.  It would thus follow that removal of these binding domains would not only 
relieve the inhibition of dsGT but also convert it into a stimulatory effect.  Moreover, any 
potential sequestration of hRad51 and hRPA by hRad52 would not be expected to affect 
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SSA-mediated pathways and thus the strand annealing activity of overexpressed hRad52 
would be expected to stimulate these pathways.   
8.2 Generation of Clones with Stable Expression of the Rad52-
Related Proteins 
The effects of hRad52 and scRad52 overexpression on HR have been studied to some 
degree, but the variability in the experimental conditions between these studies has 
made it difficult to draw conclusions regarding which HR assays are stimulated or 
inhibited, the magnitude of the stimulation or inhibition and to what extent the effect is 
dependent on the host cell used.  The Rht14-10 cell line was initially chosen to host stable 
expression because of its advantage of site-specific integration (ScIn system) of the 
Rad52-related transgenes (Chapter 3).  Had this system been successful, the effects of the 
Rad52-related proteins could have been directly compared and would have eliminated 
many of the inconsistencies of previous studies.  Disappointingly, the cellular levels of the 
Rad52-related proteins in the Rht14-10-Rad52-related clones were not comparable and, 
in some clones, the proteins were undetectable by immunoblot.  The reasons for the 
expression problems are unknown though the results suggest that loss of Rad52-related 
transgene expression occurred after the step of flp-mediated excision, which was 
designed to delete the ORF of the neomycin selection marker and bring the Rad52-related 
transgene under control of the TRP.  It is possible that low levels of Rad52-related protein 
were expressed even in the presence of tet which could have resulted in methylation of 
the TRP or transgene.  This could be tested using the demethylating agent 5-aza-2’-
deoxycytidine to determine if Rad52-related transgene expression could be stimulated.   
 
In light of the problems with the ScIn system, it was clear that an alternative expression 
system had to be selected.  Random integration of the Rad52-related transgenes into the 
Rht14 cell line would still have the advantage of generating pure populations of clones 
with similar and high overexpression levels of the Rad52-related proteins, although there 
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would also be the associated disadvantages of chromosomal position effects leading to 
variability between different clones and differences in expression levels.  Alternatively, 
with transient expression of the Rad52-related proteins there would be less variability 
between clones, although there would be greater variations in expression levels within a 
population of transiently transfected cells which would be less desirable for experiments 
requiring long exposure to the Rad52-related proteins (e.g. growth curves and cell 
viability).  In the end, stable Rht14-Rad52-related clones were generated using random 
integration of the transgenes.  I selected this approach in favour of transient expression 
(Chapter 4) because I felt that the ability to induce expression of the Rad52-related 
proteins prior to performing a particular experiment (i.e. dsGT and ssGT) would yield 
greater effects.  On the other hand, using transient expression, pTRE-Rad52-related 
expression constructs would be co-transfected with the dsGT HPRT targeting construct 
(Chapter 6) or ssGT repair ssO which would result in a delay of transgene expression and 
thus exposure time.  Although the Rad52-related expression constructs could have been 
transiently transfected 48hrs in advance of transfection with the targeting or ssO 
constructs, this was not selected as an alternative method to avoid subjecting the cells to 
consecutive transfections with little recovery time between transfections.  In retrospect 
however, transient expression avoided the problems associated with the different plating 
efficiencies between + and – tet cultures (Chapter 5).  In the one dsGT experiment with 
transient hRad52* expression, a 3-fold inhibition was achieved which was similar to the 
results obtained with the stable Rht14-hRad52 clone (Chapter 6).  In future, I believe 
more reliable results could be obtained using transient expression of the Rad52-related 
proteins in HR assays whereas studying the physiological effects (e.g. cell viability, 
apoptosis) of the Rad52-related  proteins would be more appropriate with stable clones.   
 
The nuclear distributions of the Rad52-related proteins (Chapter 4) were interesting 
because they suggested that different sections of the C-terminal region of hRad52 can 
mediate intranuclear localisation.  Full length hRad52-related proteins appeared to be 
excluded from the nucleoli, the regions of ribosomal RNA synthesis within the nucleus.  In 
contrast, the C-terminal truncation mutants appeared to be located predominantly in the 
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nucleoli while Δ290-330* and (NLS)scRad52* were found in both the nucleoli and 
nucleoplasm although there was a higher concentration of Δ290-330* in the nucleoli.  
That in G1, exogenous murine Rad52 in mouse cells is also located in the nucleoplasm and 
relocalises to the nucleoli in S phase (Liu, 1999) suggests that PTMs of murine Rad52, and 
thus possibly hRad52 and scRad52, can dictate the location of the protein. It is possible 
that Rad52 is relocalised to the nucleolus to prevent Rad52-mediated recombination in 
the nucleoplasm during DNA synthesis.  Evidence in yeast suggests that in response to 
DSB damage, only scRad52 involved in foci formation is excluded from the nucleolus to 
prevent Rad52-mediated hyperrecombination of the ribosomal DNA whereas free 
scRad52 can still be found within the nucleolus (Eckert-Boulet, 2009; Torres-Rosell, 2007).  
It would be interesting to synchronise the Rht14-Rad52-related clones in each phase of 
the cell cycle and, using immunofluorescence, to visualise whether the Rad52-related 
proteins co-localise with a nucleolar protein (e.g. nucleolin).  In addition, I would be 
curious to determine whether a correlation could be drawn between the effects on dsGT 
or ssGT and the intranuclear location of the Rad52-related proteins in S and G2 phases of 
the cell cycle.  As both (NLS)Δ284* and (NLS)Δ238* stimulate dsGT and also seem to be 
excluded from the nucleoplasm, in what is likely G1 phase, and conversely that hRad52* 
and Y104E* inhibit dsGT and are excluded from the nucleoli, it is not unreasonable to 
postulate that the localisation of the Rad52-related proteins may also be a factor in 
influencing the efficiency of HR.   
8.3 Characterisation of the Rad52-Related Clones 
Negative effects on viability 
There is evidence suggesting that the recombination activity of Rad52 is tightly controlled 
within the cell, likely to prevent inappropriate recombination.  In yeast, Rad51 attenuates 
the strand annealing activity of Rad52 in vitro (Wu, 2008) and as previously mentioned, 
upon DNA damage, Rad52 foci formation is inhibited in the nucleolus through 
sumoylation which prevents hyperrecombination and ribosomal DNA instability (Eckert-
Boulet, 2009).  Thus, it was perhaps unsurprising that overexpression of all of the hRad52-
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related proteins negatively affected growth rates and cell viabilities, presumably as a 
result of disrupting appropriate HR and causing genomic instability (Chapter 5).  Indeed, 
most cells exhibited visibly reduced levels of Rad52-related proteins after continuous 
induction over 14 days, which suggests that exposure to the Rad52-related proteins is 
harmful and cells in which there has been a loss of expression (e.g. by epigenetic 
silencing) are favoured.  Cell viability was affected by all Rad52-related proteins, with the 
exception of (NLS)scRad52*, and to investigate this further the effects of the Rad52-
related proteins on apoptosis could be tested by staining with Annexin V and PI followed 
by analysis by flow cytometry to reveal any changes in the proportions of live and dead 
cells.  The magnitude of growth and cell viability defects varied between the Rht14-
Rad52-related clones and it is unclear whether these differences can be attributed to the 
particular Rad52-related protein or random clonal differences.  To determine this, future 
experiments could include repeating the growth rate and cell viability experiments using 
pools of stable Rht14-Rad52-related clones.   
 
Cell cycle redistribution 
The changes in cell cycle distributions upon Rad52-related protein induction were 
disappointingly small (2-8%) (Chapter 5).  Previously, hRad52 was reported to increase the 
proportion of G1 cells by 15% (Yanez, 2002) and hRad51 induction to cause a 34% 
increase in the number of G2 cells (Flygare, 2001).  Although I did not observe similar 
changes with the Rad52-related proteins, the cell cycle analysis was only performed once 
and may require further optimisation.  It is possible that greater effects may be generated 
by increasing the length of Rad52-related protein induction to upwards of the 4 days I 
used.  In addition, using pools of stable Rht14-Rad52-related clones may also provide 
results with less variability than using individual Rht14-Rad52-related clones.  In addition, 
synchronising the cells (e.g. using α-factor) and monitoring their progression through the 
cell cycle following release may provide a clearer picture of the effects of Rad52-related 
protein overexpression on cell cycle progression.  
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Radiation-resistance 
The Rad52-related proteins did not enhance resistance to γ-irradiation, contrary to 
previous hRad52 and scRad52 overexpression studies (Di Primio, 2005; Park, 1995).  
Different experimental conditions (e.g. host cell line, expression level, etc) may account 
for this.  The failure of Rht14-Y104E and Rht14-Y104F to alter radiation resistance was 
perhaps the most surprising (Figure 5.6).  A previous study (Kitao, 2002) had 
demonstrated that the Y104F mutation diminished the number of hRad52 foci following 
exposure to γ-irradiation and thus I predicted that the Y104F protein would sensitise cells 
to DSB damage while the Y104E protein would confer resistance.  The irradiation 
experiments with Rht14-Y104E and Rht14-Y104F must be repeated, however, to confirm 
the observed results.  In addition, the number of DSB-induced foci of hRad52*, Y104E* 
and Y104F* can be analysed by immunofluorescence to determine whether mutation of 
Y104 alters the efficiency of foci formation in this system.  I made two attempts to 
visualise Y104E* and Y104F* foci which were unsuccessful and unfortunately I did not 
have enough time to optimise the experimental conditions further.  In the first instance, 
the primary and secondary antibody dilutions were too high and I could not see any foci 
as a result of the high background levels.  In the second instance, the radiation dose I 
selected was too high (10 Gy) making it difficult to count and discern differences in the 
number of foci.  Further optimisations will allow the importance of Y104 phosphorylation 
in focus formation to be addressed. 
8.4 Gene Targeting with Overexpressed Rad52-Related 
Proteins 
dsGT and ssGT assays were used to assess the practicality of using any of the Rad52-
related proteins to stimulate GT as well as to investigate the roles of the Rad52 domains 
in GT. That residues 331-418 of hRad52 were responsible for inhibiting dsGT by increasing 
RI was quite surprising (Chapter 6).  Given the apparent decrease in TI (Yanez, 2002) in 
hRad52 overexpressing cells, and the increase in hRad51 overexpressing cells (Yanez 
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1999), I had focused on the idea that excess hRad52 impaired dsGT by sequestering 
hRad51 and/or hRPA and so reducing TI.  Furthermore, dsGT was stimulated in the 
presence of the non-conserved Redβ protein (Xu, 2011 unpublished) and scRad52 (Di 
Primio, 2005; Kalvala, 2010), neither of which share homology with the regions of hRad52 
containing the hRad51 and hRPA binding domains.  Although unexpected and contrary to 
my initial hypothesis, it is exciting that my results have identified the presence of a novel 
and potential regulatory domain within residues 331-418 which has never been 
investigated by other groups.  It is possible, however, that these residues mediate 
functions which have been identified by other groups, such as the C-terminal self-
association domain (Ranatunga, 2001), which have yet to be finely mapped to a region of 
hRad52.  Nevertheless, my results suggest that residues 331-418 contribute to the 
function of hRad52 in vivo and demonstrate that this region deserves further study.  It 
was also surprising that the degree of Δ290-330* inhibition (5-fold) was greater than for 
hRad52* (2.5-fold), suggesting that the Rad51 binding domain limits dsGT inhibition in the 
presence of residues 331-418.  The inability of Δ290-330* to interact with hRad51 may 
augment the dominant negative effect generated by residues 331-418.  However, the 
differences may also be the result of clonal variation.  Repeating the dsGT assay using 
transient expression of Δ290-330* or hRad52 would provide a more meaningful 
comparison of the effects on dsGT.   
 
Future experiments could include expressing a Δ330-405 Rad52 variant, which would still 
contain the endogenous nuclear localisation signal but lack the majority of residues 331-
418.  Using transient expression of the Rad52-related proteins on various HR assays (i.e. 
dsGT, ssGT, ICHR), the Δ330-405 mutant could be compared to the Rad52-related 
proteins to determine which repair processes are affected by the deleted residues.  Pull 
down assays with a minimal hRad52 region containing 331-418 followed by mass 
spectrometry of the immunoprecipitated proteins may identify potential candidates 
which interact with residues 331-418 of hRad52.   
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Stimulation of ssGT by hRad52*, (NLS)Δ284* and (NLS)Δ238* was consistent with the 
hypothesis that the central and C-terminal regions of hRad52 are not required for the 
mechanisms responsible for ssGT (Chapter 7).  The effects were modest (up to 3-fold) but 
might be enhanced by optimising the experimental conditions, such as the DNA delivery 
method, or transient expression of the Rad52-related proteins to avoid the differences in 
plating efficiencies between + and – tet cultures.  The ssGT stimulations suggested that 
the presence of the N-terminal region of hRad52 alone could enhance ssGT.  
Unfortunately, due to time restraints, the ssGT experiments were not performed in 
triplicate and the mhprt minigene was not integrated into HPRT- Rht14-Δ290-330, Rht14-
Y104E or Rht14-Y104F* cells.  It would be interesting to observe whether ssGT would be 
similarly stimulated by Δ290-330* and whether the I-SceI induced DSB would affect the 
effects of Y104E* and Y104F* on ssGT.  
 
Because SSA is a candidate mechanism for ssGT, it was predicted that the results of the 
SSA assay using transient Rad52-related protein overexpression would be similar between 
the SSA and ssGT assays.  However, none of the Rad52-related proteins generated 
stimulatory effects in the SSA assay (Chapter 7).  One explanation is that SSA may not be 
involved in ssGT.  Alternatively, in the SSA assay, the ssDNA generated following end 
resection of the DSB may have precipitated upon interaction with excess Rad52-related 
protein resulting in an inhibition whereas the short ssOs (80nt) used in the ssGT assay did 
not precipitate (Song, 2000).  To determine whether SSA is involved in ssGT, future work 
could include knockdowns of proteins essential for SSA (e.g. ERCC1/XPF) and measuring 
the effects with a reporter assay able to measure and distinguish between both SSA and 
ssGT events.  
 
The truncation mutant (NLS)Δ238* is composed mainly of the catalytic strand annealing 
domain and ERCC1/XPF interaction domain which suggests that its ability to stimulate 
ssGT was dependent on one or both of those functions (or possibly an additional 
unknown function).  Although ERCC1/XPF is involved in both Rad51-dependent and 
Rad51-independent pathways, it seems unlikely that dsGT and ssGT use the same HR 
Chapter 8    Final Discussion and Future Work 
 
188 
 
pathway because hRad52* was able to stimulate ssGT despite inhibiting dsGT.  Hence it is 
logical to speculate that strand annealing is required for ssGT.  It could be argued, 
however, that the different targeting construct lengths (8.7kb – dsGT, 80nt – ssGT) were 
responsible for the different effects observed between the two GT assays and that in fact, 
both use the same mechanism.  Work in this lab using hRad52 overexpression 
demonstrated that with annealed ssOs (60bp) dsGT was inhibited while ssGT was 
stimulated with the ssOs (60nt) (Vangala, 2011 unpublished).  This result supports the 
hypothesis that dsGT and ssGT use different pathways 
8.5 Conclusions 
Overexpression of the Rad52-related proteins led to a number of conclusions regarding its 
potential use as a tool to increase GT and its role in HR.  These are summarised below: 
• Residues 331-418 of hRad52 are responsible for inhibiting cell viability, growth 
rate and dsGT, possibly as a result of generating a dominant negative effect. 
• The presence or absence of the hRad51 and hRPA binding domains do not appear 
to greatly affect dsGT or ssGT in contrast to residues 331-418.   
• dsGT and ssGT appear to be mediated by different mechanisms which is 
supported by the observation that residues 331-418 of hRad52 inhibit dsGT but do 
not inhibit ssGT.  
• Overexpressing truncated forms of hRad52 can serve as a useful tool for 
stimulating GT.  Further optimisation of the delivery method (e.g. using 
intranuclear permeabilisation sequences (Kalvala, 2010)) may generate even 
greater stimulations. 
 
Using overexpression as a method to understand the role of hRad52 in vivo provided 
evidence that excess levels of Rad52-related proteins containing residues 331-418 of 
hRad52 was detrimental to cell viability, perhaps as a result of causing genome instability.  
In addition, it implicated the activity of hRad52 in the mechanisms responsible for dsGT or 
ssGT.  However, similar to other investigative methods (e.g. knockouts, knockdowns) 
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overexpression has limitations and using multiple methods to investigate a mechanism 
should be used when possible.  Although the majority of the experiments must be 
repeated to obtain statistical significance, I believe my results have depicted Rad52 as a 
protein of interest that is important for maintaining the balance of HR as well as one that 
can stimulate GT.     
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Appendix 
Table A. Oligonucleotides used to amplify Rad52 transgenes for insertion into pINSneoMCS.  
Name Sequence Restr. site 
Tm 
(°C) 
a) Primer pair 
b) Rad52 Transgene 
Generated 
HA*-R52-F 5’-ATCGACTAGTATGTATGATGTTCCAGATTACGCTTCTTTG TCTGGGACTGAGGAAGCAATTCTT-3’ SpeI 68.2 -- 
Δ238-R 5’-CGATAGGCCTGTCCTGGTCCGCCGGTATC-3’ StuI 69.1 a) HA*-R52-F b) HA-Δ238 
Δ284-R 5’-CGATAGGCCTCTAAGCTGACGGCGTGGAGACTC-3’ StuI 69.6 a) HA*-R52-F b) HA-Δ284 
R52-R 5’-TTCTGGGCCCAGCCTCTG-3’ ApaI 69.3 a) HA*-R52-F b) HA-hRad52 
R52-HA*-R 5’-CGATAGGCCTCTACAAAGAAGCGTAATCTGGAACATCA TAAGATGGATCATATTTCCTTTTCTTCATG-3’ StuI 65.9 
a) R52-F 
b) hRad52-HA 
R52-F 5’-TCTTGGGACCTCCAAACTTATAGCG-3’ PpuMI 68.8 -- 
Δ238-HA*-R 5’-CGATAGGCCTCTACAAAGAAGCGTAATCTGGAACATCAT AGTCCTGGTCCGCCGGTATC-3’ StuI 69.2 
a) R52-F 
b) Δ238-HA 
Δ284-HA*-R 5’-CGATAGGCCTCTACAAAGAAGCGTAATCTGGAACATCAT AAGCTGACGGCGTGGAGACTC-3’ StuI 69.6 
a) R52-F 
b) Δ284-HA 
scR52-F 5’- CGATACTAGTATGAATGAAATTATGGATATGGATGA -3’ SpeI 68.6 a) scR52-HA*-R b) scRad52-HA 
scR52-HA*-
R 
5’- ATCTCGAGCTACAAAGAAGCGTAATCTGGAACATCATA 
AGTAGGCTTGCGTGCATGCAGG-3’ XhoI 86.8 
a) scR52-F 
b) scRad52-HA 
 
 
 
Table B. Oligonucleotides used for colony PCR. 
Name Sequence 
Tm  
(°C) 
Primer Pair 
O1 5’-TTTAGTGAACCGTCAGATCGCC-3’ 67.4 O2 or O3 
O2 5’-GGACAAAGACTACCTGAG-3’ 52.3 O1 
O3 5’-CCAAAGATAAAGCCTTGGAC-3’ 60.5 O1 
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Table B. Oligonucleotides used to amplify Rad52 transgenes for insertion into pTRE-Tight and to generate 
pTRE-derived plasmids through site-directed mutagenesis. 
Name Sequence Restr. site 
Tm 
(°C) 
a) Primer pair 
b) Rad52 
Transgene/Plasmid 
Generated 
Rad52F 5’-TGACGCGGCCGCAACATGTCTGGGACTGAGGAAGCA-3’ NotI 66.4 -- 
NLS-Rad52F 5’-TGACGCGGCCGCAACATGCCAAAAAAAAAACGAAAAG TAGAATCTGGGACTGAGGAAGCAATT-3’ NotI 60.0 -- 
Rad52R-HA 5’-GCTAGTCGACTTACGCATAGTCAGGAACATCGTATGGGT AAGATGGATCATATTTCCTTTTCTTCATG-3’ SalI 65.9 
a) Rad52F 
b) hRad52-HA 
a) NLS-Rad52F 
b) (NLS)hRad52-HA 
Rad52 
Δ238R-HA 
5’-GCTAGTCGACTTACGCATAGTCAGGAACATCGTATGGGT 
AGTCCTGGTCCGCCGGTATCA-3’ SalI 71.7 
a) Rad52F 
b) Δ238-HA 
a) NLS-Rad52F 
b) (NLS)Δ238-HA 
Rad52 
Δ284R-HA 
5’-GCTAGTCGACTTACGCATAGTCAGGAACATCGTATGGGT 
AAGCTGACGGCGTGGAGACTC-3’ SalI 69.6 
a) Rad52F 
b) Δ284-HA 
a) NLS-Rad52F 
b) (NLS)Δ284-HA 
fl-scRad52F 5’-TGACGCGGCCGCAACATGGCGTTTTTAAGCTATTTTGCC-3’ NotI 66.7 
a) scRad52R-HA 
b) scRad52-HA 
NLS-fl-
scRad52F 
5’-TGACGCGGCCGCAACATGCCAAAAAAAAAACGAAAAGT 
AGAAGCGTTTTTAAGCTATTTTGCCACT-3’ NotI 65.2 
a) scRad52R-HA 
b) (NLS)scRad52-HA 
scRad52R-
HA 
5’-GCTAGTCGACTTACGCATAGTCAGGAACATCGTATGGGT 
AAGTAGGCTTGCGTGCATGCAG-3’ SalI 69.9 
a) fl-scRad52F 
b) scRad52-HA 
a) NLS-flscRad52F 
b) (NLS)scRad52-HA 
del.NLS-F 5’- TATGATCCATCTTACCCATACGATGTTC-3’ -- 67.3 a) del.NLS-R b) pTRE-Δ405-414 
del.NLS-R 5’- ATGAGATTCCCAGTTTCCTGTTGTG-3’ -- 68.2 a) del.NLS-F b) pTRE- Δ405-414 
Y104E Fwd 5’-GAGGTGGGAGTCTGTGCATTTGTGA-3’ -- 67.7 a) Y104E/F Rev b) pTRE-Y104E 
Y104E/F Rev 5’-GAACTTGCCATTGTTGAGGTCAAC-3’ -- 67.8 
a) Y104E Fwd 
b) pTRE-Y104E 
a) Y104F Fwd 
b) pTRE-Y104F 
Y104F Fwd 5’-TTCGTGGGAGTCTGTGCATTTGTGA-3’ -- 67.7 a) Y104E/F Rev b) pTRE-Y104F 
del Rad51 
330 Fwd 5’-AAGTGGGCTGTGACTCCCG-3’ -- 68 
a) del Rad51 290 
Rev 
b) pTRE-Δ290-330 
del Rad51 
290 Rev 5’-TGCCTCACTCTTCTCAGCTGACG-3’ -- 70.5 
a) del Rad51 330 
Fwd 
b) pTRE-Δ290-330 
 
